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i 
Abstract 
 
Body Dysmorphic Disorder (BDD) is a psychological disorder characterized by the 
persistent preoccupation with one or more perceived defects in physical appearance that 
are not observable or appear slight to others (American Psychiatric Association [APA], 
2013), which is currently included into the “Obsessive-Compulsive and Related 
Disorders” category of the Diagnostic and Statistical Manual of Mental Disorders-Fifth 
Edition (DSM-5; APA, 2013). Although any body part can be the focus of concerns, the 
most common areas of concern in people with BDD are the skin (presence of acne or 
scars), the hair (hair loss, thinning, or excessive facial or body hair), and the nose (shape 
or size; Phillips 2006; Phillips & Diaz 1997; Phillips, McElroy, Keck, Pope, & Hudson, 
1993; Veale et al., 1996), and individuals with BDD may be concerned with multiple 
body parts at the same time (Phillips et al., 1993; 2005). In response to the appearance 
concerns, individuals with BDD engage in repetitive and time-consuming behaviors and 
mental actions focused on examining, being reassured about, and hiding perceived 
defects (Phillips & Diaz, 1997; Phillips, Menard, Fay, & Weisberg, 2005). The most 
common are: camouflaging (e.g., with hair, makeup, body position, or sunglasses), 
checking the perceived defect in mirrors or other reflecting surfaces (e.g., windows), 
excessively grooming (e.g., applying makeup or styling hair), seeking reassurance from 
family and friends about the defect, repeatedly touching the disliked areas, and 
comparing one’s appearance with that of other people (Phillips, 2009; Phillips & Diaz, 
1997; Phillips et al., 2005; Veale & Riley, 2001). Behaviors are unlimited (Phillips, 
1998) and can include seeking plastic surgery or cosmetic medical treatments in order to 
reduce the perceived defects (Crerand, Phillips, Menard, & Fay, 2005; Phillips, Grant, 
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Siniscalchi, & Albertini, 2001); these procedures, however, are not beneficial (Crerand 
et al., 2005; Phillips et al., 2001) and do not typically result in a decrease of BDD 
symptoms severity (Crerand et al., 2005; Phillips et al., 1993; Phillips et al., 2001). 
Rather, some patients with BDD experience symptoms exacerbation and development 
of new appearance concerns (Crerand et al., 2005; Phillips et al., 2001; Veale, 2000; 
Veale et al., 1996). In addition to core concerns about appearance, BDD is characterized 
by low self-esteem, high perfectionism, and high comorbidity rate (Phillips, 2006; 
Phillips et al., 1993; Phillips et al., 2005). The most common associated disorders are: 
Major Depressive Disorder (MDD), Social Anxiety Disorder (SAD), Obsessive 
Compulsive Disorder (OCD), and Anorexia Nervosa (AN; Dingemans, van Rood, de 
Groot, & van Furth, 2012; Grant, Kim, & Eckert, 2002; Gunstad & Phillips, 2003). 
Despite increased awareness of BDD in recent years, it continues to be an under-studied 
disorder (Buhlmann & Winter, 2011; Buhlmann et al., 2010), particularly in the Italian 
context. Indeed, little is known about BDD prevalence and phenomenology in Italy, and 
no data are available on BDD prevalence rates using DSM-5 criteria (APA, 2013) in the 
Italian general population. Therefore, the current dissertation aimed at assessing BDD 
prevalence, phenomenology, associated clinical features, and at risk populations through 
three studies.  
The first study aimed at exploring the prevalence and the phenomenology of BDD in an 
Italian community sample and its associated clinical features such as self-esteem, 
perfectionistic traits, social anxiety, depressive, and obsessive-compulsive symptoms. 
Six hundred and fifteen community individuals completed a battery of self-report 
questionnaires assessing the above-mentioned clinical features. Results showed that 10 
(1.63%) individuals met DSM-5 criteria (APA, 2013) for BDD. Hair (n = 4; 4%), nose 
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(n = 4; 4%), and teeth (n = 4; 4%) were the most common areas of concern. With 
respect to the associated clinical features, individuals who satisfied BDD diagnostic 
criteria reported lower levels of self-esteem, more severe social anxiety 
symptomatology, general distress, depression, and obsessive-compulsive features than 
people without BDD. These findings outlined that, within the Italian context, BDD is a 
relatively common psychological disorder associated with significant morbidity. 
The second study of the current dissertation focused on the shared clinical features 
between BDD and AN. Indeed, both the psychopathologies are severe body image 
disorders (Rosen, Reiter, & Orosan, 1995) characterized by body image disturbance and 
dissatisfaction, intrusive thoughts about appearance, and by an overemphasis on 
appearance in the evaluation of self-worth (Rosen & Ramirez, 1998). Furthermore, both 
BDD and AN are characterized by low self-esteem (Phillips, Pinto, & Jain, 2004; Rosen 
& Ramirez, 1998) and high levels of perfectionism (Bardone-Cone et al., 2007; 
Buhlmann, Etcoff, & Wilhelm, 2008; Bulik et al., 2003; Veale, 2004). Many studies 
underlined the high comorbidity between BDD and AN (Dingemans et al., 2012; 
Fenwick & Sullivan, 2011; Grant et al., 2002; Kollei, Schieber, Zwaan, Svitak, & 
Martin, 2013; Ruffolo, Phillips, Menard, Fay, & Weisberg, 2006), and patients with AN 
frequently report nonweight-related body image concerns (Dingemans et al., 2012; 
Grant et al., 2002; Kollei et al., 2013). Furthermore, patients with AN and comorbid 
BDD report greater body image dissatisfaction and clinical symptomatology than those 
without comorbid BDD (Dingemans et al., 2012; Grant et al., 2002). Therefore, the first 
aim of this study was to assess the prevalence of BDD and the presence of nonweight-
related body image concerns in patients with AN. Secondly, the study aimed at 
comparing patients with AN and nonweight-related body image concerns, patients with 
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weight-related body image concerns only and a healthy control group with respect to 
body image and psychological and psychopathological features. For these purposes, 61 
patients with AN were divided in two groups: 39 with nonweight-related body image 
concerns and 22 with weight-related body image concerns only. Furthermore, a group 
of 61 healthy controls was recruited. Main results of this study showed that 16 (26.23%) 
patients with AN had probable comorbid BDD. The most common nonweight-related 
body image concerns were: hair (41.02%), nose (30.77%), skin (30.77%), teeth 
(25.64%), and height (20.51%). Moreover, patients with AN and nonweight-related 
body image concerns reported greater levels of psychopathology not related to eating 
disorder than patients with weight-related body image concerns only, in accordance 
with previous studies (Dingemans et al., 2012; Grant et al., 2002). In conclusion, 
patients with AN and nonweight-related body image concerns showed a more severe 
body image disturbance unrelated to a more severe eating disorder. 
Lastly, the third study of the current dissertation aimed at assessing the prevalence of 
Muscle Dysmorphia (MD), its associated psychological features and possible predictors 
among 3 groups (N = 125) of Italian recreational athletes. MD is a subtype of BDD 
characterized by the preoccupation with the idea that one’s body is not sufficiently lean 
and muscular (APA, 2013; Pope, Gruber, Choi, Olivardia, & Phillips, 1997); however, 
individuals with MD have a normal-looking body or are even very muscular, much 
more than the average of people (Pope et al., 1997). The first aim of this study was to 
explore the prevalence and the phenomenology of MD in 3 groups of Italian participants 
who trained regularly for recreational purposes: 42 bodybuilders, 61 strength trainers, 
and 22 fitness wellness trainers. Secondly, we aimed at investigating MD related 
behaviours and psychological features such as self-esteem, perfectionistic traits, social 
 
 
v 
anxiety and orthorexia nervosa symptoms, and general distress among groups. Lastly, 
we aimed at assessing the presence of associations between MD and related 
psychological features among the 3 groups and, with exploratory purposes, possible MD 
predictors among groups. Results revealed a MD prevalence of 6.4%: 4 participants 
(9.52%) in the bodybuilding group, 2 participants (3.28%) in the strength group, and 2 
participants (9.09%) in the fitness/wellness group satisfied Pope et al. (1997) diagnostic 
criteria for MD. With respect to MD associated cognitive and behavioural symptoms, 
the bodybuilding group reported more frequently to think about taking anabolic-
androgenic steroids (AAS), to assume more than 2 daily grams of proteins, and to 
experience more beliefs about being smaller and weaker than desired or wishes to be 
more muscular than the other groups, whereas this group reported more MD general 
symptomatology only with respect to the fitness/wellness group. Moreover, the strength 
group reported to set higher standards for themselves than the other two groups. Finally, 
different correlational patterns among group emerged, as well as different MD 
predictors. Specifically, social anxiety symptoms resulted significant predictors of MD 
symptomatology for both the bodybuilding and the strength group, whereas no 
predictors emerged for the fitness/wellness group. In conclusion, results of this study 
underlined that the pursuit of a lean and muscular physique in bodybuilding is not 
always associated with MD and related psychological features. 
To conclude, this dissertation provides clinical hints as far as concern both preventive 
strategies and psychological treatment implications for BDD across at risk populations. 
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Part I- Literature review 
 
 
 
 
 
 
1 
Chapter 1 
Body Dysmorphic Disorder 
 
1.1 Description and diagnostic criteria of Body Dysmorphic Disorder 
Body Dysmorphic Disorder (BDD) is a psychological disorder characterized by the 
persistent preoccupation with one or more perceived defects in physical appearance that 
are not observable or appear slight to others (American Psychiatric Association [APA], 
2013). BDD was described for the first time in 1886 by Morselli (Phillips, 1991); the 
psychiatrist described patients who were obsessed about their ugliness even though their 
physical appearance was objectively normal (Allen & Hollander, 2000; Phillips, 1991). 
Morselli defined such condition “dysmorphophobia”, a term coming from the word 
dysmorphia, which refers to “ugliness” (Phillips, 1991). A century after its first 
description, this condition was introduced in the third edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-III; APA, 1980) and categorized as an 
atypical somatoform disorder until the 1987; indeed it was recognized as a distinct 
disorder and relabeled as BDD in the third revised edition of the DSM (DSM-III-TR; 
APA, 1987). Given that the presence of defects in physical appearance was the focus of 
concern, BDD was categorized as a somatoform disorder within the DSM-III-TR (1987); 
however, in light of the low comorbidity with others somatoform disorders and the 
shared clinical features with the obsessive-compulsive disorder (OCD), new theories 
about its classification were formulated (Neziroglu & Yaryura-Tobias, 1993; Phillips, 
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1998; Phillips & Diaz, 1997; Phillips, McElroy, Hudson, & Pope, 1995). Indeed, both 
BDD and OCD are characterized by persistent and recurrent obsessions and 
compulsions (Hollander, Neville, Frenkel, Josephson, & Liebowitz, 1992), and the 
relation between thoughts and behaviors in BDD appears similar to the relation between 
obsessions and compulsions in OCD (Bjornsson, Didie, & Phillips, 2010; Phillips, 2009; 
Phillips & Kaye, 2007). Compulsive behaviors arise in response to obsessive thoughts 
about appearance and they are meant to reduce anxiety (Phillips & Kaye, 2007). 
Moreover, the comorbidity between BDD and OCD is high (Brawman-Mintzer et al., 
1995; Hollander, Cohen, & Simeon, 1993), and many studies have reported similar 
gender ratio, onset, and course of illness for these disorders (Phillips, 1991). These 
evidences led to a new classification of BDD, which is currently included into the 
“Obsessive-Compulsive and Related Disorders” category of the DSM-5 (APA, 2013) 
along with DOC, trichotillomania, hoarding disorder, and excoriation disorder.  
The diagnostic criteria for BDD are the following (APA, 2013): 
A. Preoccupation with one or more perceived defects or flaws in physical 
appearance that are not observable or appear slight to others.  
B. At some point during the course of the disorder, the individual has performed 
repetitive behaviors (e.g., mirror checking, excessive grooming, skin picking, 
reassurance seeking) or mental acts (e.g., comparing his or her appearance with 
that of others) in response to the appearance concerns.  
C. The preoccupation causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
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D. The appearance preoccupation is not better explained by concerns with body fat 
or weight in an individual whose symptoms meet diagnostic criteria for an 
eating disorder.  
Specify if:  
With muscle dysmorphia: The individual is preoccupied with the idea that his or 
her body build is too small or insufficiently muscular. This specifier is used even 
if the individual is preoccupied with other body areas, which is often the case.  
Specify if: 
Indicate degree of insight regarding body dysmorphic disorder beliefs (e.g., “I 
look ugly” or “I look deformed”).  
With good or fair insight: The individual recognizes that the body dysmorphic 
disorder beliefs are definitely or probably not true or that they may or may not 
be true.  
With poor insight: The individual thinks that the body dysmorphic disorder 
beliefs are probably true.  
With absent insight/delusional beliefs: The individual is completely convinced 
that the body dysmorphic disorder beliefs are true.  
Individuals with BDD are concerned about the presence of one or more physical flaws 
that are not observable or appear slight to others (Criterion A). The most common areas 
of concern are the skin (e.g., scarring, acne, color), hair (e.g., going bald, excessive 
facial or body hair), and the nose (e.g., size or shape), although any body part can be the 
focus of concern (Phillips 2006; Phillips & Diaz 1997; Phillips, McElroy, Keck, Pope, 
& Hudson, 1993; Veale, Boocock et al., 1996). Concerns about appearance are intrusive, 
time-consuming, and usually difficult to resist or control (APA, 2013).  
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Repetitive behaviors or mental acts are performed in response to the appearance 
concerns (Criterion B) in order to reduce anxiety. Common behaviors are: checking 
perceived defects in mirrors or other reflecting surfaces; excessive grooming (e.g., 
combing, styling, shaving, plucking); camouflaging (e.g., covering disliked areas with 
clothing or makeup); seeking reassurance about the look of perceived flaws; and 
seeking cosmetic procedures (APA, 2013; Hollander et al., 1993; Phillips et al., 1993; 
Schieber, Kollei, De Zwaan & Martin, 2015). The most common mental act is to 
compare one’s appearance with that of other individuals (APA, 2013; Neziroglu, 
Khemlani-Patel, & Veale, 2008; Phillips, Menard, Fay, & Weisberg, 2005). Criterion B 
was introduced in the DSM-5 (APA, 2013) in order to underline the shared features 
between BDD and OCD (Phillips et al., 2010). 
The preoccupation must cause significant distress or impairment in social, occupational, 
or other important areas of functioning (Criterion C). BDD has a devastating impact on 
a patient’s life, with hours being consumed by worry and efforts to camouflage the 
perceived defects (Allen & Hollander, 2000). As a result, patients with BDD are 
frequently unable to work, attend school or have relationships (Didie, Menard, Stern, & 
Phillips, 2008; Phillips, 2009).   
The preoccupation is not better explained by concerns with body fat or weight in 
individuals whose symptoms meet diagnostic criteria for an eating disorder (ED; 
Criterion D). In particular, Criterion D indicates that a diagnosis of BDD cannot be 
provided if appearance concerns are better explained by concerns with body fat or 
weight in individuals whose symptoms meet diagnostic criteria for EDs (APA, 2013). 
However, the comorbidity of BDD and EDs is high (Dingemans, van Rood, de Groot, & 
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van Furth, 2012; Fenwick & Sullivan, 2011; Grant, Kim, & Eckert, 2002; Kollei, 
Schieber, Zwaan, Svitak, & Martin, 2013; Ruffolo, Phillips, Menard, Fay, & Weisberg, 
2006) and, in case of comorbidity, both disorders should be diagnosed (Ruffulo et al., 
2006).  
Finally, the DSM-5 criteria (APA, 2013) ask to specify the presence of Muscle 
Dysmorphia (MD) and the degree of insight. MD is a form of BDD characterized by 
concerns about the idea that one's body is too small or insufficiently muscular (Pope, 
Gruber, Choi, Olivardia, & Phillips, 1997). MD occurs almost exclusively in males, and 
individuals with this form of BDD actually have a normal-looking body or are even 
very muscular (Pope et al., 1997). As a result, individuals with MD may neglect 
important social or occupational activities because of the shame or the need to attend 
rigid diet and time-consuming workout (Olivardia, Pope, & Hudson, 2000; Phillips, 
O’Sullivan, & Pope, 1997; Pope et al., 1997). A majority of individuals with MD lift 
weights and work out excessively, sometimes causing body damage (Pope, Phillips, & 
Olivardia, 2000). People with MD can also use anabolic-androgenic steroids (AAS) in 
an attempt to make their body bigger and more muscular (Olivardia, 2001; Pope et al., 
2000).  
With respect to the degree of insight, it can range from good to absent; on average, 
insight in BDD is poor (Phillips, Menard, Pagano, Fay, & Stout, 2006). In other words, 
patients with BDD are convinced that their beliefs about appearance are accurate 
(Phillips, 2006). Moreover, patients with BDD are usually characterized by fluctuations 
in insight; they can be completely convinced about their ugliness at some times but not 
convinced in other moment (Phillips, 2005). Studies comparing patients suffering from 
delusional and nondelusional BDD have shown more similarities than differences 
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between these two groups; the primary differences were related to symptoms severity 
and suicidal attempts (APA, 2013; Mancuso, Knoesen, & Castle, 2010; Phillips, 
Menard, Pagano et al., 2006). Indeed, patients with delusional beliefs showed more 
severe BDD symptoms and were more prone to attempt suicide than patients with 
nondelusional BDD beliefs (Phillips, Menard, Pagano et al., 2006). Overall, delusional 
and nondelusional BDD may be considered presentations of the same disorder (Phillips, 
Menard, Pagano et al., 2006).  
1.1.1 BDD by proxy 
BDD by proxy (BDDBP) is a form of BDD in which the primary preoccupation 
involves perceived defects of another person who looks normal. Individuals with 
BDDBP are preoccupied with defects that they perceive in another person’s appearance 
(APA, 2013; Bouman & Gofers, 2016; Greenberg et al., 2013). Therefore, the most 
salient discriminating feature between BDD and BDDBP is the focus of the 
preoccupation (oneself defects in BDD and another person’s defects in BDDBP; 
Greenberg et al., 2013). BDDBP shares core phenomenological features with BDD, 
including the body parts focus of concerns (frequently skin and hair as in BDD), rituals, 
and avoidance behaviors; indeed, individuals with BDDBP engage in comparing, 
scrutinizing, and checking the other person’s appearance, and most of them try to 
persuade the "person of concern" to perform excessive grooming, changing clothing, 
and camouflaging (Greenberg et al., 2013). The aim of these behaviors is to make the 
other person improving or beautifying his/her appearance in a way that matches the 
patient’s desired image. Individuals with BDDBP may put a lot of pressure on the other 
person to conceal, inspect, or modify his/her perceived appearance flaws, or to seek 
medical consultations (e. g. with cosmetic surgeons and dermatologists; Greenberg et al., 
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2013; Phillips, 2005); individuals with BDDBP may also insist that their loved one get 
unnecessary cosmetic surgery (Phillips, 2009).  
 
1.2 Phenomenology 
Individuals with BDD are concerned about the idea that some aspects of their 
appearance look defective, abnormal, or "not right" in some way (Phillips, 1998; 1999); 
they frequently describe their body areas focus of concern as unattractive and ugly or 
even disfigured and deformed (Phillips, 2004; 2005). Patients with BDD (approximately 
2/3 of patients) “imagine” defects in the sense that they are concerned with something 
that other people do not perceive at all; therefore, the body areas focus of concern look 
normal to other people (Phillips, 2009). Sometimes, patients with BDD (approximately 
1/3) may have a slight defect but they are excessively concerned with it and consider it 
ugly and clearly visible to others (Phillips, 2005). Therefore, individuals with BDD 
have a problem with their body image (i.e., with how they view their physical 
appearance) and not with how they actually look (Phillips, 2009). 
Any body part can be the focus of concern, and frequently individuals with BDD may 
be concerned with multiple body parts at the same time (on average, with about five or 
six different body areas; Phillips et al., 1993; Phillips, Menard et al., 2005); these areas 
may also shift over time (Phillips & Diaz, 1997; Phillips, Menard et al., 2005). The 
perceived defects may be specific, such as a big nose, or general, such as being ugly 
(Veale, Boocock, et al., 1996). The most commonly areas focus of concern involve the 
face or hair, most often the skin (skin flaws, scars, blemishes, pallor, wrinkles and acne) 
or nose (Allen & Hollander, 2000; Phillips et al., 1993; Veale, Boocock, et al., 1996). 
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The majority of individuals with BDD have ideas of reference, believing that other 
people notice their perceived defects, react to such defects with disgust, and may 
humiliate them as a consequence of their ugliness (Phillips, McElroy, Keck, Pope, & 
Hudson, 1993). As a result, individuals with BDD limit social interactions and think 
about their perceived defects several hours each day (on average, 3-8 hours per day; 
Phillips, 1998). The obsessive thoughts about defects are distressing and associated with 
rejection sensitivity, low self-esteem, feelings of unworthiness and with anxiety and 
depression (Phillips, 2009; Rosen & Ramirez, 1998). In response to obsessive thoughts 
about appearance, individuals with BDD engage in repetitive and time-consuming 
behaviors linked to their appearance preoccupations and focused on examining, being 
reassured about, and hiding perceived defects (Phillips & Diaz, 1997; Phillips, Menard 
et al., 2005). Most of these behaviors (e. g. mirror checking and reassurance seeking) 
are considered compulsive because patients feel driven to perform them and find them 
hard to resist or control (Phillips, 2006; Phillips, Gunderson, Mallya, McElroy, & Carter, 
1998). Other behaviors (e.g. camouflaging) may be defined as safety behaviors because 
they are performed in order to prevent something bad from happening, such as being 
humiliated or embarrassed by others (Phillips, 2009; Veale, 2004). Therefore, patients 
with BDD perform multiple compulsive and safety behaviors in order to reduce anxiety 
and other unpleasant emotions (Phillips & Diaz, 1997; Phillips & Kaye, 2007; Phillips, 
Menard et al., 2005); nevertheless, such behaviors usually increase anxiety and 
dysphoria (Neziroglu et al., 2008). The most common are: camouflaging (e. g., with hair, 
makeup, body position, or sunglasses), checking the perceived defects in mirrors or 
other reflecting surfaces (e. g., windows), excessively grooming (e. g., applying makeup 
or styling hair), seeking reassurance from family and friends about the defects and 
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repeatedly touching disliked areas (Phillips, 2009; Phillips & Diaz, 1997; Phillips, 
Menard et al., 2005; Veale & Riley, 2001; Veale, Boocock, et al., 1996). Moreover, 
patients with BDD may pick the skin in an attempt to improve defects; these behaviors, 
however, may cause damage such as skin infections (Grant, Menard, & Phillips, 2006; 
O'Sullivan, Phillips, Keuthen, & Wilhelm, 1999; Phillips & Taub, 1995). Behaviors are 
unlimited (Phillips, 1998) and can include seeking plastic surgery or cosmetic medical 
treatments in order to reduce the perceived defects (Crerand, Phillips, Menard, & Fay, 
2005; Phillips, Grant, Siniscalchi, & Albertini, 2001); these procedures, however, are 
not beneficial (Crerand et al., 2005; Phillips et al., 2001). Individuals with BDD may 
also engage in mental actions such as comparing one’s appearance with that of other 
people (Phillips, 2009; Phillips & Diaz, 1997; Phillips, Menard et al., 2005; Veale & 
Riley, 2001): they report to spend a lot of time comparing their body area of concern to 
the same area in other people. This mental act happens quite automatically, and can 
cause anxiety and difficulty to concentrate (Bjornsson et al., 2010).  
Avoidance is another common behavior in BDD, and patients often engage in avoidance 
strategies in order to gain relief from BDD-related anxiety and distress (Kelly, Walters, 
& Phillips, 2010; Pinto & Phillips, 2005). For example, patients with BDD can avoid 
social situations because of the fear of being negatively judged by others as a 
consequence of their ugliness (Kelly et al., 2010). Avoidance, as well as compulsions, 
contributes to the chronicity and severity of BDD (Phillips, 2009; Veale, 2004). 
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1.3 Epidemiology and gender differences 
Although BDD is thought to be a relatively common disorder (Crerand et al., 2005; 
Phillips et al., 2001; Veale, 2000; Veale, Boocock, et al., 1996), few prevalence studies 
exist, and prevalence rates appear to vary widely; this may be due to methodological 
differences between studies and by some limitations characterizing them (e.g., non-
representative populations, different inclusion/exclusion criteria, and small sample 
sizes). Moreover, patients with BDD are secretive about their symptoms and reluctant to 
seek psychiatric treatment (Neziroglu & Yaryura-Tobias, 1993; Phillips, 1991) because 
they are afraid of drawing attention on their perceived defect or to appear vain (Fang & 
Wilhelm, 2015). As a consequence, they may not report BDD symptoms to clinicians 
(Bjornsson et al., 2010; Marques, Weingarden, LeBlanc, & Wilhelm, 2011); thus, BDD 
goes unrecognized and under-diagnosed (Bjornsson et al., 2010; Grant, Kim, & Crow, 
2001; Marques et al., 2011; Phillips, 1998).  
International studies based on general population reported prevalence rates ranging from 
0.7% to 2.9% (Brohede, Wingren, Wijma, & Wijma, 2015; Buhlmann et al., 2010; 
Faravelli et al., 1997; Koran, Abujaoude, Large, & Serpe, 2008; Otto, Wilhelm, Cohen, 
& Harlow, 2001; Rief, Buhlmann, Wilhelm, Borkenhagen, & Brähler 2006; Schieber et 
al., 2015), and a recent review published by Veale, Gledhill, Christodoulou, & Hodsoll 
(2016) found an overall weighted prevalence of 1.9% in the community. In each studies 
both males and females were included, and the prevalence of BDD was found to be 
higher among females (2.1%) than males (1.6%), with a gender ratio of 1.27 (Veale et 
al., 2016). As far as concern nonclinical student samples, the prevalence of BDD ranges 
from 1.2% to 13% (Bartsch, 2007; Biby, 1998; Bohne, Whilelm et al., 2002; Boroughs, 
Krawczyk, & Thompson, 2010; Cansever, Uzun, Dönmez, & Özşahin 2003; Liao et al., 
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2010; Sarwer et al., 2005; Taqui et al., 2008), whereas the overall weighted prevalence 
was 3.3%, with higher prevalence among females (3.6%) than males (2.2%) and a 
gender ratio of 1.64 (Veale et al., 2016). Given that patients with BDD frequently seek 
for cosmetic procedures (e.g. rhinoplasty, jaw surgery, collagen injections, and tooth 
whitening) in order to fix the perceived defects (Crerand et al., 2005; Crerand, Franklin, 
& Sarwer, 2006), many studies focused on BDD prevalence in cosmetic settings and 
found a wide range prevalence (from 6.3% to 53%; Altamura, Paluello, Mundo, Medda, 
& Mannu, 2001; Bellino et al., 2006; Dey et al., 2015; Pavan et al., 2006; Veale et al., 
2014). In contrast with prevalence studies conducted on general and student populations, 
the prevalence of BDD in cosmetic settings is higher among males (15.3%) than 
females (10.9%), with a gender ratio of 0.71 (Veale et al., 2016). Focusing on specific 
cosmetic surgery, rhinoplastry is the surgical procedure with the highest prevalence rate 
of BDD, with rates ranging from 1.8% (Picavet et al., 2013) to 31.5% (Fathololoomi, 
Goljanian, Fattahi, Noohi, & Makhdoom, 2013), and a weighted prevalence of 20.1%. 
Within rhinoplastry settings, the prevalence of BDD is slightly higher among males 
(18.4%) than females (16.7%), with a gender ratio of 0.91 (Veale et al., 2016). Within 
dermatological settings the prevalence of BBD is high as well, with prevalence rates 
ranging from 4.2% (Dogruk Kacar et al., 2014) to 29.4% (Hsu, Ali Juma, & Goh, 2009), 
and a weighted prevalence of 11.3% (13.4% in females and 14.0% in males, with a 
gender ratio of 0.96; Veale et al., 2016).  
With respect to gender prevalence, as reported, prevalence rates depend on the setting, 
with general and student populations studies reporting a slightly higher prevalence 
among females, whereas the opposite pattern has emerged in cosmetic settings (Veale et 
al., 2016). With respect to differences related to areas of concern, two studies 
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underlined that women were more likely to be concerned with skin, stomach, weight, 
breasts/chest, buttocks, legs, hips, and excessive body/facial hair than men (Phillips & 
Diaz, 1997; Phillips, Menard & Fay, 2006); moreover, women were excessively 
concerned with multiple body areas at the same time (Phillips & Diaz, 1997; Phillips, 
Menard & Fay, 2006). Women also performed more repetitive and safety behaviors 
compared to men (Phillips & Diaz, 1997; Phillips, Menard & Fay, 2006). In contrast, 
men were more likely to be concerned about their genitals, body build, and thinning 
hair/balding, and to engage in weight-lifting behaviors. With respect to comorbidity, 
women were more likely to suffer from an ED, whereas substance use disorder was 
more frequent in men (Phillips & Diaz, 1997; Phillips, Menard & Fay, 2006). The 
above mentioned gender differences reflect common concerns in our culture, suggesting 
that cultural norms and values may influence the content and the expression of BDD 
symptoms (Phillips & Diaz, 1997).  
No gender differences has been reported in relation to age of onset; BDD usually begins 
during adolescence, with a mean age of onset of 16 years old (Coles et al., 2006) and a 
modal age of onset of 12-13 years old (Bjornsson et al., 2013). BDD may also be 
present in children; in these cases, symptoms consist in refusing to attend school and 
planning suicide (Albertini & Phillips, 1999). Early onset is associated with greater 
comorbidity (frequently anorexia nervosa [AN] or bulimia nervosa [BN]), and with a 
lifetime history of attempted suicide (Bjornsson et al., 2013). In both genders BDD 
presents a chronic and unremitting course, unless it is treated (Phillips & Diaz, 1997; 
Phillips, Menard, et al., 2005), with a low probability (20%) of full remission and high 
probability (42%) of relapse (Phillips, Menard, Quinn, Didie, & Stout, 2013). More 
severe BDD symptoms at pre-treatment, longer duration of BDD, and presence of one 
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or more comorbid personality disorders are relevant factors involved in BDD chronic 
course (Phillips, Pagano, Menard, Fay, & Stout, 2005).  
 
1.4 Cosmetic procedures in BDD 
Individuals with BDD frequently seek and receive cosmetic procedures and other 
related treatments to fix the perceived defects (Phillips et al., 2001); this means that, due 
to their poor insight (Phillips, Menard, Pagano et al., 2006), individuals with BDD seek 
cosmetic treatments for a psychological problem (Crerand et al., 2005; Phillips et al., 
1993; Phillips, Dufresne, Wilkel, & Vittorio, 2000; Phillips et al., 2001; Sarwer, 
Wadden, Pertschuk, & Whitaker 1998; Uzun et al. 2003; Veale, Boocock et al., 1996). 
As mentioned above, a number of studies underlined the high prevalence of BDD in 
cosmetic settings (Aouizerate et al., 2003; Bellino et al., 2006; Castle, Molton, Hoffman, 
Preston, & Phillips, 2004; Dufresne, Phillips, Vittorio, & Wilkel, 2001; Ishigooka et al., 
1998; Sarwer et al., 1998); dermatologists and plastic surgeons are the professionals 
most often consulted, even if any type of physician may be involved (e.g., 
endocrinologists to evaluate the excessive body hair or ophthalmologists to correct 
cross-eyed; Phillips, 1998). The most common cosmetic procedures required by patients 
with BDD are rhinoplasty, liposuction, and breast augmentation among surgical 
procedures; collagen injections and microdermabrasion among minimally invasive 
cosmetic procedures; and topical acne agents and hair treatment among dermatological 
treatments (Crerand et al., 2005). Despite the huge request of cosmetic treatments, 
several studies indicated that appearance-enhancing treatments do not typically result in 
a decrease of BDD symptoms severity (Crerand et al., 2005; Phillips et al., 1993; 
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Phillips et al., 2001). Rather, individuals with BDD are often dissatisfied with the 
results of cosmetic treatments, and some patients experience symptoms exacerbation 
and development of new appearance concerns (Crerand et al., 2005; Phillips et al., 2001; 
Veale, 2000; Veale et al., 1996). Given that BDD is a psychological condition, the area 
focus of concern may change over time, and this may explain why, after cosmetic 
surgery, the patient’s focus of concern may shift to another body area (Veale, 2004). 
With respect to the small number of patients who reported improvement in perceived 
defects, some became anxious about how long the improvement would last (Crerand et 
al., 2005). Another issue is that patients with BDD can threaten or execute lawsuits 
against surgeons because of the dissatisfaction with their operations (Leonardo, 2001; 
Sarwer, 2002; Yazel, 1999); indeed, patients with BDD can feel angry with the surgeon 
for having make their appearance worse (Leonardo, 2001; Sarwer, 2002; Yazel, 1998) 
and may become violent (Phillips et al., 2001): indeed, several patients with BDD report 
fantasies about physically harming their surgeons (Phillips et al., 2001). The 
dissatisfaction related to the cosmetic procedures may also exasperate compulsive 
behaviours and the craving for more surgery (Phillips, 1998). In particular, Fukuda 
(1977) referred to patients with BDD as “polysurgery addicts”. Is not uncommon that 
patients with BDD, when refused by a surgeon or when unable to afford a cosmetic 
treatment, engage in “Do It Yourself” (“DIY”) surgery (Veale, 2000).“DIY” surgery is 
performed in order to alter dramatically one’s physical appearance trying to achieve an 
unrealistic ideal by one’s own hands (Veale, 2000). Therefore, “DIY” surgery is viewed 
as an extreme safety-seeking behaviour (Veale, 2000). Examples of “DIY” surgery 
described by Veale (2000) are: using a pair of pliers in an attempt to make the nose 
thinner, filed down teeth in order to alter the appearance of jaw-line, and use sandpaper 
 
 
15 
as a form of dermabrasion to remove scars and lighten the skin. Therefore, “DIY” 
surgery can be very extreme and dangerous for patients.   
Because of the legal and personal safety issues associated with treating individuals with 
BDD and in light of the evidence that cosmetic treatments rarely improve BDD 
symptoms, there is growing consensus that BDD should be considered a 
contraindication for cosmetic treatments (Cotterill, 1996; Crerand et al., 2006; 
Honigman, Phillips, & Castle, 2004; Phillips, et al., 2001; Sarwer, 2002; Veale et al., 
1996). Given that patients with BDD frequently seek cosmetic procedures, a 
psychological assessment is highly recommended for all patients requiring cosmetic 
procedures before undergoing treatment (Crerand et al., 2006); this assessment should 
avail of interviews and self-report questionnaires asking for the presence of BDD 
symptoms and cosmetic treatment-related expectations (Crerand et al., 2006). Many 
patients with BDD, indeed, have unrealistic expectations and believe that cosmetic 
treatments would change and improve their life (e. g. help them to obtain a new job or a 
partner; Veale, 2000).   
 
1.5 Risky behaviours and quality of life in BDD 
Suicidal ideation and attempts appear common in patients with BDD (Phillips, 1991; 
Phillips & Diaz, 1997; Phillips et al., 1993; Veale et al., 1996). Approximately the 80% 
of patients with BDD report past or current suicidal ideation, and about one quarter have 
attempted suicide due to BDD symptoms (Perugi et al., 1997). With respect to death by 
suicide, the study of Phillips and Menard (2006) documented 0.3% cases per year, a rate 
45 times higher than the rate observed in the general population. Such an elevated rate 
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can be explained by BDD suicide risk factors, which include: high rates of psychiatric 
hospitalization; unemployment; being single or divorced; poor social supports; poor 
self-esteem; high levels of anxiety and depression; and feelings of shame and 
humiliation (Phillips, 2009; Phillips, Coles, et al., 2005). Therefore, patients with BDD 
must be carefully monitored for suicidality (Wilhelm, Phillips, & Steketee, 2013). 
Approximately one third of patients with BDD show violent behaviors due to BDD 
symptoms (Phillips, 2009; Perugi et al., 1997). Violent behaviors may be elicited by 
anger about looking “deformed”, inability to fix the defects, delusions of reference, 
feeling rejected by others because of the defects, and dissatisfaction with cosmetic 
procedures (Bjornsson et al., 2010; Leonardo, 2001; Sarwer, 2002; Yazel, 1999). 
Another concern is the use of alcohol or illegal substances in social situations in order to 
endure such situations (Veale & Neziroglu, 2010). 
Although the level of functioning of patients with BDD varies, BDD nearly always 
causes marked functional impairment (Perugi et al., 1997; Phillips, 1991; Phillips et al., 
1993). Most of the patients have impaired academic, occupational, or role functioning 
(such as being a parent) because of BDD obsessions and behaviors, that can diminish 
concentration and productivity (Phillips, 2009). Indeed, BDD can have a devastating 
impact on the patient’s life with a number of hours per day consumed by worry, rituals, 
and efforts to camouflage (Allen & Hollander, 2000). As a consequence, patients 
frequently drop out of school or stop working (Phillips, 2009). A study by Phillips 
(2004) has shown that nearly the 30% of the patients with BDD had been completely 
housebound for at least one week, more than half had been psychiatrically hospitalized, 
and more than two thirds had experienced suicidal ideation due to BDD. Individuals 
with BDD also have markedly impaired psychosocial functioning. They may have few 
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or no friends, and may avoid situations such as dating, intimacy, and other social 
interactions that may expose or exacerbate the perceived defect or in which they feel 
particularly self-conscious about their appearance (Phillips, 1991). As a consequence, 
patients with BDD withdraw from interactions with others and have poor social lives, as 
well as social, school, and occupational performance (Allen & Hollander, 2000). 
Consequently, individuals with BDD usually report higher levels of perceived distress 
(Cotterill & Cunliffe, 1997; DeMarco, Li, Phillips, & McElroy, 1998) and markedly 
poorer quality of life than general population (Phillips, Quinn, & Stout, 2008). 
Moreover, patients with BDD appear to have poorer quality of life than either patients 
with major depression and dysthymia or patients with a medical condition such as type 
II diabetes or heart attack (Phillips et al., 2008). 
 
1.6 Differential diagnosis and comorbidity 
As reported above, BDD is usually missed or misdiagnosed as another disorder (Phillips, 
2005; Phillips et al., 1993; Phillips, Nierenberg, Brendel, & Fava, 1996; Zimmerman & 
Mattia, 1998). A guiding principle for making a differential diagnosis of BDD is to 
assess whether the problem is due to one’s perceived appearance defects (Fang & 
Wilhelm, 2015). Perhaps, the most important factor to consider in differential diagnosis 
is distinguishing BDD from normal concerns about appearance, given that the majority 
of the people are dissatisfied in some way with their appearances (Fitts, Gibson, 
Redding, & Deiter, 1989). Individuals with BDD are not only dissatisfied with some 
aspects of their appearance; rather, they are concerned about how they look (Phillips, 
2005). Their concerns about appearance cause them extreme distress and functional 
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impairment and can lead to avoidance of many aspects of their life and to suicide 
attempts (Phillips et al., 2005). Moreover, patients with BDD describe this intense 
preoccupation as painful and tormenting (Allen & Hollander, 2000; Phillips, 2005). 
Therefore, BDD consists in an extreme body image distortion and dissatisfaction (Allen 
& Hollander, 2000), different from normal concerns about appearance. 
Although BDD is often comorbid and share clinical features with other disorders such 
as Obsessive Compulsive Disorder (OCD), Major Depressive Disorder (MDD), Social 
Anxiety Disorder (SAD), and Anorexia Nervosa (AN; Gunstand & Phillips, 2003), it 
appears to be distinct from them (Phillips & Stout, 2006). Comorbidity is the rule, rather 
than the exception, in BDD (Gunstand & Phillips, 2003; Phillips, 2006; Phillips et al., 
1993; Phillips et al., 2005), and the majority, and perhaps nearly all, patients with BDD 
have at least one comorbid condition (Hollander et al., 1993; Perugi et al., 1997; 
Phillips & Diaz, 1997). For example, the study of Zimmerman and Mattia (1998) found 
that patients with BDD were more likely than other psychiatric outpatients to have three 
or more comorbid axis I disorders. In one of the largest comorbidity studies (n = 293) 
conducted in the US, the disorders most commonly associated with BDD were MDD 
(76%), SAD (37%), and OCD (32%; Gunstad & Phillips, 2003). Furthermore, many 
studies reported high comorbidity and shared clinical features with AN (Dingemans et 
al., 2012; Fenwick & Sullivan, 2011; Grant et al., 2002; Kollei et al., 2013; Ruffolo et 
al., 2006).  
1.6.1 BDD and MDD 
Both BDD and MDD are disorders characterized by feelings of low self-esteem, shame, 
guilt, and unworthiness (Phillips, 1999; 2009; Phillips, Pinto, & Jain, 2004). 
 
 
19 
Furthermore, BDD and MDD share symptoms such as avoidance of social activities and 
being withdrawn (Veale & Neziroglu, 2010). Supporting the observed similarities, BDD 
and MDD are frequently comorbid; the study of Gustand and Phillips (2003) found, in a 
sample of patients with BDD, a current prevalence of 58% and a lifetime prevalence of 
76% for MDD, and MDD was more than twice as common as any other Axis I disorder. 
Literature suggests that the onset of MDD most often occurs after the onset of BDD, 
consistently with clinical impressions that depression is often secondary to BDD 
(Phillips, 2005). In patients with MDD (especially the atypical subtype), a high lifetime 
prevalence of BDD ranging from 8% to 42% (Nierenberg et al., 2002; Perugi et al., 
1997) has been observed. In this regard, the study of Phillips and Stout (2006) 
highlighted that improvements in BDD and MDD were closely linked in time, with 
significant associations in both directions: improvement in MDD predicted BDD 
remission, and improvement in BDD predicted MDD remission. 
Although the shared features and the high comorbidity between BDD and MDD support 
the existence of an association between these disorders, important differences exist, 
suggesting that BDD is not simply a symptom of depression (Phillips, 1999). A notable 
difference is the presence of prominent obsessional preoccupations and repetitive 
compulsive behaviors related to appearance concerns in BDD (Phillips, 1991; 2006). On 
the contrary, patients with MDD do not perform time-consuming, repetitive, and 
compulsive behaviors (Phillips, 1991; 2006), and frequently neglect how they look 
rather than becoming obsessed about their appearance as patients with BDD. Additional 
differences include an earlier age of onset and more chronic illness in patients with 
BDD than patients with MDD (Phillips, 1991; 2006).  
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1.6.2 BDD and SAD 
Many studies documented a strong link between BDD and SAD in terms of 
demographic and clinical characteristics, course and onset, and treatment outcomes 
(Fang & Hofmann, 2010; Kelly et al., 2010). Specifically, BDD and SAD share similar 
gender ratio, onset in early adolescence, a chronic course, and common clinical features 
such as poor insight and risk for suicidal behaviors (Coles et al., 2006; Fang & 
Hofmann, 2010; Pinto & Phillips, 2005). BDD and SAD also share a bias for 
information processing, because in both disorders ambiguous social situations are 
interpreted in negative ways (Amin, Foa, & Coles, 1998; Buhlmann, McNally, Wilhelm, 
& Florin, 2002). Furthermore, either patients suffering from BDD and patients suffering 
from SAD appear to benefit from the same treatments: Cognitive Behavior Therapy 
(CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs; Heimberg et al., 1998; 
Pinto & Phillips, 2005; Veale, Gournay, et al., 1996). Etiological models of BDD 
(Neziroglu et al., 2008; Veale, 2004; Veale & Gilbert, 2014) also show strong 
theoretical overlap with models of SAD (Clark & Wells, 1995; Rapee & Heimberg, 
1997). For example, cognitive-behavioral models of BDD emphasize that the 
dysfunctional cognitive processes (such as self-focused attention and negative 
appraisals of body image processes) and maladaptive behaviors (such as compulsive 
and safety behaviors) that maintain BDD are consistent with processes that are proposed 
to maintain SAD (Fang, Sawyer, Aderka, & Hofmann, 2013; Hofmann, 2007; Rapee & 
Heimberg, 1997). In both BDD and SAD, the mental representation of the self (as an 
aesthetic object in BDD and as a social object in SAD) might be generated from both 
internal (e.g., physical symptoms) and external environmental (e.g., facial expressions) 
cues (Clark & Wells, 1995; Hofmann, 2007; Rapee & Heimberg, 1997; Veale, 2004). 
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As a consequence, concerns about defects in physical appearance in BDD may be 
associated with the fear of negative evaluation by others, which is also the core feature 
of SAD (Fang & Hofmann, 2010). Indeed, both BDD and SAD are characterized by 
fear of negative evaluation in social situations (Buhlmann et al., 2002; Pinto & Phillips, 
2005), avoidance of social interactions (Phillips & Diaz, 1997), as well as fear of 
embarrassment and social rejection (Wilhelm, Otto, Zucker, & Pollack, 1997). Given 
the above-mentioned similarities, BDD and SAD are commonly comorbid. In patients 
with SAD, BDD current prevalence ranges from 5% to 12% (Brawman-Mintzer et al., 
1995; Wilhelm et al., 1997); in patients with BDD the current prevalence of SAD 
ranges from 31% to 34.3% (Coles et al., 2006; Gunstad & Phillips, 2003; Phillips & 
Stout, 2006), and the lifetime prevalence ranges from 12% to 69% (Gunstad & Phillips, 
2003; Hollander et al., 1993; Phillips & Diaz, 1997; Phillips et al., 2005; Veale et al., 
1996; Zimmerman & Mattia, 1998).  
Despite the several similarities, BDD and SAD are distinct disorders. The reasons of 
concerns are different: patients with BDD are concerned about their perceived defects 
and, as a consequence, fear negative evaluation by others; patients with SAD are 
concerned about being negatively evaluated in social situations (Chosak et al., 2008; 
Moutier & Stein, 1999). Moreover, compulsive behaviors aimed at hiding, improving, 
or checking perceived defects are a prominent feature of BDD and not a diagnostic 
feature of SAD (Phillips, 2009). Understanding whether the fear of being negatively 
evaluated by others is specifically due to one’s appearance rather than representing a 
more general concern about being embarrassed in social situations is the main issue to 
be taken into account for differential diagnosis (Fang & Wilhelm, 2015). 
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1.6.3 BDD and OCD 
BDD and OCD are related conditions presenting similar phenomenological features 
(Phillips et al., 2007; 2010). These disorders are both characterized by persistent and 
intrusive preoccupations that are obsessional in nature, accompanied by 
repetitive/ritualistic behaviors and, sometimes, by a desire to have things “just right” 
(Phillips et al., 1998). For example, individuals with BDD experience recurrent and 
intrusive preoccupations about their perceived physical defects, which are similar to the 
obsessions experienced by patients with OCD, followed by ritualistic behaviors (e.g. 
mirror checking and reassurance seeking; Phillips et al., 1993; Veale & Riley, 2001) 
that are similar to compulsions of OCD (Buhlmann et al., 2002; Perugi et al., 1997; 
Phillips et al., 1993). The similarity of BDD and OCD is also supported by comparable 
descriptive characteristics such as early onset, chronic course (Phillips, 1996; Phillips et 
al., 2007) and treatment response profiles (CBT and SSRIs; Hollander et al., 1999; 
McKay, Neziroglu, & Yaryura-Tobias, 1997; Neziroglu & Yaryura-Tobias, 1993; 
Phillips, 1998; Phillips, Kim, & Hudson, 1995; Veale, Gournay et al., 1996). In addition, 
symmetry concerns, perfectionism, and avoidance are observed in both patients with 
BDD and patients with OCD (Nakata et al., 2007; Phillips et al., 2007). Supporting the 
observed similarities, a number of studies have reported elevated comorbidity rates 
between BDD and OCD (Gunstad & Phillips, 2003); the current prevalence of BDD in 
patients with OCD ranges from 3.8% to 15.3% (mean = 9%; Brakoulias & Starcevic, 
2011; Brawman-Mintzer et al., 1995; Stewart, Egan Stack, & Wilhelm, 2008), whereas 
the lifetime prevalence ranges from 3% to 16% (mean =10.4%; Bienvenu et al., 2000; 
Bienvenu et al., 2012; Costa et al., 2012; Jaisoorya, Reddy, & Srinath, 2003; Lochner & 
Stein, 2010; Phillips et al., 1998; Simeon, Hollander, Stein, Cohen, & Aronowitz, 1995; 
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Wilhelm et al., 1997). On the other hand, the current prevalence of OCD in patients 
with BDD ranges from 16.7% to 37% (mean = 25.7%; Gunstad & Phillips, 2003; 
Hollander et al., 1999; Zimmerman & Mattia, 1998), whereas the lifetime prevalence 
ranges from 14% to 43% (mean =27.5%; Altamura et al., 2001; Gunstad & Phillips, 
2003). 
Despite the above-mentioned similarities, BDD and OCD present also significant 
clinical differences (Frare, Perugi, Ruffolo, & Toni, 2004). Unlike compulsions in OCD, 
BDD rituals are performed in order to hide, improve, or check the perceived defects 
(Fang & Wilhelm, 2015): a diagnosis of BDD should be given if a patient’s obsession is 
focused on appearance (Allen & Hollander, 2000). Moreover, patients with BDD have 
poorer insight and greater delusional endorsement (Labuschagne, Castle, Dunai, Kyrios, 
& Rossell, 2010) than patients with OCD (Frare et al., 2004; Phillips, McElroy et al., 
1995), and are more likely than patients with OCD to present lifetime suicidal ideation, 
lifetime MDD and lifetime Substance Use Disorder (SUD; Phillips et al., 2007).  
1.6.4 BDD and AN 
BDD and AN are both severe body image disorders (Rosen, Reiter, & Orosan, 1995) 
characterized by body image disturbance and dissatisfaction and by an overemphasis on 
appearance in the evaluation of self-worth (Rosen & Ramirez, 1998). Both disorders 
involve intrusive thoughts about appearance and are characterized by repetitive 
checking behaviors (e.g. mirror checking) and avoidance (e.g.. places, activities, and 
ways of dressing that might provoke self-consciousness about appearance; Phillips, Kim 
et al., 1995; Rosen & Ramirez, 1998). BDD and AN share common descriptive 
characteristics, such as early age of onset and chronic course, as well as personality 
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dimensions such as high harm avoidance, neuroticism, perfectionism, and low self- 
directedness (Hartmann, Greenberg, & Wilhelm, 2013). Furthermore, body image 
disturbance appears to be a crucial factor involved in both the disorders (Hartmann et al., 
2013; Hrabosky et al., 2009; Kollei et al., 2013). With respect to comorbidity, the 
current prevalence of BDD in patients with AN ranges from 9.8% to 46% (Digenmans 
et al., 2012; Grant et al., 2002; Gupta & Johnson, 2000; Fenwick & Sullivan, 2011; 
Kollei et al., 2013), with a lifetime prevalence of 15.7% (Kollei et al., 2013). 
Concerning the prevalence of AN in patients with BDD, the study of Ruffolo and 
colleagues (2006) reported a current prevalence of 2% and a lifetime prevalence of 9%.  
Despite BDD and AN have similarities as well as many areas of overlap, they also have 
important differences. Important differences regard, for example, demographic features: 
the 90% of patients with AN are females, whereas BDD is characterized by a more 
balanced gender ratio (Hartmann et al., 2013). Furthermore, patients with AN and 
patients with BDD differ with respect to reasons of concern about appearance: indeed, 
while individuals with AN are concerned about being too fat despite they are 
dangerously underweight, patients with BDD have appearance concerns with regard to 
their face, skin, or other specific body areas frequently unrelated to weight (Hartmann et 
al., 2013). Therefore differential diagnosis can be made, in the first place, by assessing 
the areas of concern and the presence of an eating pathology, which is more atypical in 
BDD (Fang & Wilhelm, 2015).  
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1.7 Etiology 
The etiology of BDD is multifactorial and several key factors involved in its 
development have been identified: the disorder is the manifestation of multiple 
biological, psychological, and sociocultural factors playing a role in its etiology 
(Wilhelm, 2006). These factors probably interact in a complex way to produce BDD, 
and no one alone is sufficient to produce the disorder. First, genetic predisposition, 
neuroanatomical differences, and neurotransmitters alterations can contribute to the 
development of BDD. Furthermore, psychological factors such as early life experiences 
(e.g. teasing or bullying) and personality traits (e.g. perfectionism and aesthetic 
sensitivity) might also facilitate its development (Weiffenbach & Kundu, 2015). Lastly, 
society and media could be further crucial contributors (Phillips, 2009). 
1.7.1 Biological factors 
Genetics 
Genetic factors play an important role in the etiology of BDD, as evidenced by its 
pattern of heritability (Bienvenu et al., 2000). The eight percent of individuals with 
BDD have a family member with a lifetime diagnosis of BDD, which is 4 to 8 times the 
prevalence of BDD in the general population (Feusner, Yaryura-Tobias, & Saxena, 
2008). The disorder is not caused by one single gene: many different genes act together 
to increase the chance of getting BDD (Phillips, 2009). Nonetheless, a preliminary 
genetic study has found that the gamma-aminobutyric acid (GABA) A-γ2 gene was 
more common in people with BDD than in those without BDD (Phillips et al., 2015). 
 
 
 
26 
Neuroanatomy 
A complex interplay of dysfunctions in several neural regions and systems of the brain 
is involved in BDD (Phillips, 2009). Brain imaging studies have suggested that BDD 
may be characterized by an impairment of the frontal-striatal and temporo-parietal-
occipital circuits which process facial images and emotional information. A preliminary 
volumetric magnetic resonance imaging (MRI) study found leftward shift in caudate 
volume asymmetry and greater total white matter volume in eight women with BDD 
than in eight female controls (Rauch et al., 2003). A functional imaging study of 
patients with BDD, using single photon emission computed tomography (SPECT), 
showed relative perfusion deficits in bilateral anterior-medial temporal and occipital 
regions and asymmetric perfusion in parietal lobes in individuals with BDD (Carey, 
Seedat, Warwick, van Heerden, & Stein, 2004). A functional imaging study compared 
patients with BDD to healthy controls in the visual information processing of faces 
(Feusner, Townsend, Bystritsky, & Bookheimer, 2007). Patients with BDD and healthy 
controls underwent functional magnetic resonance imaging (fMRI) while matching 
photographs of faces. Participants with BDD showed greater left hemisphere activity in 
the lateral prefrontal cortex and lateral temporal lobe than healthy controls; these areas 
are specialized for detail-focused visual processing and greater left-sided activity 
suggests a predominance of detail encoding and analysis (Feusner et al., 2007). These 
laterality patterns in participants with BDD suggest a bias for local, or detail-oriented, 
processing of faces than healthy controls. Another finding emerged in the group with 
BDD was an abnormal activation of the amigdala. The results of this fMRI study 
suggested that participants with BDD present differences from healthy controls in visual 
processing, with different laterality of activation patterns in areas representing an 
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extended visual processing network and abnormal amigdala activation (Feusner et al., 
2007). 
Neurotransmitters 
Several studies have investigated the role of serotonin (5-HT) in BDD and found that 
individuals with BDD may have an imbalance in the brain chemical serotonin (Barr, 
Goodman, & Price, 1992; Marazziti et al., 1999; Phillips, 2009). Marazziti and 
colleagues (1999) studied platelet 5-HT transporter binding density in patients with 
BDD and found significantly lower platelet 5-HT transporter binding density in 
individuals with BDD than healthy controls. Additional indirect evidence of the 
involvement of serotonergic transmission in BDD comes from several open and 
controlled treatment studies that demonstrated that high-dose SSRIs (Phillips & Najjar, 
2003; Phillips, Albertini, & Rasmussen, 2002) are effective for treating BDD. 
1.7.2 Psychological 
Early life experiences 
Extensive research has shown that childhood experiences may increase the risk of 
developing BDD (Phillips, 2009). The importance placed on physical appearance by 
family may increase the chance to develop BDD because the child learns that physical 
appearance is very important and to associate physical attractiveness with being 
desirable or successful, or with getting attention or other rewards for being pretty or 
cute (Phillips, 2009). Appearance-based teasing during childhood may be another risk 
factor for BDD (Feusner, Neziroglu, Wilhelm, Mancusi, & Bohon, 2010). Appearance-
based teasing may have a long-term impact on an individual; once the negative 
association is made between one’s appearance features and others’ reactions, everyday 
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interactions and experiences may continue to imprint these thoughts and emotions, 
which may be theorized to contribute to symptoms of BDD (Wilhelm, 2006). Two 
studies have demonstrated that individuals with BDD retrospectively reported greater 
appearance-based teasing during childhood than healthy controls (Buhlmann, Cook, 
Fama, & Wilhelm, 2007). Trauma, abuse, and neglect may also represent possible risk 
factors for BDD. One study found that 38% of individuals with BDD reported some 
form of abuse during childhood (e.g. emotional abuse, sexual abuse, physical abuse; 
Neziroglu, Khemlani-Patel, & Yaryura-Tobias, 2006). Consistently, another study 
observed that the 78.7% of individuals with BDD reported a history of childhood 
maltreatment (e.g. emotional neglect, emotional abuse, physical abuse, physical neglect, 
and sexual abuse; Didie et al., 2006).  
Personality traits 
Specific personality traits may represent potential risk factors for BDD. Specifically, 
perfectionism and aesthetic sensitivity are considered vulnerability factors for BDD 
(Veale, 2004; Wilhelm, 2006). Research suggests that individuals with BDD often 
display perfectionistic thinking, including distorted beliefs about attractiveness 
(Buhlmann, Etcoff, & Wilhelm, 2008; Schieber, Kollei, de Zwaan, Müller, & Martin, 
2013; Veale, Boocock et al., 1996). Perfectionism might increase selective attention to 
slight appearance defects and determine preoccupation and dissatisfaction thus leading 
to bad feelings and distress; therefore, individuals with BDD are unable to tolerate their 
imperfections (Wilhelm, 2006). Perfectionism may also increase BDD symptoms given 
the typical discrepancy in patients with BDD between their actual self and their ideal 
self (how they think they actually look and how they ideally would like to look; Veale, 
Kinderman, Riley, & Lambrou, 2003).  
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In addition to perfectionism, Veale (2004) considers aesthetic sensitivity as a specific 
risk factor for BDD. Aesthetic sensitivity is based on Harris’ concept of “aestheticality” 
(Harris, 1982) and refers to awareness and appreciation of beauty and harmony (Veale 
& Neziroglu, 2010). The sense of “aestheticality” is inborn and varies among 
individuals; therefore, individuals differ in their view of beauty due to variability in the 
aesthetic sensitivity. Individuals with a high sense of aestheticality are more self-
conscious of abnormalities of appearance (Harris, 1982), which can lead to feelings of 
irritation and, by focusing on these symptoms, even BDD. Individuals with BDD 
overemphasize the importance of appearance and aesthetic, are aesthetically sensitive, 
demonstrate great aesthetical skills and set high aesthetic standards (Veale & Lambrou, 
2002). Furthermore, they view themselves as an aesthetics object (Veale & Riley, 2001). 
1.7.3 Sociocultural 
Society’s messages about the importance of appearance may contribute to the 
development of BDD (Phillips, 2009). Constantly, the media reinforce the importance 
of appearance and, at the same time, create unrealistic expectations about beauty (Veale 
& Neziroglu, 2010). As a result, about a quarter of people with BDD declared that the 
society’s focus on appearance is one of the major reasons of their BDD symptoms 
(Phillips, 2009). Therefore, the media may enforce unrealistic beauty expectations and 
lead to the maintenance of BDD. However, sociocultural and media pressures are 
unlikely to be the only cause for BDD; BDD has been described since the 1800s, long 
before the media and advertising (Phillips, 2009). In addition, BDD occurs in societies 
where the media are less powerful or even absent (Phillips, 2005).  
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1.7.4 Cognitive-behavioral models of BDD 
Cognitive-behavioral models of BDD incorporate biological, psychological, and 
sociocultural factors in the development and maintenance of BDD (Neziroglu et al., 
2008; Neziroglu, Roberts, & Yaryura-Tobias, 2004; Veale, 2004). Although the models 
of Veale (2004) and Neziroglu et al. (2008) are specific for BDD, they include many 
elements of Cash’s (2002, 2008) model of body image disturbance. 
Veale’s cognitive-behavioral model (2004) 
The model of BDD proposed by Veale (2004) focuses on the experience of patients 
when they are alone. Veale (2004) claimed that the cycle begins when an external 
representation of the individual’s physical appearance (e.g. looking in a mirror or 
looking at an old photograph) or an intrusive thought activates a distorted mental image. 
The external representation or the intrusive thought may trigger a process of self-
focused attention with the outcome of “self as an aesthetic object”. Therefore, 
individuals with BDD view themselves as an aesthetic object. The self-focused attention 
increases awareness of the image and of specific features and body parts; the image is 
used to construct how the person looks and provides information about how the person 
appears to others from an observer perspective (Osman, Cooper, Hackmann, & Veale, 
2004). An observer perspective consists of the individual looking at himself or herself 
from another person’s perspective; patients with BDD may use the observer perspective 
in order to avoid emotions associated with negative evaluative experiences (as a sort of 
“detachment” strategy). Therefore, the observer perspective may become a maintaining 
factor given that it allows avoiding negative emotions. The process of selective attention 
appears to be focused on specific features and body parts, leading to a heightened 
 
 
31 
awareness and amplification of given features, which contribute to the development of a 
distorted body image. The next step is the negative appraisal and aesthetic judgment of 
the image, by activation of assumptions and values about the importance of physical 
appearance. In individuals with BDD, appearance is over-identified with the self and at 
the centre of a “personal domain” (Veale, 2002). At the centre of a personal domain 
there are a person’s characteristics, her/his physical attributes, her/his goals and values. 
The idealized value in BDD is the importance of physical appearance but other values 
may include perfectionism, symmetry or youth; such values reinforce the view of 
herself/himself as an aesthetic object. The model predicts that the activation of the 
negative appraisals have a negative feedback and increase self-focused attention on the 
image and body parts. This leads to a negative aesthetic appraisal and comparisons of 
three different images: the external representation (mirror or photograph), the ideal body 
image, and the distorted body image. These repeated comparisons have a negative 
feedback and increase negative appraisals and self-focused attention on the image 
leaving the patient uncertain about his or her appearance, which encourages further 
mirror gazing. The patient’s desire to see exactly how he or she looks is only rewarded 
by looking in the mirror. However, the longer the person looks, the worse he or she 
feels and the more the belief of ugliness and defect is reinforced.   
Emotions in BDD are based on the appraisal of the situation. The most common 
emotions are shame (or self-disgust) when individuals compare and rank their 
appearance as lower than others; external shame and anticipatory social anxiety based 
on judgments about how others are likely to humiliate or reject them; depression and 
hopelessness due to the failure to reach the aesthetic standard; anger and frustration at 
oneself for damaging his or her appearance (e.g. skin-picking, cosmetic surgery) and 
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because others do not understand their concerns; guilt at damaging one’s appearance 
either by oneself or seeking cosmetic surgery. Increases in emotional arousal increase 
the frequency or severity of negative appraisals of one’s body image and increase self-
focused attention in a negative feedback loop. Safety behaviors are performed to reduce 
the risk of danger aiming at damage-limiting self-presentations (Gilbert, 2000).  
The model also claims the existence of another important negative feedback loop: safety 
behaviors may briefly decrease distress but are counter-productive and increase self-
awareness, preoccupation, and negative appraisal. Furthermore, safety behaviors 
involve mental efforts which means less attention for external information; often lead to 
further monitoring (e.g. mirror checking to determine if the camouflage is “working”); 
may make one’s appearance worse; and increase attention by others to one’s 
appearance. 
Neziroglu et al. (2008)’s model 
Neziroglu et al. (2008)’s model emphasizes evaluative (classical) and operant 
conditioning in the development and maintenance of BDD. According to Neziroglu et al. 
(2008), early experiences may play an important role in the development of BDD. Early 
experiences that positively reinforce the individual for the importance of physical 
appearance (or for the importance of particular body parts) may reinforce the belief that 
appearance is very important. For a significant portion of individuals with BDD, 
appearance was one of the factors most frequently reinforced during their childhood 
(Neziroglu et al., 2004). Also aversive early experiences (for example teasing, neglect, 
bullying) may condition the individual to the negative affect when he/she observes 
his/her body parts in later life (Cash, Winstead, & Janda, 1986; Osman et al., 2004; 
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Rieves & Cash, 1996; Veale, 2004; Zimmerman & Mattia, 1998). Vicarious learning 
(Bandura, 1977) could also play a role because it gives further confirmation that 
appearance is an important trait valued in society. Indeed, a child can learn that physical 
attractiveness leads to rewards: besides the individual’s socio-cultural environment, 
one’s family can provide numerous learning opportunities as well.  
BDD might begin with classical conditioning experiences. Aversive events involving 
one’s physical appearance, such as being teased, may serve as unconditioned stimuli 
(UCS) because they cause an unconditioned emotional response (UCR) such as 
depression, anxiety, disgust, or shame. The UCS can cause an aversive reaction and 
then, when paired with a neutral stimulus (CS), elicits the same reaction. In other words, 
the teasing becomes associated with a word or body part (an aversive stimulus; CS) that 
is then also evaluated as negative. Therefore, both the UCS and CS evoke emotions 
such as anxiety, depression, and disgust. It can be hypothesized that a biological 
predisposition, early childhood reinforcement history, and vicarious learning are 
necessary for the development of BDD. The combination of these factors may cause an 
increased sensitivity to this type of classical conditioning events. BDD is then 
maintained though operant conditioning, specifically by negative reinforcement, 
because aversive emotions are reduced by avoidance and safety behaviors. These 
avoidance behaviors are self-regulatory processes that function as a dysfunctional 
coping mechanism to avoid, escape, or manage body image discomfort (Cash, 2008). 
Therefore, patients with BDD may engage in safety behaviors in order to reduce disgust, 
anxiety, or negative feelings. In conclusion, the model of Neziroglu and colleagues 
(2008) suggests that a biological predisposition paired with early learning experiences 
make individuals vulnerable to evaluative conditioning experiences that can lead to 
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BDD symptomatology. Moreover, according to the model, BDD behaviors are 
maintained via negative reinforcement. 
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Chapter 2 
Prevalence of Body Dysmorphic Disorder and its 
associated psychological features in an Italian 
community sample 
 
2.1 Introduction 
Body Dysmorphic Disorder (BDD) is a psychological disorder characterized by 
preoccupation with one or more perceived defects in physical appearance that are not 
observable to others. To be diagnosed, the preoccupation must cause significant distress 
or impairment. Moreover, during the course of the disorder, individuals must perform 
repetitive behaviours or mental acts in response to the appearance concerns (American 
Psychiatric Association [APA], 2013). The most common areas of concern in people 
with BDD are the skin (presence of acne or scars), the hair (hair loss, thinning, or 
excessive facial or body hair) and the nose (shape or size; Phillips 2006; Phillips & Diaz 
1997; Phillips et al., 1993; Veale, Boocock et al., 1996). Appearance concerns, however, 
may involve any body areas (Phillips, 2006; Phillips et al., 1993; Veale, 2000), and 
individuals with BDD may be concerned with multiple body parts at the same time 
(Phillips et al., 1993; Phillips et al., 2005).  
In addition to core concerns about appearance, BDD is characterized by low self-esteem, 
high perfectionism, time-consuming repetitive behaviours (e.g., mirror checking, 
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camouflaging, reassurance seeking), avoidance (e.g., of social situations, mirrors) and 
high comorbidity (Phillips, 2006; Phillips et al., 1993; Phillips et al., 2004; Phillips et al., 
2005). Low self-esteem is often implicated in body image disorders, and several studies 
found that low self-esteem is associated with poor body esteem (Biby, 1998), especially 
in females (Thompson & Altabe, 1991). Indeed, Rosen and Ramirez (1998) found lower 
levels of self-esteem in patients with body image disorders (e.g., eating disorders and 
BDD) compared to a control group. Conversely, Silberstein and colleagues (1988) did 
not find a relationship between self-esteem of women who wanted to be thinner and 
women that reported satisfaction with the shape of their body, and Bohne, Keuthen, 
Wilhelm, Deckersbach, & Jenike (2002) did not find significant differences in the level 
of self-esteem between people who met criteria for BDD and people who did not. It is 
therefore important to clarify the relation between self-esteem and body dissatisfaction.  
Similarly to low self-esteem, perfectionism may be a risk factor for the development of 
body image disorders (Andreasen & Bardach, 1977; Bartsch, 2007; Hanstock & 
O’Mahony, 2002). In support of this association, Buhlmann, Etcoff and Wilhelm (2008) 
found higher levels of perfectionism in patients with BDD compared to healthy control 
participants. Moreover, there is anecdotal clinical evidence that BDD patients are often 
characterized by thoughts such as ‘‘As long as I don’t look perfect, I won’t be able to be 
happy’’ (Buhlmann, Etcoff, & Wilhelm, 2008) and “I have to have perfection in my 
appearance” (Veale, Boocock, et al., 1996). Several studies have attempted to 
investigate which components of perfectionism are implicated in BDD. A study 
conducted by Veale and colleagues (2003) revealed that BDD was related to high self-
standards of perfectionism, whereas another study conducted by Hanstock and 
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O’Mahony (2002) found that dysmorphic concerns were associated with socially 
prescribed perfectionism.  
With respect to comorbidity, in one of the largest comorbidity study (n = 293) 
conducted in the US, the most common disorders associated with BDD were Major 
Depressive Disorder (MDD; 76%), Social Anxiety Disorder (SAD; 37%), and 
Obsessive Compulsive Disorder (OCD; 32%; Gunstad & Phillips, 2003). Notably, all of 
these disorders share clinical features with BDD. Feelings of low self-esteem, shame, 
guilt, and unworthiness are frequently reported by patients with both BDD and MDD, 
consistent with the association between these conditions (Phillips, 1999). Importantly, 
the study of Phillips and colleagues (1995) found, in a sample of patients with BDD, a 
current prevalence of 59% and a lifetime prevalence of 83% for MDD. BDD also shares 
clinical features with SAD: both disorders are characterized by fear of negative 
evaluation in social situations (Buhlman et al., 2002; Pinto & Phillips, 2005), as well as 
avoidance of social interactions (Phillips & Diaz, 1997). Furthermore, several studies 
observed that people with BDD report higher levels of social anxiety symptoms than 
nonclinical controls (Pinto & Phillips, 2005; Veale et al., 2003). Regarding similarities 
between BDD and OCD, both disorders are characterized by intrusive thoughts and 
ritualistic behaviours that cause distress and interference with the person’s functioning 
(Hollander et al., 1992). Moreover, BDD and OCD have been found to often co-occur 
(Gunstad & Phillips, 2003).  
Although BDD is thought to be a relatively common disorder (Crerand et al., 2005; 
Phillips et al., 2001; Veale, 2000; Veale, Boocock et al., 1996), few prevalence studies 
exist and the observed rates widely vary, which may be due to methodological 
differences and limitations (e.g., non-representative populations and small sample sizes). 
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International studies based on general population reported a BDD prevalence ranging 
from 0.7% to 2.9% (Brohede et al., 2015; Buhlmann et al., 2010; Faravelli et al., 1997; 
Koran et al., 2008; Otto et al., 2001; Rief et al., 2006; Schieber et al., 2015). Recently, 
Veale and colleagues (2016) published a review based on BDD prevalence and found an 
overall weighted prevalence of 1.9% in the community. Among nonclinical student 
samples, the prevalence of BDD ranges from 1.2% to 13% (Bartsch, 2007; Biby, 1998; 
Bohne, Whilelm et al., 2002; Boroughs et al., 2010; Cansever et al., 2003; Liao et al., 
2010; Sarwer et al., 2005; Taqui et al., 2008).   
Despite increased awareness of BDD in recent years, it continues to be an under-studied 
disorder (Buhlmann & Winter, 2011; Buhlmann et al., 2010), particularly in the Italian 
context. Indeed, to the Authors’ knowledge, only one study has explored the prevalence 
of BDD in the Italian general population, and found a prevalence of 0.7% (Faravelli et 
al., 1997). This study, however, focused on the Diagnostic and Statistical Manual of 
Mental Disorders, third edition revised (DSM-III-R; APA, 1987) criteria, in which BDD 
was included in the somatoform disorders category (APA, 1987). Therefore, the main 
purpose of the present study was to explore the prevalence and the phenomenology of 
BDD in an Italian community sample. Little is known about BDD in the Italian context, 
and there are no data available on BDD prevalence rates using DSM-5 (APA, 2013) 
criteria. Shedding light on the prevalence of BDD in the Italian context might improve 
assessment and treatment methodologies, as well as raise awareness about this under-
diagnosed disorder. Given that no Italian standardized measures to assess BDD were 
available, two ad hoc self-report instruments were developed. The Body Dysmorphic 
Questionnaire (BDQ) was developed as a screening tool to assess DSM-5 (APA, 2013) 
criteria for BDD; therefore, it was employ to identify participants with probable BDD. 
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In order to assess BDD clinical features we developed the Questionario sul 
Dismorfismo Corporeo (QDC). Therefore, before the assessment of BDD prevalence 
and phenomenology, a preliminary aim of the present study was to investigate the QDC 
psychometric properties and its sensitivity and specificity in identifying individuals with 
probable BDD. 
The second aim of the present study was to investigate self-esteem, perfectionistic traits, 
social anxiety, depressive, and obsessive-compulsive symptoms in participants with 
probable BDD compared to participants without BDD. In accordance with previous 
results (Biby, 1998; Phillips et al., 1993), we expected lower levels of self-esteem and 
higher perfectionistic traits, as well as higher social anxiety and depressive features in 
participants with probable BDD relative to participants without BDD, since these 
features frequently co-occur with dysmorphic concerns. Moreover, we expected higher 
OCD features in people with probable BDD compared to participants without BDD due 
to the overlap in the clinical features between BDD and OCD.  
 
2.2 Methods 
2.2.1 Participants and procedure 
In response to newspaper advertisements for volunteers for psychological research, 615 
community individuals (69.4% female; all Caucasian) were recruited from different 
towns across Northern and Southern Italy. All individuals participated on a voluntary 
basis and provided their written informed consent before entering the study. Participants 
were requested to individually complete a battery of self-report measures which was 
counter-balanced to control for order effects. The study was conducted in accordance 
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with the Declaration of Helsinki and was approved by the institutional board of the 
University of Padova. The mean age of the sample was 30.51 (SD = 13.26; range = 18-
71) and the mean age of education was 13.45 (SD = 2.33; range = 3-26). Marital status 
was 62.28% married or cohabitating, 34.15% single, 3.25% separated or divorced, and 
0.32% widowed. The employment profile of the total sample was: 59.35% student, 
21.30% full-time employed, 7.15% part-time employed, 2.93% full-time homemaker, 
1.79% unemployed, 1.30% retired, and 6.18% other. This research did not receive any 
specific grant from funding agencies in the public, commercial, or not-for-profit sectors.  
 2.2.2 Measures 
All participants completed a socio-demographic schedule including information about 
gender, age, education and occupation, as well as about the presence of any medical or 
mental disorder, in order to assess Criterion D of the DSM-5 (APA, 2013) for BDD. 
Because no Italian standardized measures assessing BDD were available, two ad hoc 
self-report instruments were developed: the Body Dysmorphic Questionnaire (BDQ) 
and the Questionario sul Dismorfismo Corporeo (QDC). 
The Body Dysmorphic Questionnaire (BDQ) is a self-report questionnaire assessing 
DSM-5 (APA, 2013) diagnostic criteria for BDD. The questionnaire is made up of 5 
dichotomous items. The first item assesses the presence of concerns with one or more 
perceived defects in physical appearance that are not observable or appear slight to 
others. If the answer is positive, the participant is required to list the areas of concerns 
and the degree of dissatisfaction. The second item evaluates the presence of repetitive 
behaviours (e.g. mirror checking, excessive grooming, skin picking, reassurance 
seeking) or mental acts (e.g. comparing appearance with that of others) in response to 
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the appearance concerns. Two positive answers are required to continue the 
questionnaire. The third question asks whether the main source of concern is not being 
thin enough or being too fat. The aim of this item is the exclusion of participants when 
an eating disorder might be a more accurate diagnosis. The fourth question assesses the 
presence of significant distress or impairment in social and occupational functioning 
and the presence of avoidant behaviours due to the appearance concerns. Finally, the 
last item measures the time daily spent thinking about supposed defects. Phillips (1998) 
suggested that the time spent by thinking about the perceived defects should be at least 
1 hour every day. A positive screen for BDD is obtained if participants report positive 
answers to questions one, two and four. Moreover, a negative answer to question 
number three is required. Finally, in accordance with Phillips (1998) advice, 
participants should spend at least 1 hour per day thinking about perceived defects.  
The Questionario sul Dismorfismo Corporeo (QDC) is a self-report questionnaire made 
up of 40 items assessing BDD clinical features. The QDC was developed based on BDD 
literature to capture BDD phenomenology, symptoms, and related clinical features. 
Notably, several international self-report questionnaires assessing BDD are currently 
available; nonetheless, they are characterized by some lacks. In particular, the most 
commonly used self-report questionnaires to assess BDD in the international context are 
the Body Dysmorphic Disorder Questionnaire (BDDQ; Phillips, 2005), the Body Image 
Disturbance Questionnaire (BIDQ; Cash, Phillips, Santos, & Hrabosky, 2004), and the 
Dysmorphic Concern Questionnaire (DCQ; Oosthuizen, Lambert, & Castle, 1998). The 
BDDQ (Phillips, 2005) is a brief self-report questionnaire to screen for BDD according 
to the DSM-IV diagnostic criteria (APA, 1994), comprising 4 items with a yes/no 
response format; therefore, since the primary function of the BDDQ is to screen 
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clinically for BDD, it does not provide a dimensional measure of BDD symptoms 
severity. In an attempt to overcoming this limitation, Cash and colleagues (2004) 
developed the BIDQ, which is made up of 7 items assessing a continuum of body image 
disturbance. However, the BIDQ lacks in the assessment of important areas related do 
BDD such as the requirement of aesthetical surgical procedures to fix the defects and 
the presence of repetitive behaviors or mental acts in response to the appearance 
concerns. Finally, the DCQ (Oosthuizen et al., 1998) is made up of 7 items assessing 
overconcern with physical appearance, without seeking to establish a diagnosis of BDD. 
In general, the DCQ attempts to capture the nature of dysmorphic concerns, as well as 
past attempts to deal with the problem. However, important areas of BDD such as 
repetitive behaviors and mental actions performed in response to the appearance 
concerns, suicidal thoughts related to the appearance concerns and impairment in social 
functioning are not investigated by DCQ. 
The QDC was developed to overcome the limitations characterizing such measures and 
to broadly assess BDD symptomatology. Indeed, the QDC takes into account different 
aspects of BDD (e.g. mental actions and repetitive behaviors, suicidal thoughts, request 
for cosmetic procedures, impairment in different areas of functioning), whereas the 
other already available measures were designed to focus only on specific aspects of 
BDD or were developed in accordance with different conceptualizations of the disorder 
(Cororve & Gleaves, 2001). As a matter of fact, most of the available measures 
assessing BDD focus on the BDD features overlapping with OCD, EDs, and delusions 
and overvalued ideas (Cororve & Gleaves, 2001). Furthermore, such measures were 
developed before the new categorization of BDD as an OCD-related disorder within the 
DSM-5 (APA, 2013).  
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Items of the QDC are rated on a 7-point Likert scale (from 1 = “strongly disagree” to 7 
= “strongly agree”), with higher scores representing more severe BDD symptomatology. 
As above-mentioned, the QDC evaluates the presence of typical behaviours associated 
with BDD, such as repetitive behaviours (e. g., mirror checking, excessive grooming, 
reassurance seeking), mental acts (e. g. comparing the “defective” body areas with the 
same body areas of other people), and avoidant behaviours related to appearance 
concerns. Finally, the QDC also assesses the request of cosmetic and surgical 
procedures and suicidal thoughts due to appearance concerns.  
The Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965; Italian version by Prezza et 
al., 1997) consists of 10 items measuring global self-esteem. Items are rated on a 4-
point Likert scale (from 1= “strongly disagree” to 4 = “strongly agree”), with higher 
scores representing positive self-esteem. Good internal consistency values have been 
reported for the original RSES, ranging between α = .77 and α = .88 (Dobson, Goudy, 
Keith, & Powers, 1979; Fleming & Courtney, 1984; Robinson et al., 1991). The Italian 
version also showed good psychometric properties: its internal consistency was α = .84 
and the 15-days test-retest reliability was r = .76 (Prezza et al., 1997). Internal 
consistency coefficient was excellent in the present sample (α = .90). 
The Multidimensional Perfectionism Scale (MPS; Hewitt & Flett, 1991) is a 45 items 
self-report questionnaire assessing three different domains of perfectionism: self-
oriented, socially prescribed and other-oriented. Each sub-scale of the questionnaire 
contains 15 items evaluated on a 7-point Likert scale, ranging from strongly disagree (1) 
to strongly agree (7), with higher scores relating to greater levels of perfectionism. 
Good internal consistency values have been reported for the original MPS, ranging 
between α = .79 and α = .89 in a student sample (Hewitt & Flett, 1991). The Italian 
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validation of the MPS is not available to date, therefore an ad hoc translation was 
employed. In the present sample, the alpha coefficient was .90 for the self-oriented 
scale, .84 for the socially prescribed scale and .78 for the other-oriented perfectionism 
scale. 
The Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998; Italian version by 
Sica et al., 2007) is a 19-item self-report measure designed to assess social interaction 
anxiety on a 5-point Likert scale ranging from 0 (“not at all characteristic of true of me”) 
to 4 (“extremely characteristic of true of me”); higher scores indicate higher levels of 
social interaction anxiety. The SIAS showed strong psychometric properties (Mattick & 
Clarke, 1998), including high internal consistency (α = .94) and 1 month test-retest 
stability (r = .92). The Italian version proved to be highly reliable and stable as well 
(Sica et al., 2007). In the present study, the alpha coefficient for the SIAS was excellent 
(α  = .93). 
The Depression Anxiety Stress Scale (DASS; Lovibond & Lovibond, 1995; Italian 
version by Bottesi et al., 2015) is a 21 items self-report questionnaire designed to assess 
depression, anxiety, and stress on a 4-point Likert scale (ranging from 0 to 3), with 
higher scores indicating greater levels of distress. Three subscale scores as well as a 
“general distress” total score can be computed (Bottesi et al., 2015). The original 
DASS-21 demonstrated adequate reliability, with coefficient alphas ranging from .73 
to .81 in non-clinical samples (Lovibond & Lovibond, 1995). The Italian version proved 
to be highly reliable as well, with internal consistency ranging from α = .74 and α = .90 
(Bottesi et al., 2015). Given that findings on the Italian version suggested that use of the 
total score, measuring a “general distress” factor, could be more appropriate than 
calculating the three subscale scores separately (Bottesi et al., 2015), for the purpose of 
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the presence research we focused only on the total score of the questionnaire and on 
depression subscale. The alpha coefficient for the total DASS was .94, whereas the 
alpha coefficients for the DASS depression subscales was α = .88.  
The Obsessive Compulsive Inventory-42 (OCI-42; Foa et al., 1998; Italian version by 
Sica et al., 2009) is a 42-item self-report questionnaire assessing the frequency and 
distress caused by OCD symptoms. Each item is rated on a 5-point Likert scale (0–4), 
and the questionnaire is made up of 7 subscales: washing, checking, ordering, obsessing, 
doubting, mental neutralizing, and hoarding. Internal consistency values of the original 
version were good (α  = .86 to .95; Foa et al., 1998), as were those observed in an Italian 
clinical group (α = .77 to .94; Sica et al., 2009). In the present study only distress 
associated with obsessions and compulsions was taken into account since the two scales 
(frequency and distress) have been demonstrated to yield redundant information (e.g., 
Foa et al., 2002; Wu & Watson, 2003). The OCI was preferred over the shorter version 
composed by 18 items (OCI-R) because previous investigations showed that the brevity 
of the OCI-R scales may be of concern especially for an excessive restriction of score 
range (Ghisi et al., 2010; Sica et al., 2012). In the present study, the alpha coefficient for 
the total OCI distress was .95, whereas alpha coefficients for the OCI subscales ranged 
from .70 to .87. 
2.2.3 Statistical Analyses 
Preliminary, to test the factorial structure of the QDC, a principal components factor 
analysis (PCA) was conducted. The number of factors identified was based on an 
examination of eigen values greater than one and on the scree plot. Cronbach’s alpha 
coefficient was computed to evaluate internal consistency; an alpha of .70 or above was 
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used as a cut point (Cronbach, 1951). Test-retest reliability was analyzed using 
Pearson’s product-moment correlation. Subsequently, the Receiver Operating 
Characteristic (ROC) curve analysis was performed and specificity and sensitivity at 
each possible cut-off point were calculated in order to establish the optimal QDC cut-off 
value. 
With respect to the main purposes of the study, participants were classified as 
‘‘probable BDD’’ if they fulfilled the diagnostic criteria for BDD evaluated by the BDQ. 
For these participants, descriptive analyses (frequencies and percentages) were 
conducted in order to assess the most frequently areas of concern, distress experienced 
and avoidance behaviours. Then, participants with probable BDD were compared with 
participants without BDD on demographic variables, psychological and 
psychopathological features performing a non-parametric Mann-Whitney U-test. 
Individuals with probable BDD were significantly younger than those without BDD 
(see Results section), and Pearson’s correlations between age and scores obtained on 
dependent variables were performed on the whole sample. Only one significant 
correlation emerged: Age was negatively correlated with the QDC (r = −.36, p < .001). 
Non-parametric Mann-Whitney U-tests were performed in order to compare the two 
groups (probable BDD vs. without BDD) on psychological and psychopathological 
measures. Furthermore, in light of correlational findings, a non-parametric Mann-
Whitney U-test was performed on the QDC score considering only the 18-28 range for 
age. 
Conventional significance levels were used (p < .05). All statistical analyses were 
conducted using IBM Statistical Package for Social Science, version 21, and MedCalc. 
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2.3 Results 
2.3.1 Preliminary analyses: QDC psychometric properties  
Exploratory factor analysis 
An exploratory factor analysis using the principle-axis factor extraction was conducted 
on the total sample (N = 615), to determine the factor structure of the QDC. Results 
revealed a one-factor solution to best explain the data. This factor accounted for the 36.7% 
of the variance, whereas the second factor explained only the 5% more of the total 
variance. Therefore, the one-factor solution was the best to explain the data. 
 
Internal consistency and test-retest reliability 
Reliability analysis on the total sample (N = 615) resulted in an internal consistency of 
Cronbach’s α = .95, indicating strong internal consistency. No item diminished the 
scale’s overall reliability, thus indicating good to excellent internal consistency (Table 
1). One hundred and sixty-three participants completed the QDC 1 month after the first 
administration; an excellent test-retest reliability value emerged (r = .91, p < .001; first 
administration: M = 105.86; SD =37.54; second administration: M = 100.62; SD = 
38.73).  
 
 
 
 
 
 
 
 
 
50 
Table 1.  
Internal consistency variations 
Item Variation of internal consistency  
QDC1 .95 
QDC2 .94 
QDC3 .95 
QDC4 .94 
QDC5 .95 
QDC6 .94 
QDC7 .94 
QDC8 .95 
QDC9 .94 
QDC10 .94 
QDC11 .95 
QDC12 .95 
QDC13 .94 
QDC14 .95 
QDC15 .95 
QDC16 .94 
QDC17 .94 
QDC18 .94 
QDC19 .95 
QDC20 .95 
QDC21 .95 
QDC22 .95 
QDC23 .95 
QDC24 .94 
QDC25 .95 
QDC26 .95 
QDC27 .94 
QDC28 .95 
QDC29 .95 
QDC30 .95 
QDC31 .95 
QDC32 .95 
QDC33 .94 
QDC34 .94 
QDC35 .95 
QDC36 .94 
QDC37 .95 
QDC38 .95 
QDC39 .95 
QDC40 .94 
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ROC analysis and cut-off value 
The ROC curve for participants is represented in Figure 1. The Area Under the Curve 
(AUC) was 0.908 (95% CI = 0.881-0.930; p < .001) indicating that QDC is an accurate 
diagnostic test (Streiner & Cairney, 2007). In order to establish the optimal cut-off value, 
we analyzed both specificity and sensitivity at each possible cut-off point (Table 2). The 
best performance of the QDC in discriminating between participants with and without 
BDD is reached at the cut-off point of > 130 (specificity = 83.48; sensitivity = 90.00).  
Figure 1.  
ROC curve  
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Table 2. 
Criterion values and coordinates of the ROC curve for QDC 
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR +PV -PV 
≥ 40 100,00 69,2 - 100,0 0,00 0,0 - 0,6 1,00   1,6   
>105 100,00 69,2 - 100,0 65,20 61,1 - 69,1 2,87 0,00 4,5 100,0 
>106 90,00 55,5 - 99,7 66,08 62,0 - 70,0 2,65 0,15 4,2 99,7 
>130* 90,00 55,5 - 99,7 83,48 80,2 - 86,4 5,45 0,12 8,3 99,8 
>131 80,00 44,4 - 97,5 83,83 80,5 - 86,8 4,95 0,24 7,6 99,6 
>132 80,00 44,4 - 97,5 84,71 81,5 - 87,6 5,23 0,24 8,0 99,6 
>133 70,00 34,8 - 93,3 85,41 82,2 - 88,2 4,80 0,35 7,4 99,4 
>151 70,00 34,8 - 93,3 91,74 89,2 - 93,9 8,47 0,33 12,3 99,5 
>152 60,00 26,2 - 87,8 92,09 89,6 - 94,2 7,59 0,43 11,2 99,3 
>153 60,00 26,2 - 87,8 92,44 90,0 - 94,5 7,94 0,43 11,6 99,3 
>154 50,00 18,7 - 81,3 92,62 90,2 - 94,6 6,77 0,54 10,1 99,1 
>169 50,00 18,7 - 81,3 95,43 93,4 - 97,0 10,94 0,52 15,3 99,1 
>170 40,00 12,2 - 73,8 95,78 93,8 - 97,3 9,48 0,63 13,6 99,0 
>181 40,00 12,2 - 73,8 96,66 94,8 - 98,0 11,98 0,62 16,6 99,0 
>182 30,00 6,7 - 65,2 96,84 95,0 - 98,1 9,48 0,72 13,6 98,8 
>191 30,00 6,7 - 65,2 97,89 96,3 - 98,9 14,23 0,72 19,1 98,8 
>192 20,00 2,5 - 55,6 98,24 96,8 - 99,2 11,38 0,81 15,9 98,7 
>207 20,00 2,5 - 55,6 99,12 98,0 - 99,7 22,76 0,81 27,4 98,7 
>208 10,00 0,3 - 44,5 99,12 98,0 - 99,7 11,38 0,91 15,9 98,5 
>215 10,00 0,3 - 44,5 99,65 98,7 - 100,0 28,45 0,90 32,0 98,5 
>218 0,00 0,0 - 30,8 99,65 98,7 - 100,0 0,00 1,00 0,0 98,4 
>228 0,00 0,0 - 30,8 100,00 99,4 - 100,0   1,00   98,4 
 
2.3.2 Prevalence of BDD 
Ten participants (1.63%) [95% confidence interval (CI) .63–2.63%] fulfilled all the 
diagnostic criteria for BDD. Among the 10 participants who met criteria for probable 
BDD, 9 were females. Participants with probable BDD were aged between 18 and 28 
years old (M = 20.70; DS = 2.71), and the educational level ranged between 11 and 22 
years (M = 14; DS = 2.98). Six participants with probable BDD were single, 3 were 
partnered and 1 was married. Nine participants with probable BDD were students and 1 
had a part-time job. Two probable BDD participants indicated concern with one aspect 
of appearance. For the remaining 8 participants, the number of physical flaws ranged 
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from 2 to 6. Hair (n = 4; 4%), nose (n = 4; 4%) and teeth (n = 4; 4%) were the most 
common areas of concern, followed by skin (n = 2; 2%), legs (n = 2; 2%), breasts (n = 2; 
2%), lips (n = 1; 1%), ankles (n = 1; 1%), stomach (n = 1; 1%), height (n = 1; 1%), chin 
(n = 1; 1%), arms (n = 1; 1%), hips (n = 1; 1%), feet (n = 1; 1%), and thighs (n = 1; 1%). 
The most common consequence of preoccupation was significant distress, which was 
referred by 90% of the participants who fulfilled the BDD diagnostic criteria. Avoidant 
behaviours were reported by 50%, social impairment by 40% and occupational 
impairment by 30% of the participants. Nine participants reported to spend 1 to 3 hours 
per day thinking about the defects and 1 participant reported to spend more than 3 hours 
per day thinking about it. Two participants sought cosmetic surgery for their nose and 
one underwent to chemical peel treatments for skin.  
 2.3.3 Differences between participants who met the criteria for probable BDD and 
those who did not 
Differences in age were found between participants who met criteria for probable BBD 
and those who failed to meet the criteria (U = 1370.50; p = .003). Individuals with 
probable BDD were younger (M = 20.70; SD = 2.71) than individuals who did not meet 
criteria for BDD (M = 30.67; SD = 13.67). No other demographical differences 
emerged between the groups (p > .05). With respect to psychological and 
psychopathological features, participants with probable BDD scored significantly higher 
than those without BDD on the QDC, U = 1370.5, p < .001. Conversely, participants 
with probable BDD scored significantly lower on the RSES than those without BDD, U 
= 1349.5, p = .003. With respect to perfectionistic traits, no differences between groups 
emerged on any of the MPS subscales (p > .05). The probable BDD respondents scored 
significantly higher than those without on the SIAS, U = 1729, p = .03, on the DASS-21 
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depression subscale, U = 1406, p = .02, and on the total score of the DASS-21, U = 
1288.5, p = .01. Regarding the obsessive-compulsive symptomatology measured by the 
OCI-42, probable BDD respondents scored higher on the washing, U = 1680.5, p = .02, 
checking, U = 1627.5, p = .01, doubting, U = 1928.5, p = .04, ordering, U = 1628, p 
= .01, obsessing, U = 1422, p = .02, and neutralizing subscales, U = 1795.5, p = .03. 
Moreover, probable BDD participants scored higher also on total OCI-42 score, U = 
1003.5, p = .002 (Table 3).    
Table 3. 
Comparison between individuals with probable BDD and individuals without BDD on 
psychological and psychopathological features 
 
Individuals with probable 
BDD  (N = 10) 
M (SD) 
 
Individuals without BDD 
(N = 605) 
M (SD) 
QDC 164.60 (35.98) 94.65 (37.41) 
RSES 25.60 (5.64) 31.34 (5.59) 
MPS Self-Oriented 72 (19.63) 60.89 (17.71) 
MPS Other-Oriented 55.60 (10.96) 50.50 (12.57) 
MPS Socially Prescribed 55.40 (16.77) 47.31 (13.64) 
DASS depression 8.22 (6.12) 4.06 (3.97) 
DASS total score 24.22 (13.42) 13.74 (10.45) 
SIAS 32.70 (16.38) 21.93 (12.98) 
OCI washing 8.70 (7.63) 3.90 (4.97) 
OCI checking 6.90 (4.70) 3.95 (4.61) 
OCI doubting 2.60 (2.01) 1.56 (2.21) 
OCI ordering 5.50 (4.17) 3.06 (3.78) 
OCI obsessing 11.89 (8.78) 5.31 (5.44) 
OCI hoarding 2.40 (2.12) 1.84 (2.20) 
OCI neutralizing 4.20 (3.29) 2.41 (2.74) 
OCI total score 43.44 (23.27) 22.09 (20.43) 
 
2.4 Discussion 
BDD is a debilitating disorder that is still under-recognized and often inadequately 
treated in Italian clinical settings, despite its severity and its growing prevalence. To our 
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knowledge, this is the first study assessing the prevalence and the phenomenology of 
BDD in an Italian community sample according to the DSM-5 criteria (APA, 2013).  
With respect to the preliminary aim of the present study, the QDC showed one factorial 
structure and excellent internal consistency (α = .95), indicating that the items of the 
QDC converge to the same construct. Furthermore, the QDC demonstrated excellent 
one-month test-retest reliability (r = .91), indicating that the measure scores are stable 
after a month. The QDC also demonstrated high sensitivity and specificity with a cut-
off point of > 130, indicating that individuals who score 130 or above should be referred 
for further assessment because may be at risk for developing BDD. In light of these 
findings, the QDC appears a reliable and valid measure to assess BDD in the Italian 
context. 
With respect to the main aim of the present study, assessing BDD prevalence, the 
current study found a prevalence of 1.63%. Similar rates were obtained in previous 
studies conducted in Germany with a representative sample of the general population 
(1.7%, Rief et al., 2006; 1.8%, Buhlmann et al., 2010) and in Sweden within a 
representative sample of women (2.1%; Brohede et al., 2015). Moreover, we found a 
BDD prevalence closed to the overall weighted prevalence in the community found by 
Veale and colleagues (2016). Interestingly, we found a BDD prevalence rate slightly 
higher than the one emerged in Faravelli and colleagues (1997; 0.7%) among Italian 
general population. The slightly higher prevalence found in our study could be 
explained by methodological and sample differences. Specifically, Faravelli and 
colleagues (1997) utilized structured interview and applied DSM-III-TR (APA, 1987) 
criteria. Alternatively, this result could be explained by a higher interest in physical 
appearance in our contemporary culture relative to two decades ago when Faravelli and 
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colleagues (1997) conducted their study. On the other hand, our rate is slightly lower 
compared to studies conducted with students, for example, Biby (1998; 13%), Bohne, 
Keuthen et al. (2002; 4%), and Cansever et al. (2003; 4.8%). These differences may be 
explained, once again, by sampling and methodological variation. The high prevalence 
of BDD rates in students can be explain by the fact that young people are vulnerable 
with respect to the development of body image disorders, since adolescence is the time 
when individuals are most sensitive to their appearance (Phillips, Didie et al., 2006; 
Veale, Boocock et al., 1996). Consistent with this proposed vulnerability, participants 
who fulfilled diagnostic criteria for BDD were younger than people who did not and 9 
of the 10 individuals who fulfilled BDD criteria were students.  
Concerning gender prevalence in our study, the 90% of participants with probable BDD 
were female. This prevalence ratio is different compared to other studies that have 
reported an equal gender ratio (Phillips, 1991; Phillips & Diaz, 1997), but consistent 
with several other studies about BDD (Bartsch, 2007; Biby, 1998; Phillips et al., 1993; 
Phillips et al., 2005; Veale, Boocock et al., 1996) and with studies that underlined that 
women are generally more dissatisfied with their appearance than men (Cash, 1990; 
Davis & Cowles, 1991; Rozin & Fallon, 1988). To note, studies that found equal gender 
ratios assessed individuals seeking psychological treatment and not general population. 
Another possible (and presumably related) explanation for the difference in gender ratio, 
as reported by Phillips and Diaz (1997), might be the illness severity. It is possible that 
mild BDD might be closely related to normal appearance concerns, and that among 
individuals with milder BDD, women predominate.  
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With respect to phenomenology, people who satisfied BDD criteria reported multiple 
areas of concern, ranging between 2 to 6. The most disliked body parts were the hair, 
nose and teeth. These results are in accordance with studies conducted with general 
population and with clinical samples and reporting that head and face in general are the 
most common areas of concern in patients with BDD (Cansever et al., 2003; Phillips et 
al., 1993; Rief et al., 2006; Veale, Boocock et al., 1996). With respect to skin concerns, 
our study found a lower prevalence of dissatisfaction with the skin than other studies. 
This result may reflect a cross-cultural difference in the phenomenology of BDD, given 
that cultural-specific factors may influence the clinical expression of BDD (Phillips, 
2005). Understanding cultural factors that influence the expression of BDD may have 
relevant implications for diagnosis and treatment of BDD (Perugi et al., 1997). 
Moreover, in accordance with other literature studies, participants who fulfilled BDD 
criteria reported significant distress (90%; Bjornsson et al., 2010) and social and 
occupational impairment (respectively, 40% and 30%; Didie et al., 2008). Finally, 
consistent with previous findings, participants reported spending many hours every day 
thinking about the presence of defects in physical appearance (Veale, 2004).  
With respect to self-esteem, participants who satisfied BDD criteria were found to have 
lower self-esteem than people who did not. This result is in accordance with the study 
of Rosen and Ramirez (1998) that found low self-esteem in patients with body image 
disorders. Moreover, this result is in line with the study of Buhlmann, Teachman and 
colleagues (2008) that assessed explicit and implicit self-esteem in people with BDD, 
subclinical BDD and healthy controls. Buhlmann, Teachman and colleagues (2008) 
found that self-esteem represent a step-wise function of BDD status, with individuals 
with subclinical BDD scoring intermediate between healthy controls and patients with 
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BDD. Finally, many studies found that low self-esteem was correlated with poor body 
esteem (Biby, 1998; Bohne, Wilhelm et al., 2002). Therefore, a deficiency in self-
esteem might be essential for the development and course of body image disorders 
(Grubb et al., 1993).  
Given that perfectionism may play a key role in the development of body image 
disorders (Andreasen & Bardach, 1977; Bartsch, 2007; Hanstock & O’Mahony, 2002), 
we assessed the presence of differences in self-oriented, socially prescribed-oriented 
and other-oriented perfectionism. Results of our study showed no differences in terms 
of perfectionism between people who satisfied BDD criteria and people who did not. 
These results are different from previous studies reported in the literature, given that 
many studies indicated that at least one of the three dimensions of perfectionism is 
higher in people with BDD than in general population (Buhlmann, Etcoff, & Wilhelm, 
2008; Veale, Boocock et al., 1996). These results, however, should be interpreted with 
caution given that the group of individuals who satisfied BDD criteria was small; 
furthermore, the questionnaire we used to assess perfectionism is still being validated in 
the Italian context. Lastly, given that no other studies about BDD psychological features 
in Italian population are available, cross-cultural differences related to perfectionism 
may explain this result and, therefore, perfectionism might not be such a relevant trait in 
the development and maintenance of BDD in the Italian population.  
With respect to psychopathological features, as expected, people who satisfied BDD 
criteria reported higher levels of social anxiety characteristics than people who did not, 
in accordance with studies that underlined the presence of social anxiety 
symptomatology in people with BDD (Pinto & Phillips, 2005; Veale et al., 2003). Fang 
and Hofmann (2010) reported that concerns about defects in physical appearance in 
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BDD people may be likely associated with the fear of negative evaluation by others, 
which also is the core feature of social anxiety disorder. People who satisfied BDD 
criteria also reported greater levels of depressive features and general distress than 
people who did not, as expected and in accordance with literature studies (Biby, 1998; 
Phillips, 1999; Phillips et al., 1995). In fact, BDD is a severe condition impairing the 
individual’s life in many domains (Phillips, 2004) and BDD and MDD frequently co-
occur (Phillips, 1999). The study by Gunstad and Phillips (2003) revealed that MDD 
most often occurred after the onset of BDD, consistently with clinical impressions that 
depression could be often secondary to BDD. Finally, people who satisfied BDD 
criteria reported more OCD features than people who did not. This was expected and is 
consistent with studies that underlined the presence of higher OCD symptoms in 
patients with BDD (Bohne, Wilhelm et al., 2002; Gunstad & Phillips, 2003). This 
finding is in line with the new categorization of BDD in the fifth edition of the DSM as 
a disorder related to OCD (APA, 2013). BDD and OCD, in fact, share clinical features 
and the study by Biby (1998) and of Bohne, Wilhelm et al. (2002) showed that body 
image dissatisfaction was related to high obsessive-compulsive tendencies. Therefore, 
our study underscores that, also in the Italian context, BDD features are associated with 
low self-esteem and high levels of social anxiety, depression, distress and obsessive-
compulsive characteristics. 
The present study has several limitations. First, we used self-report questionnaires rather 
than clinical structured interviews (which are considered the gold standard for screening 
people with BDD; Brohede et al., 2015) to identify people with probable BDD. On the 
other hand, it is noteworthy that people with BDD are usually very ashamed about their 
symptoms (Phillips, 2006), and it might be easier for them to disclose their concerns 
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through a questionnaire rather than in an in-person interview (Buhlmann et al., 2010; 
Phillips, 2006; Rief et al., 2006); therefore, the employment of self-report instruments 
allowed us to reach a large number of individuals. The absence of psychometric 
information for some of our measures is another shortcoming of this research. Moreover, 
one of the exclusion criteria we used for identify people with BDD in our research was 
the absence of primary body concerns focused on body weight, in order to avoid the 
over-diagnosis of BDD when an eating disorder might have been the more accurate 
diagnosis. This criterion, however, can be very restrictive, because people who are 
concerned with body weight might present also dissatisfaction with other body parts, 
given that EDs and BDD frequently co-occur (Grant et al., 2002; Kollei et al., 2013; 
Ruffolo et al., 2006). Therefore, the exclusion of people with primary body weight 
concerns may lead to a risk of under-diagnosis of BDD in patients with weight concerns 
if interpreted too restrictively. Finally, the sampling strategy (participants were 
volunteers) and the high presence of students, as well as the relatively small sample size, 
limited the generalizability of our results. Future studies overcoming these limitations 
are recommended, especially focused on the relationship between BDD and EDs, 
because many studies underlined that the co-occurrence of the disorders confer 
additional severity in terms of body image disturbance and clinical symptomatology 
(Dingemans et al., 2012; Grant et al., 2002). Overall, despite the above-mentioned 
shortcomings, the present study represents the first study that assessed the prevalence 
and the phenomenology of BDD according to the new DSM-5 criteria (APA, 2013) in 
the Italian context. We found a prevalence of 1.63% and low self-esteem, higher social 
anxiety, distress and depressive and obsessive-compulsive features in people who 
satisfied BDD criteria compared to people who did not.  
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Chapter 3 
Nonweight-Related Body Image Concerns and Body 
Dysmorphic Disorder Prevalence in Italian Patients with 
Anorexia Nervosa 
 
3.1 Introduction 
Body Dysmorphic Disorder (BDD) is a psychological condition included in the 
“Obsessive-Compulsive and Related Disorder” category of the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; American Psychiatric 
Association [APA], 2013). BDD is characterized by concerns regarding one or more 
perceived defects in physical appearance that are not observable to others (APA, 2013); 
the preoccupation is time-consuming and causes significant distress or impairment in 
the individual’s functioning (Cororve & Gleaves, 2001). Appearance concern is often 
focused on skin, hair, and nose (Phillips, 2006; Phillips & Diaz, 1997; Phillips, McElroy, 
Keck, Pope, & Hudson, 1993; Veale, Boocock et al., 1996); however, it may involve 
any body areas (Phillips, 2006; Phillips et al., 1993; Veale, 2000) and individuals with 
BDD may be simultaneously concerned with multiple body parts (Phillips et al., 1993; 
Phillips, Menard, Fay, & Weisberg, 2005).  
Because the essential pathology of BDD is a disturbance in body image (Rosen & 
Ramirez, 1998), it has been suggested that BDD might be better clustered under an 
encompassing ‘body image disorder’ category, along with Eating Disorders (EDs; 
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Cororve & Gleaves, 2001; Mitchison, Crino, & Hay, 2013). Both BDD and EDs are 
severe body image disorders (Rosen, Reiter, & Orosan, 1995) characterized by body 
image disturbance and dissatisfaction. Moreover, BDD and EDs share clinical features 
(Grant & Phillips, 2004; Phillips, 2005): both disorders are characterized by 
dissatisfaction and intrusive thoughts about appearance and by an overemphasis on 
appearance in the evaluation of self-worth (Phillips, Kim, & Hudson, 1995; Rosen & 
Ramirez, 1998). Furthermore, BDD and EDs are both characterized by repetitive 
checking behaviors such as mirror checking and body measuring (Phillips, Kim, & 
Hudson, 1995), as well as behavioral avoidance (e.g., social situations, places, activities, 
and ways of dressing) and requests for beauty remedies for the appearance concerns 
(e.g., weight control in anorexia nervosa and cosmetic surgery in BDD; Rosen & 
Ramirez, 1998). With respect to psychological features, both disorders are characterized 
by low self-esteem (Phillips, Pinto, & Jain, 2004; Rosen & Ramirez, 1998) and high 
levels of perfectionism (Bardone-Cone et al., 2007; Buhlmann, Etcoff, & Wilhelm, 
2008; Bulik et al., 2003; Veale, 2004).  
Due to this considerable overlap, distinguishing between BDD and EDs is sometimes 
challenging (Dingemans, van Rood, de Groot, & van Furth, 2012). However, people 
with EDs focus primarily on overall body weight and shape, whereas people with BDD 
more often focus on specific body parts. The current hierarchical organization of the 
DSM-5 (APA, 2013) stipulates that a diagnosis of BDD cannot be provided if 
appearance concerns are better explained by concerns with body fat or weight in an 
individual whose symptoms meet diagnostic criteria for EDs (APA, 2013); this 
frequently results in not diagnosing BDD when patients also fulfill the criteria for EDs 
(Dingemans et al., 2012).  
 
 
63 
However, comorbidity of BDD and EDs is high (Dingemans et al., 2012; Fenwick & 
Sullivan, 2011; Grant, Kim, & Eckert, 2002; Kollei, Schieber, Zwaan, Svitak, & Martin, 
2013; Ruffolo, Phillips, Menard, Fay, & Weisberg, 2006). For example, the study of 
Grant et al. (2002), conducted on 41 inpatients with anorexia nervosa, found that 16 
patients (39%) also met criteria for BDD. The study of Dingemans et al. (2012) found 
that 45% of patients with EDs (n = 158) probably suffered from BDD, and contrary to 
the Authors’ expectations, no differences in the prevalence of BDD by ED subtype 
(anorexia nervosa [AN], bulimia nervosa [BN] or eating disorder not otherwise 
specified [EDNOS]) emerged. These results are in accordance with the study of Kollei 
et al. (2013), who found that 14.3% of patients with BN and 9.8% of patients with AN 
met criteria for BDD; the most commonly reported areas of concern were the skin, arms, 
eyebrows, and nose. Moreover, inpatients with comorbid BDD referred earlier onset of 
AN and reported greater severity of eating disorder pathology and general 
symptomatology than those without comorbid BDD (Grant et al., 2002; Dingemans et 
al., 2012). Lastly, inpatients with comorbid BDD were three times more likely to have 
attempted suicide secondary to appearance concerns than those without comorbid BDD.  
Given this evidence, assessing the presence of BDD in patients with EDs is important, 
particularly because the co-occurrence of the disorders appears to confer additional 
severity (Dingemans et al., 2012; Grant et al., 2002). Furthermore, failures in 
diagnosing BDD in patients with EDs may have important treatment implications; 
intense body dissatisfaction can persist after a successful treatment for EDs and it is a 
reliable predictor for relapse (Cash & Hrabosky, 2004; Marco, Perpina, & Botella, 
2013). Usually, standard EDs programs have been demonstrated to have a smaller 
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treatment effectiveness with respect to body image compared to eating behaviors 
(Rosen, 1996).  
Therefore, the first aim of the present study was to assess the prevalence of BDD and 
the presence of nonweight-related body image concerns in a sample of Italian patients 
with AN. Similar to previous studies (Dingemans et al., 2012; Grant et al., 2002; Kollei 
et al., 2013) and given the shared clinical features between BDD and AN (Grant & 
Phillips, 2004; Mitchison et al., 2013), we expected high BDD prevalence and presence 
of nonweight-related body image concerns in patients with AN. Moreover, we aimed at 
comparing patients with nonweight-related body image concerns, patients with weight-
related body image concerns only and a control group as regards BDD symptoms, 
severity of EDs symptoms, obsessive-compulsive symptomatology, general distress, 
social anxiety symptoms, self-esteem, and perfectionism. Based on previous studies 
(Dingemans et al., 2012; Grant et al., 2002) we expected that patients with nonweight-
related body image concerns would show higher levels of BDD symptoms, severity of 
EDs symptoms, obsessive-compulsive symptomatology, and general distress compared 
to patients with weight-related body image concerns only and compared to a control 
group. Although the present research represents one of the first studies to compare 
social anxiety symptoms, self-esteem, and perfectionism among these three groups, we 
hypothesized that patients with nonweight-related body image concerns would report 
more severe social anxiety symptoms, lower levels of self-esteem, and higher levels of 
perfectionism than patients with weight-related body image concerns only and the 
control group. Indeed, patients with AN plus nonweight-related body image concerns 
present a more severe body image disorder than patients with weight-related body 
image concerns only and the control group (Dingemans et al., 2012; Grant et al., 2002). 
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Therefore, this more complex group may present more psychological symptoms than 
the other two groups.  
 
3.2 Methods 
3.2.1 Participants  
Sixty-one females patients suffering from AN (77% restricting type and 23% purging 
type) enrolled in the study. Diagnostic status was ascertained using the Structured 
Clinical Interview for Axis I Disorders, Patient Edition (SCID-I/P; First, Spitzer, 
Gibbon & Williams, 2002). Inclusion criteria for all participants were meeting DSM-5 
(APA, 2013) diagnostic criteria for current AN and being aged at least 18 years old. 
Exclusion criteria were the existence of severe neurological diseases, current or past 
psychotic disorders, and mental retardation. All patients were in treatment (57.4% 
inpatient and 42.6% outpatient/day hospital) and most of them (68.85%) were 
medicated: fluoxetine and sertraline were the most represented medications. Patients 
with AN were divided, according to the Body Dysmorphic Questionnaire (BDQ; see 
measures section), in two subgroups:  patients with weight-related body image concerns 
only (AN-only; N = 22; 59.1% restricting type) and patients with nonweight-related 
body image concerns (AN+NWRC; N = 39; 87.2% restricting type). An additional 
group of 61 healthy controls (HCs) was recruited. None of the HCs met diagnostic 
criteria for any current psychiatric disorder and none were taking any psychiatric 
medications. Groups were equivalent with respect to age and years of education (Table 
1), whereas significant differences on Body Mass Index (BMI) emerged: Bonferroni 
post hoc comparisons revealed that the BMI of the clinical groups was lower than the 
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BMI of the HC group (p < .001), whereas no differences between clinical groups 
emerged (p = .99; Table 1). With respect to marital status and occupation, significant 
differences among the groups emerged (p = .002 and p = .001, respectively; Table 2). 
Table 1.  
Comparisons among patients with weight-related body image concerns only (AN-only group), 
patients with nonweight-related body image concerns (AN+NWRC group) and healthy controls 
(HC group) on age, education and BMI 
 
AN-only (1) 
(N = 22) 
M (SD) 
AN+NWRC (2) 
(N = 39) 
M (SD) 
HC (3) (N = 61) 
M (SD) 
F 
(2,120) 
p Post-hoc 
Age 28 (10.12) 24.56 (8.81) 25.97 (9.34) .96 .39 - 
Years of education 12.73 (3.64) 12.84 (2.54) 12.98 (2.48) .08 .92 - 
BMI 16.68 (2.38) 16.32 (2.41) 22.02 (3.12) 61.19 <.001 1 = 2 < 3 
 
Table 2.  
Frequencies of occupation and marital status 
Occupation 
AN-only 
(N = 22) 
 
AN+NWRC 
(N = 39) 
 
HC  
(N = 61) 
 
Marital 
status 
AN-only 
(N = 22) 
 
 
AN+NWRC 
(N = 39) 
 
HC 
(N = 
61) 
 
Student 9 21 37 Single 14 27 20 
Full time 
employed 
2 
6 9 
In a 
relationship 
3 7 
29 
Part time 
employed 
0 
4 5 Married 5 4 
12 
Unemployed 8 5 0  
Other 2 3 7  
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3.2.2 Measures 
All participants completed a brief schedule collecting socio-demographic information. 
Given that no Italian standardized measures assessing BDD were available, two ad hoc 
self-report instruments were developed: the Body Dysmorphic Questionnaire (BDQ) 
and the Questionario sul Dismorfismo Corporeo (QDC). 
The Body Dysmorphic Questionnaire (BDQ) is a self-report measure assessing DSM-5 
criteria for BDD. The measure is made up of 5 dichotomous items. The first item 
evaluates concerns with one or more perceived defects in psychical appearance that are 
not observable to others. If the answer is positive, the participant is required to list areas 
of concerns and degree of dissatisfaction. The second item assesses the presence of 
repetitive behaviours (e.g., mirror checking, excessive grooming, skin picking, 
reassurance seeking) or mental acts (e.g., comparing appearance with that of others) in 
response to the appearance concerns. In order to proceed, positive answers to these two 
items should be provided. The third question asks whether the main source of concern is 
not being thin enough or being too fat. The fourth question assesses the presence of 
distress or impairment in social and occupational functioning and the presence of 
avoidant behaviours because of the appearance concerns. Finally, the last item measures 
the time spent every day thinking about defects. Phillips (1998) suggested that the time 
spent by thinking about perceived defects should be at least 1 hour every day. A 
positive screen for BDD is obtained if participants report positive answers to questions 
one, two and four. Moreover, a negative answer to question number three is required. 
Finally, in accordance with Phillips’s (1998) advice, participants should spend at least 1 
hour per day thinking about perceived defects.  
 
 
68 
The Questionario sul Dismorfismo Corporeo (QDC) is a self-report measure made up 
of 40 items assessing clinical features of BDD. Items are rated on a 7-point Likert scale 
(from 1 = “strongly disagree” to 7 = “strongly agree”). Higher scores represent more 
severe BDD symptomatology. The QDC evaluates the presence of typical behaviours 
associated with BDD, such as repetitive behaviours (e.g., reassurance seeking and 
mirror checking), mental acts (e. g., comparing the supposed defect with the same body 
areas of other people), and avoidant behaviours related to appearance concerns. The 
QDC also assesses the request of cosmetics and surgical procedures and suicidal 
thoughts due to appearance concerns. Internal consistency coefficient in the present 
sample was excellent (α = .97). 
The Eating Disorder Inventory-2 (EDI-2; Garner, 1991; Rizzardi, Trombini, & 
Trombini, 1995) is a 91-item self-report questionnaire revised from the EDI-1 (Garner 
& Olmsted, 1984) assessing psychological features and behaviours relevant in eating 
problems on a 6-point Likert scale (ranging from 1 = “Never” to 6 = “Always”). The 
EDI-1 was made up of 64 items forming eight scales (drive for thinness, bulimia, body 
dissatisfaction, ineffectiveness, perfectionism, interpersonal distrust, interoceptive 
awareness, maturity fears) and then expanded with 27 additional items to form the three 
new scales (asceticism, impulse regulation, social insecurity) of the EDI-2. The original 
scales of EDI-2 showed good internal consistency, with coefficient alphas ranging 
from .80 to .91 in a clinical samples (Eberenz & Gleaves, 1994), whereas coefficient 
alphas of the 3 new subscales ranging from .70 to .80 (Garner, 1991). With respect to 
the Italian version of the questionnaire, coefficient alphas ranging from .78 to .84 in a 
clinical sample (Rizzardi et al., 1995). In the present sample, alpha coefficients for the 
EDI-2 subscales ranged from α = 65. to α = .93. 
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The Obsessive Compulsive Inventory-42 (OCI-42; Foa, Kozak, Salkovskis, Coles, & 
Amir, 1998; Italian version by Sica et al., 2009) is a 42-item self-report measure 
assessing frequency and distress caused by OCD symptoms. Each item is rated on a 5-
point Likert scale (ranging from 0 = “Not at all” to 4 = “Extremely”), and the 
questionnaire is made up of 7 subscales: washing, checking, ordering, obsessing, 
doubting, mental neutralizing, and hoarding. Internal consistency values of the original 
version were good (α = .86 to .95; Foa et al., 1998), as were those observed in an Italian 
clinical group (α = .77 to .94; Sica et al., 2009). In the present study, only distress 
associated with obsessions and compulsions was taken into account since the two scales 
(frequency and distress) have been demonstrated to yield redundant information (e.g., 
Foa et al., 2002; Wu & Watson, 2003). The OCI was preferred over the shorter 18-item 
version (OCI-R) because previous investigations showed that the brevity of the OCI-R 
may be of concern, especially for a restricted score range (Ghisi, Chiri, Marchetti, 
Sanavio, & Sica, 2010; Sica, Caudek, Chiri, Ghisi, & Marchetti, 2012). In the present 
study, the alpha coefficient for the total OCI distress was α = .96, whereas alpha 
coefficients for the OCI subscales ranged from α = .79 to α = .91. 
The Depression Anxiety Stress Scale-21 (DASS-21; Lovibond & Lovibond, 1995; 
Italian version by Bottesi et al., 2015) is a 21-item self-report measure that assesses 
depression, anxiety, and stress on a 4-point Likert scale (ranging from 0 = “Did not 
apply to me at all,” to 3 = “Applied to me very much or most of the time”), with higher 
scores representing greater distress. Three subscale scores as well as a “general distress” 
total score can be computed (Bottesi et al., 2015). The original DASS-21 showed 
adequate reliability, with coefficient alphas ranging from .73 to .81 in non-clinical 
samples (Lovibond & Lovibond, 1995). The Italian version proved to be highly reliable 
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as well, with internal consistency values ranging from α = .74 and α = .90 (Bottesi et al., 
2015). Given that findings on the Italian version suggested that use of the total score, 
measuring a “general distress” factor, could be more appropriate than calculating the 
three subscale scores separately (Bottesi et al., 2015), for the purpose of the presence 
research we focused only on the total score of the questionnaire. In the present study, 
the alpha coefficient for the total DASS was excellent (α = .95). 
The Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998; Italian version by 
Sica et al., 2007) is a 19-item self-report questionnaire designed to assess social 
interaction anxiety on a 5-point Likert scale (0 = “not at all characteristic of true of me”; 
4 = “extremely characteristic of true of me”); higher scores represent higher levels of 
social interaction anxiety. The SIAS showed strong psychometric properties (Mattick & 
Clarke, 1998), including high internal consistency (α = .94) and 1 month test-retest 
stability (r = .92). The Italian version proved to be highly reliable and stable as well 
(Sica et al., 2007), with an internal consistency value of α = .86 and 1 month test-retest 
stability of r = .93. In the present study, the alpha coefficient for the SIAS was excellent 
(α = .95). 
The Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965; Italian version by Prezza, 
Trombaccia, & Armento, 1997) is a self-report questionnaire made up of 10 items 
assessing global self-esteem. Items are rated on a 4-point Likert scale (from 1= 
“strongly disagree” to 4 = “strongly agree”), with higher scores representing positive 
self-esteem. Good internal consistency values have been reported for the original RSES, 
ranging between α = .77 and α = .88 (Dobson, Goudy, Keith, & Powers, 1979; Fleming 
& Courtney, 1984; Robinson, Shaver, & Wrightsman, 1991). The Italian version also 
showed good psychometric properties: its internal consistency was α = .84 and the 15-
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days test-retest reliability was r = .76 (Prezza et al., 1997). Internal consistency 
coefficient in the present sample was excellent (α = .93). 
The Multidimensional Perfectionism Scale (MPS; Hewitt & Flett, 1991) is a 45-item 
measure evaluating three different domains of perfectionism: self-oriented, socially 
prescribed and other-oriented. Self-oriented perfectionism includes internal beliefs 
about striving for perfection and setting high standards for oneself, socially prescribed 
perfectionism involves beliefs that high standards are expected by significant others, 
and other-oriented perfectionism places importance on significant others being perfect 
(Hewitt & Flett, 1991). Each subscale contains 15 items evaluated on a 7-point Likert 
scale (1 = “strongly disagree”; 7 = “strongly agree”), with higher scores indicating 
greater levels of perfectionism. Good internal consistency values have been reported for 
the original MPS, ranging between α = .79 and α = .89 in a student sample (Hewitt & 
Flett, 1991). The Italian validation of the MPS is not available to date, therefore an ad 
hoc translation was employed. In the present sample, the alpha coefficient was .93 for 
the self-oriented scale, .88 for the socially prescribed scale and .79 for the other-oriented 
perfectionism subscale. 
3.2.3 Procedure 
Patients with AN who entered the study were recruited from both inpatient and 
outpatient mental health clinics in the Northern Italy. The HC group was recruited 
through advertisements in public settings, railway stations, libraries, and university 
buildings, requesting potential volunteers for psychological studies. Before entering the 
study, all participants were informed about the study’s aims and about the voluntary 
nature of their participation; furthermore, they were aware of the possibility of 
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withdrawing from the study without penalty. All participants provided written informed 
consent and completed a brief schedule collecting socio-demographic information. 
Subsequently, they filled in self-report questionnaires administered in a rotated 
sequence to avoid order effects. No time limit for completion was imposed (the mean 
time spent filling in questionnaires was approximately 45 minutes).  
The study was conducted in accordance with the Declaration of Helsinki and approved 
by the Ethical Committee of the Psychological Sciences, University of Padova. 
3.2.4 Statistical Analyses 
In order to assess the presence of differences among groups on socio-demographic 
variables, chi-squared analyses and one-way analyses of variance (ANOVAs) were 
conducted. Bonferroni post-hoc comparisons were conducted to compare the groups 
when significant differences emerged. In order to estimate the presence of nonweight-
related body image concerns and prevalence of BDD in patients with AN, descriptive 
analyses (frequencies and percentages) were performed. Finally, one-way ANOVAs 
were performed in order to compare groups (AN-only group vs. AN+NWRC group vs. 
HC group) on psychological and psychopathological features and Bonferroni post hoc 
comparisons were computed when significant differences emerged. Conventional 
significance levels were used (ps < .05) for the QDC, the DASS-21, the SIAS, the RSES, 
and the MPS, whereas Bonferroni’s corrections for multiple comparisons were applied 
to the EDI-2 and the OCI-42 subscales (p < .004 and p < .006, respectively). All 
statistical analyses were conducted using IBM SPSS statistics, version 21. 
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3.3 Results 
3.3.1 Presence of nonweight-related body image concerns and prevalence of BDD in 
patients with AN 
Among all of the 61 patients with AN who entered the study, 39 (63.93%) reported the 
presence of nonweight-related body image concerns. The most frequent nonweight-
related body image concerns were: hair (41.02%), nose (30.77%), skin (30.77%), teeth 
(25.64%), and height (20.51%; Table 3). Among these 39 patients with nonweight-
related body image concerns, 16 (41.03%) had probable comorbid BDD based on the 
questions of the BDQ (see measures section). With respect to the overall sample, 26.23% 
of patients had probable comorbid BDD. Patients diagnosed with comorbid BDD were 
primary concerned with one or more perceived defects in physical appearance unrelated 
to weight or body shape. Of these 16 patients with AN, 13 (81.25%) had the restrictive 
subtype and 3 (18.75%) the purging/binge subtype. 
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Table 3.  
Frequencies of nonweight-related body image concerns in patients with AN 
 
 
Frequencies 
Hair 16 
Nose 12 
Skin 12 
Teeth 10 
Height 8 
Face (shape) 8 
Body hair 8 
Breast 8 
Feet 6 
Eyes 5 
Hands 5 
Scars 4 
Shoulders 2 
Lips 2 
Moles 2 
Finger 1 
Knees 1 
Ears 1 
Back 1 
 
3.3.2 Psychological and psychopathological features among AN-only, AN+NWRC and 
HC 
BDD symptoms. With respect to BDD symptoms, the ANOVA revealed differences 
among groups on QDC. Both the AN-only and the AN+NWRC groups scored 
significantly higher than the HC group on QDC total score (both ps < .001). Moreover, 
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the AN+NWRC group scored significantly higher than the AN-only group (p = .02). 
Means, standard deviations and comparisons are reported in Table 4.  
EDs symptoms. With respect to EDs symptoms, the ANOVAs revealed differences 
among groups on all the EDI-2 subscales with the exception of the Bulimia subscale. 
Both AN-only and AN+NWRC groups scored significantly higher than the HC group 
on the Drive for thinness, Body dissatisfaction, Ineffectiveness, Interpersonal distrust, 
Interoceptive awareness, Asceticism, Impulse regulation and Social insecurity subscales 
(all ps < .05). Moreover, the AN+NWRC group scored significantly higher than the 
AN-only group on the Ineffectiveness, Interpersonal distrust, Interoceptive awareness, 
Asceticism, and Social insecurity subscales (all ps < .05). With respect to the 
Perfectionism subscale, the AN+NWRC group scored significantly higher than the HC 
group (p < .001), while the AN-only group did not differ from neither the AN+NWRC 
(p = .06) nor the HC groups (p = .81). Means, standard deviations and comparisons are 
reported in Table 4.  
Obsessive-compulsive symptoms and general distress. With respect to obsessive-
compulsive symptoms, significant differences among groups on the OCI-42 Washing, 
Doubting, Ordering, Obsessing, and Neutralizing subscales, and on the total score were 
found. On each scales, both the AN-only and the AN+NWRC groups scored 
significantly higher than the HC group (ps < .05). Moreover, the AN+NWRC group 
scored higher than the AN-only group on the Obsessing subscale and on the total score 
(p = .03 and p = .04, respectively). There were no differences among the groups on the 
Checking and Hoarding subscales of the OCI-42 (ps > .05).  
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Concerning general distress, both the AN-only and the AN+NWRC groups scored 
significantly higher than the HC group on DASS-21 total score (p < .05), whereas no 
difference between the AN-only and the AN+NWRC emerged (p > .05). Means, 
standard deviations and comparisons are reported in Table 4.  
Social anxiety, self-esteem and perfectionism. With respect to social anxiety, significant 
differences between groups on the SIAS total score were found. Both the AN-only and 
the AN+NWRC groups scored significantly higher than the HC group (p < .05). 
Moreover, the AN+NWRC group scored significantly higher than the AN-only group (p 
< .05). Means, standard deviations and comparisons are reported in Table 4.  
Significant differences between groups were found on the RSES total score. Both the 
AN-only and the AN+NWRC groups scored significantly lower than the HC group 
(both ps < .001). Moreover, the AN+NWRC group scored significantly lower than the 
AN-only group (p = .02). Means, standard deviations and comparisons are reported in 
Table 4.  
Concerning perfectionism, differences among groups emerged. The AN+NWRC group 
scored significantly higher on the Self-oriented and Socially prescribed perfectionism 
MPS subscales than the HC group (both ps < .001), whereas the AN-only group did not 
differ from either the AN+NWRC (p = .08 and p = .51, respectively) and HC groups (p 
= .75 and p = .09, respectively). There was no difference between the groups on the 
MPS Other-oriented subscale (ps > 0.05; Table 4).  
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Table 4.  
Comparisons among patients with weight-related body image concerns only (AN-only group), 
patients with nonweight-related body image concerns (AN+NWRC group) and healthy controls 
(HC group) on psychological and psychopathological features 
 
AN-only (1) 
(N = 22) 
M (SD) 
AN+NWRC (2) 
(N = 39) 
M (SD) 
HC (3) (N = 61) 
M (SD) 
F (2,120) p Post-hoc 
QDC 
140.19 
(56.93) 
172.54 (42.69) 
94.64 (32.62) 39.79 <.001 2 > 1 > 3 
EDI drive for 
thinnes 
12.90 (7.80) 13.92 (7) 
3.27 (3.79) 46.98 <.001 1 = 2 > 3 
EDI bulimia 3.50 (4.56) 2.47 (3.95) 1.57 (2.56) 2.68 .07 - 
EDI body 
dissatisfaction 
12.73 (8.27) 17.21 (6.46) 
7.41 (6.69) 23.64 <.001 1 = 2 > 3 
EDI 
ineffectiveness 
9 (5.79) 16.08 (7.96) 
2.79 (3.07) 68.35 <.001 2 > 1 > 3 
EDI 
perfectionism 
3.91 (3.08) 6.26 (4.70) 
2.88 (3.19) 9.79 <.001 2 > 3 = 1  
EDI 
interpersonal 
distrust 
5.90 (3.99) 8.51 (4.52) 
2.69 (2.77) 31.25 <.001 2 > 1 > 3 
EDI 
interoceptive 
awerness 
9 (6.12) 12.81 (7.87) 
2.06 (3.35) 44.79 <.001 2 > 1 > 3 
EDI maturity 
fears 
7.33 (5.62) 8.72 (7.12) 
5 (4.99) 4.93 .01 2 > 3 = 1  
EDI asceticism 6.33 (3.69) 8.86 (4.32) 3.26 (2.75) 29.71 <.001 2 > 1 > 3 
EDI impulse 
regulation 
5.80 (5.64) 8.03 (6.79) 
2.02 (3.38) 16.22 <.001 1 = 2 > 3 
EDI social 
insecurity 
7.52 (3.88) 11.43 (4.82) 
3.57 (2.86) 51.23 <.001 2 > 1 > 3 
OCI washing 5.71 (4.88) 7.87 (7.67) 3.59 (3.95) 7.05 .001 1 = 2 > 3 
OCI checking 5.81 (6.18) 7.22 (7.45) 4.46 (4.38) 2.62 .08 - 
OCI doubting 2.62 (2.84) 4 (3.52) 1.61 (1.78) 9.79  <.001 1 = 2 > 3 
OCI ordering 5.55 (5.63) 7.58 (6.64) 3.22 (3.01) 9.33 <.001 1 = 2 > 3 
OCI obsessing 8.91 (7.87) 13.37 (8.67) 4.47 (3.85) 22.19 <.001 2 > 1 > 3 
OCI hoarding 2.71 (3.10) 3.10 (3.26) 2.13 (2.08) 1.59 .21 - 
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OCI 
neutralizing 
3.05 (3.33) 5.77 (6.37) 
2.75 (2.76) 6.07 .003 2 > 1 > 3 
OCI total score 29.95 (27.35) 48.23 (36.85) 21.63 (15.11) 11.89 <.001 2 > 1 > 3 
DASS total 
score 
25.24 (13.15) 31.60 (14.50) 
13.27 (9.78) 27.45 <.001 1 = 2 > 3 
SIAS 27.24 (16.88) 41.47 (17.29) 21.49 (11.59) 21.38 <.001 1 = 3 < 2 
RSES 23.73 (5.63) 19.81 (5.81) 31.70 (5.02) 59.84 <.001 2 < 1 < 3 
MPS Self-
Oriented 
66.41 (21.37) 78.60 (22.98) 
60.67 (17.24) 9 <.001 1 = 2 > 3 
MPS Other-
Oriented 
53 (12.04) 48.76 (15.41) 
50.93 (13.11) .62 .54 - 
MPS Socially 
Prescribed 
57.67 (18.20) 63.71 (18.55) 
48.80 (13.65) 10.29 <.001 2 > 1 > 3 
 
3.4 Discussion 
BDD and AN are severe disorders characterized by body image concerns (Rosen et al., 
1995). Despite the high comorbidity between these disorders (Dingemans et al., 2012; 
Fenwick & Sullivan, 2011; Grant et al., 2002; Kollei et al., 2013; Ruffolo et al., 2006), 
few studies have explored the relation between BDD and AN. Indeed, to the Authors’ 
knowledge, this is the first study assessing the prevalence of BDD and the presence of 
nonweight-related body image concerns in an Italian clinical sample with AN. 
Moreover, this is the first study assessing the prevalence of BDD in patients with AN 
accordingly with DSM-5 criteria (APA, 2013).  
The present study showed that 63.93% of the patients with AN reported the presence of 
nonweight-related body image concerns. Moreover, 26.23% of these patients screened 
positive for BDD. Therefore, the present study suggested a BDD prevalence of 26.23% 
in Italian patients with AN. These findings are in accordance with previous studies that 
found a high presence of nonweight-related body image concerns and high rates of 
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BDD prevalence in patients with AN, ranging from 9.8% (Kollei et al., 2013) to 46% 
(Dingemans et al., 2012). Our study found a prevalence of BDD in the middle of the 
range reported by the literature. The prevalence we found may be explained by the 
adoption of DSM-5 (APA, 2013) diagnostic criteria and by methodological and sample 
differences. The study of Dingemans et al. (2012), for example, employed self-report 
questionnaires assessing BDD according to DSM-IV (APA, 1994) criteria in a sample 
of AN patients from The Netherland, whereas the studies of Kollei et al. (2013) and 
Grant et al. (2002) employed both structured clinical interviews and self-report 
questionnaires to assess DSM-IV (APA, 1994) BDD criteria in a German and USA 
sample, respectively.  
Furthermore, we found that hair, nose, skin, teeth, and height were the most common 
nonweight-related body image concerns. As reported in previous studies (Gupta, Gupta, 
& Haberman, 1987; Kollei et al., 2013; Tyler, Wiseman, Crawford, & Birmingham, 
2002), the presence of concerns with hair, skin and teeth may be partially explained by 
the consequences of AN core symptoms (for example, starvation, vomiting, and abuse 
of laxatives and diuretics); however, the presence of concerns unrelated to organ 
systems affected by AN, such as nose and height, may be explained by a severe body 
image disturbance not limited to weight and shape in a subgroup of our clinical sample. 
Therefore, based on the presence of nonweight-related body image concerns, we 
decided to divide the clinical sample in two subgroups: the AN+NWRC group and the 
AN-only group.  
The evidence of a subgroup of patients in our sample characterized by a severe body 
image disturbance not limited to weight and shape is supported by the finding that the 
two clinical groups differed with respect to BDD symptomatology. Patients in the 
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AN+NWRC group presented with more BDD symptoms such as repetitive behaviours, 
mental acts, avoidant behaviours, request of aesthetical procedures, and suicidal 
thoughts related to appearance concerns than the AN-only group, suggesting the 
presence of a more severe body image disorder. Interestingly, both the clinical groups 
emerged to differ from the HC group but were equivalent with respect to weight-related 
measures such as the BMI and the EDI-2 subscales, which assess the core features of 
AN symptomatology (drive for thinness and body dissatisfaction, as suggested by the 
study of Gupta and Johnson, 2000). Therefore, the presence of nonweight-related body 
image concerns in the AN+NWRC group seems unrelated to a more severe eating 
pathology, as emerged in the study of Dingemans and colleagues (2012).  
Therefore, our clinical sample includes a subgroup of patients characterized by a severe 
body image disturbance not limited to weight and shape. This result is only partially in 
accordance with the study of Gupta and Johnson (2000). Indeed, these authors found 
multiple nonweight-related body image concerns in patients with AN but, in contrast to 
our findings, these areas of concerns emerged to be associated with greater 
dissatisfaction with the usual weight-related indices, such as drive for thinness and body 
dissatisfaction. Concerning other EDs symptoms, the two clinical groups differed from 
each other with respect to symptom dimensions that measure broad constructs, rather 
than those related to weight and shape.  
Relative to the AN-only group, the AN+NWRC group showed higher levels of feeling 
of inadequacy and worthlessness, social fears, as well as reluctance to develop close 
relationships. Moreover, the AN+NWRC group showed greater lack of confidence in 
recognizing emotions and sensations of hungry and satiety and a stronger need to 
control one’s need by self-discipline and sacrifices than the AN-only group. Lastly, both 
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clinical groups differed from the HC group with respect to all EDI-2 subscales, with the 
exception of Bulimia subscale, assessing the presence of binge eating episodes followed 
by the impulse to engage in self-induced vomiting. Nevertheless, only the AN+NWRC 
group showed higher levels of perfectionistic traits and fears of facing the demands of 
adult life than the HC group, whereas no differences emerged with respect to the AN-
only group. These results are in accordance with studies underlined that patients with a 
more severe body image concerns are characterized by more impairment that patients 
with body image concerns only (Grant et al., 2002; Dingemans et al., 2012). 
With respect to OCD symptoms, as expected, both clinical groups showed more OCD 
features than the HC group, with the exception of checking and hoarding 
symptomatology, where no differences among groups emerged. Although checking 
behaviours are more common in patients with AN than in healthy controls (Mountford, 
Haase, & Waller, 2006; Shafran, Fairburn, Robinson, & Lask, 2004), our results did not 
underline a difference with respect to checking behaviours between clinical groups and 
healthy controls. This result may explain by the fact that patients in the present study 
were in treatment; giving that the severity of AN is associated with the frequency of 
body checking and it represent one of the most important maintaining factors of AN 
(Shafran, Teachman, Kerry, & Rachman, 1999; Shafran et al., 2004), one of the aims of 
AN treatment is to reduce checking behaviours, particularly body checking. The 
AN+NWRC group showed also more severe overall OCD features and obsessive 
symptoms than the AN-only group. This result is consistent with studies that underlined 
the presence of higher OCD symptoms in patients with BDD (Bohne, Wilhelm et al., 
2002; Gunstad & Phillips, 2003) and studies underscoring that a more severe body 
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image disturbance is associated with greater OCD symptomatology (Biby, 1998; Bohne, 
Keuthen, Wilhelm, Deckersbach, & Jenike, 2002; Tamini, Rahdar, & Kahrazei, 2015). 
Concerning general distress, both clinical groups showed higher distress than the HC 
group, whereas the two clinical groups did not differ. This result was somewhat 
unexpected given that the presence of a more severe body image disturbance should 
lead to a greater distress (Grant et al., 2002; Dingemans et al., 2012), and it might be 
explained by the fact that all patients in our study were in undergoing psychological 
treatment, therefore general distress may have been attenuated in the AN+NWRC group.  
With respect to social anxiety, as hypothesized, both clinical groups scored higher than 
the HC group. Moreover, the AN+NWRC group reported higher levels of social anxiety 
characteristics than the AN-only group, in accordance with studies reporting that the 
presence of multiple concerns about defects in physical appearance may be likely 
associated with the fear of negative evaluation by others, which is also the core feature 
of social anxiety disorder (Fang & Hofmann, 2010). 
Concerning self-esteem, as expected, both clinical groups scored lower than the HC 
group. This result is in accordance with the study of Rosen and Ramirez (1998) that 
found low self-esteem in patients with body image disorders compared to nonclinical 
controls. Indeed, a deficiency in self-esteem might be essential for the development and 
course of body image disorders (Grubb, Sellers, & Waligorski, 1993). In addition, the 
AN+NWRC group showed lower levels of self-esteem than the AN-only groups, in 
accordance with studies that found a correlation between low self-esteem and poor body 
esteem (Biby, 1998; Bohne, Wilhelm et al., 2002).  
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Lastly, the AN+NWRC group reported that they set higher standards for themselves and 
had stronger beliefs that high standards are expected by significant others than the AN-
only group and the HC group. This finding is in accordance with studies underlining 
that perfectionism may play a key role in the development of body image disorders, 
especially BDD (Andreasen & Bardach, 1977; Bartsch, 2007; Hanstock & O’Mahony, 
2002).  
Although current findings are intriguing, several limitations characterizing the present 
study deserve to be mentioned. First of all, the sample size was somewhat small and 
there was a lack of information regarding past and current comorbidity; second, patients 
in the current study were in treatment and our findings may not be generalizable to other 
patients with AN; third, there was an absence of psychometric information for some of 
our self-report measures.  
As a whole, in accordance with the study of Rosen and Ramirez (1998), both clinical 
groups were more impaired than the HC group. Moreover, the AN+NWRC group was 
revealed to be more impaired than the AN-only group with respect to almost all the 
psychological and psychopathological features we assessed, with the exception of core 
ED symptoms (such as BMI and drive for thinness and body dissatisfaction subscales of 
EDI-2) and general distress. These findings are in accordance with previous studies that 
highlighted a more severe psychopathology in patients with AN and nonweight-related 
body image concerns (Grant et al., 2002; Dingemans et al., 2012); therefore, it is 
important to assess the presence of nonweight-related body image concerns in patients 
with AN, giving that it seems to confer additional risk and severity (Grant et al., 2002; 
Dingemans et al., 2012). 
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Chapter 4 
Prevalence of Muscle Dysmorphia and its associated 
psychological features in three groups of Italian recreational 
athletes 
 
4.1 Introduction 
Muscle Dysmorphia (MD) is a subtype of Body Dysmorphic Disorder (BDD) 
characterized by the preoccupation with the idea that one’s body is not sufficiently lean 
and muscular (American Psychiatric Association [APA], 2013; Pope, Gruber, Choi, 
Olivardia, & Phillips, 1997; Pope, Phillips, & Olivardia, 2000). Individuals with MD 
perceive themselves as small and weak even if they look normal or more muscular than 
the average of people (Choi, Pope, & Olivardia, 2002; Pope et al., 1997). As a 
consequence, individuals with MD engage in behaviors aiming at achieving the desired 
lean and muscular physique (Pope et al., 1997); these behaviors are compulsive and 
include excessively workout and rigid diet, as well as excessive use of dietary 
supplements and anabolic-androgenic steroids (AAS) use (Olivardia, 2001; Olivardia, 
Pope, & Hudson, 2000; Phillips, O’ Sullivan, & Pope, 1997; Pope et al., 1997). 
Individuals with MD frequently avoid important social or occupational activities 
because of the compulsive need to maintain their workout and rigid diet (Olivardia, 
2001; Pope et al., 1997); any deviation from these regimens results in marked distress 
(Pope et al., 1997). In regard to compulsive workout and rigid diet, many studies stated 
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that MD shares clinical features with Eating Disorders (EDs), specifically with 
Anorexia Nervosa (AN); indeed MD was first described as “reverse anorexia” 
(Kuennen & Waldron, 2007; Pope, Katz, & Hudson, 1993). MD and AN share body 
distortion and dissatisfaction, dysfunctional eating behaviors and psychological features 
such as perfectionism and low self-esteem (Grieve, 2007; Pope et al., 1993). Literature 
well documented the high comorbidity between MD and EDs (Nieuwoudt, Zhou, Coutts, 
& Booker, 2015; Olivardia et al., 2000), but little is known about dysfunctional eating 
patterns such as Orthorexia Nervosa (ON) in individuals with MD. ON is defined as an 
obsession for healthy food and differs from EDs since the eating pathology is expressed 
in a “qualitative” way in the former and in a “quantitative” manner in the latter (Donini, 
Marsili, Graziani, Imbriale, & Cannella, 2005; Olivardia et al., 2000). 
As mentioned, psychological features may play a role in the development of MD. 
Perfectionism might be involved given that individuals with MD struggle to reach an 
unattainable body shape (Grieve, 2007; Skemp, Mikat, Schenck, & Kramer, 2013), and 
it may influence the development of MD both directly and indirectly. The direct 
influence relies in the pursuit of the perfect body, whereas the indirect influence might 
be enacted through body dissatisfaction (Grieve, 2007). 
Also self-esteem might play a key role in the development of MD (Cafri et al., 2005; 
Grieve, 2007; Lantz, Rhea, & Mayhew, 2001; Olivardia, 2001): the existence of a 
negative association between self-esteem and MD symptoms has been documented 
(Kuennen & Waldron, 2007; Olivardia, Pope, Borowiecki, & Cohane, 2004); 
furthermore, individuals with MD are characterized by lower self-esteem levels than 
individuals without MD (Pope et al., 2000). In individuals with MD, self-esteem 
depends on physical appearance (Olivardia, 2001; Pope et al., 2000); therefore, their 
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level of self-esteem varies accordingly to the satisfaction with their physical appearance 
(Grieve, 2007). Low self-esteem provides a source of motivation for MD behavioral 
symptoms (Crocker, 2002): individuals with MD may engage appearance-improving 
behaviors such as weightlifting, excessive workout, rigid diet, and heavy use of dietary 
supplements and AAS to enhance their self-esteem (Crocker, 2002). The muscular 
development obtained performing these activities enhance self-esteem, and the person is 
reinforced to engage in these activities again. Low self-esteem may also contribute to 
the avoidance of social situations in which the body is exposed to others, and such 
avoidance is negatively reinforced by a temporary reduction in anxiety (Olivardia, 
2001); indeed, individuals with MD try to avoid any places and situations in which their 
body might be seen by others (e.g. beaches, swimming pools), or endure such situations 
with marked distress and anxiety (Olivardia, 2001; Pope et al., 1997). Although the role 
of social physique anxiety has been well explored with respect to MD development 
(Ebbeck, Watkins, Concepcion, Cardinal, & Hammermeister, 2009; Pope et al., 1997), 
little is known about social anxiety in MD. 
MD affects mostly men (Pope et al., 1997), and its prevalence rates vary significantly 
depending on the sample population; in particular, athletes involved in weightlifting 
activities are considered at high-risk for MD development (Pope et al., 1993; Pope et al., 
1997). However, a generalization for all athletes involved in weight training activities 
does not appear to be justified: a discrepancy of MD prevalence and features among 
subgroups within the weightlifting community exists, and it depends on the goals of the 
weight training activity (Skemp et al., 2013). Indeed, athletes who engage in 
appearance-related weight training (e.g. bodybuilders) may be at greater risk for MD 
development than athletes involved in weight training to improve strength (e.g. strength 
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trainers/power lifters; Skemp et al., 2013). In fact, many studies underlined that 
bodybuilders display higher MD prevalence rates and more MD features than other 
weightlifting trainers (e. g. strength trainers/power lifters; Cella, Iannaccone, & Cotrufo, 
2012; Lantz, Rhea, & Cornelius, 2002; Mitchell et al., 2016; Pope et al., 1997; Skemp et 
al., 2013), with prevalence rates within this population ranging from 3.4% (Cella et al., 
2012) to 53.6% (Hitzeroth, Wessels, Zungu-Dirwayi, Oosthuizen, & Stein, 2001). 
Therefore, differences in goals characterizing bodybuilders and other weightlifters may 
influence the prevalence and the manifestation of MD symptoms (Mosley, 2009) 
Although bodybuilders are considered at high risk for developing MD (Pope et al., 1993; 
Pope et al., 1997; Skemp et al., 2013), the study of Pickett, Lewis, & Cash (2005) 
reported that competitive bodybuilders did not differ from other weight trainers with 
respect to the self- evaluation of their body image; furthermore, both groups reported 
higher positive self-evaluation of their body than physically active controls. Moreover, 
both competitive bodybuilders and weigh trainers were more satisfied about their upper 
torso and muscle tone than physically active controls. Finally, competitive bodybuilders 
reported more social self-esteem than both weight trainers and athletically active 
controls (Pickett et al., 2005). Also results from the study of Finkenberg and Teper 
(1991) highlighted that bodybuilders had significantly higher scores on personal, social, 
and satisfaction dimensions of self-concept than non-bodybuilders. These inconsistent 
findings may be due to sampling methods (e. g. different level of competition) and by 
the self-report measures employed to assess MD, that may fail in the evaluation of the 
condition’s key features (Mosley, 2009).  
As far as concern psychological features that may play a different role with respect to 
MD development within the weightlifters community, a recent review and meta-
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analysis by Mitchell and colleagues (2016) found that anxiety, depression, and 
neuroticism were positively associated with MD, whereas self-esteem was negatively 
associated with it within a bodybuilding group. Interestingly, within a sample of non-
bodybuilder resistance trainers, MD was positively associated with anxiety, depression, 
and also with social physique anxiety and perfectionism; with respect to self-esteem, as 
in the bodybuilding group, it resulted negatively associated with MD (Mitchell et al., 
2016). 
Despite the increased awareness and interest towards MD in recent studies, it continues 
to be an under-studied disorder, especially in the Italian context. Indeed, to the Authors’ 
knowledge, only one study has explored the prevalence of MD in the Italian context, 
and it found a prevalence rate of 3.4% in bodybuilders (Cella et al., 2012). Also the 
study of Santarnecchi and Dèttore (2012) assessed MD in samples of Italian competing 
bodybuilders, non-competing bodybuilders and non-training individuals, but no data 
pertaining its prevalence were reported. Therefore, the main purpose of the present 
study was to explore the prevalence and the phenomenology of MD in three groups of 
Italian participants who trained regularly for recreational purposes: bodybuilders, 
strength trainers, and fitness wellness trainers. Given that MD prevalence varies 
according to the goals of weight training activity (Skemp et al., 2013) and may varies in 
accordance with the level of competition, we decided to focus on bodybuilders and 
strength trainers given that they are characterized by different goals in weight training 
activity and because both athletes train for recreational purposes. To note, we included 
the fitness/wellness group as a control group given that it shares training features with 
bodybuilders and strength trainers.  
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In accordance with some of the previous studies, we expected higher MD prevalence 
and features in bodybuilders than in the other two groups (Cella et al., 2012; Hitzeroth 
et al., 2001; Lantz et al., 2002; Mitchell et al., 2016; Pope et al., 1997). Shedding light 
on the prevalence and phenomenology of MD in these groups of athletes might improve 
MD assessment and treatment methodologies, as well as raise awareness about this 
disorder. The second aim of the present study was to investigate MD related 
psychological features such as self-esteem, perfectionistic traits, social anxiety and ON 
symptoms, and general distress within these groups of athletes. In accordance with the 
majority of the previous studies, we expected to observe lower levels of self-esteem and 
higher perfectionistic traits, as well as higher orthorexic behaviors in bodybuilders than 
in the other two groups, given that these features frequently co-occur with MD and we 
hypothesized that bodybuilders are characterized by higher MD prevalence and features 
(Anderson et al., 1995; Blouin & Goldfield, 1995; Muller, Dennis, Schneider, & Joyner, 
2004). On the other hand we hypothesized to observe higher levels of social anxiety 
symptoms and general distress in bodybuilders than in the other two groups; 
nonetheless, it is to note that no studies have explored these characteristics among these 
groups of athletes yet. Lastly, we aimed at assessing the presence of associations 
between MD and related psychological features among the three groups and, with 
exploratory purposes, possible MD predictors among groups. In accordance with the 
meta-analysis of Mitchell and colleagues (2016) we expected a different pattern of 
correlation among groups. With respect to the bodybuilding group we expected positive 
correlations between MD and perfectionistic traits, social anxiety and ON symptoms, 
and general distress, and a negative correlation with self-esteem. We expected this 
pattern of correlations because all of these psychological features are associated with 
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MD (Cafri et al., 2005; Ebbeck et al., 2009; Grieve, 2007; Kuennen & Waldron, 2007; 
Lantz et al., 2001; Olivardia, 2001; Olivardia et al., 2004; Pope et al., 1997). With 
respect to the strength trainer group, in accordance with the meta-analysis of Mitchell 
and colleagues (2016), we expected positive associations between MD and 
perfectionistic traits, social anxiety symptoms, and general distress, and a negative 
correlation between MD and self-esteem. Given that we considered the fitness/wellness 
group as a control group, we expected no significant correlations between MD and 
psychological features within this group. Finally, given that no studies have examined 
MD predictors among the groups of interest, we conducted regression analyses with 
exploratory purposes; therefore, no hypotheses have been made. 
 
4.2 Method 
4.2.1 Participants 
Participants were 125 males who trained regularly for recreational purposes: 
bodybuilders (n = 42; BB group), strength trainers (n = 61; ST group) and 
fitness/wellness trainers (n = 22; FW group). All participants satisfied the following 
general inclusion criteria: at least 18 years of age; absence of severe neurological or 
medical conditions; no current or past psychotic disorders; no evidence of intellectual 
disabilities. The mean age of the total sample was 30.89 (SD = 8.90; range = 19-55) and 
the mean age of education was 15.02 (SD = 2.85; range = 8-21). The majority of 
participants reported to be single (36%) and full employed (46.4%). Groups were 
equivalent with respect to age, years of education, marital status and occupation (p > .05; 
Table 1), whereas differences emerged on BMI (p = .01): Bonferroni post hoc 
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comparisons revealed that the BMI of the ST group was higher than the BMI of the FW 
group (p = .01), whereas the BB group did not differ from neither the ST (p = .06) nor 
the FW (p = .99) groups (Table 1). 
 
Table 1.  
 
Comparisons among bodybuilders (BB group), strength trainers (ST group) and fitness/wellness 
trainers (FW group) on age, education, marital status, occupation and BMI 
 
  BB group  
(N = 42) 
ST group  
(N = 61) 
FW group 
(N = 22) 
χ2 /F df p 
Age  28.17 (8.14) 32.26 (9.08) 32.27 (8.97) 3.05 2,123 .06 
Education  15.10 (2.93) 14.92 (2.73) 15.14 (3.17) .07 2,123 .93 
Marital status (% single)  50 26.23 36.36 8.38 6 .21 
Occupation (%full-employed)  45.24 45.90 50 11.12 10 .35 
BMI  24.77 (2.12) 25.89 (2.36) 24.23 (2.53) 5.32 2,123 .01 
  
4.2.2 Measure 
All participants completed a brief schedule collecting socio-demographic information, 
self-reported weight and height, daily proteins assumption, anabolic-androgenic steroids 
use, and checking weight behaviors. Given that no Italian standardized measures 
assessing Pope et al. (1997) diagnostic criteria for MD were available, an ad hoc self-
report instrument was developed: 
The Pope’s Criteria Questionnaire (PCQ) is a self-report measure assessing Pope et al. 
(1997) diagnostic criteria for MD made up of 4 dichotomous items (Yes/No). The first 
item evaluates the preoccupation with the idea that one’s body is not sufficiently 
muscular and lean. If the answer is positive, the participant is required to express the 
degree of preoccupation (little, moderate, much, very much). The second item assesses 
the presence of compulsive workout, excessive attention to diet and avoidance of 
situations where one’s body is exposed to others in response to concerns about being 
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not sufficiently muscular and lean. The third question assesses the presence of distress 
or impairment in social and occupational functioning because of the concern about 
being not sufficiently muscular and lean. Finally, the last question asks whether the 
main source of concern is not being sufficiently muscular and lean as distinguished 
from fear of fat (as in anorexia nervosa [AN]) or primary preoccupation with other 
aspects of appearance (as in BDD). Participants can be classified as ‘‘probable MD’’ if 
they fulfill all the diagnostic criteria for MD evaluated by the PCQ. 
The Muscle Dysmorphic Disorder Inventory (MDDI; Hildebrandt, Langenbuchert, & 
Schlundt, 2004; Italian version by Santarnecchi & Dèttore, 2012) is a 13 items self-
report questionnaire assessing symptoms associated with muscle dysmorphia (MD) on a 
5 point Likert scale (from 0 = “never” to 4 = “always”). It contains 3 subscales: desire 
for size (DFS), appearance intolerance (AI), and functional impairment (FI); a total 
score can also be computed. The DFS subscale assesses beliefs of being smaller and 
weaker than desired, or wishes to be more muscular. The AI is made up of questions 
regarding negative beliefs and anxiety associated with one’s body and appearance. 
Finally, the FI assesses the presence of negative emotions when deviating from daily 
exercise, or avoidance of social situations because of the preoccupation with one’s body. 
The questionnaire showed good internal consistency, with alpha’s coefficients raining 
from α = .77 to α = .85 (Hildebrandt et al., 2004). The Italian version proved to be 
highly reliable as well, with the exception of the AI subscale (α = .45; Santarnecchi & 
Dèttore, 2012). In the current study, the alpha coefficient was .80 for the DFS scale, .73 
for AI scale and .83 for FI subscale. Finally, the alpha coefficient of the total score 
was .83. 
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The Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965; Italian version by Prezza, 
Trombaccia, & Armento, 1997) consists of 10 items measuring global self-esteem. 
Items are rated on a 4-point Likert scale, ranging from 1 = “strongly disagree” to 4 = 
“strongly agree”, with higher scores representing greater self-esteem. Good internal 
consistency values have been reported for the original RSES, ranging between α = .77 
and α = .88 (Dobson, Goudy, Keith, & Powers, 1979; Fleming & Courtney, 1984; 
Robinson, Shaver, & Wrightsman, 1991). The Italian version showed good 
psychometric properties as well: its internal consistency was α = .84 (Prezza et al., 
1997). The internal consistency coefficient was excellent also in the present sample (α 
= .88). 
The Multidimensional Perfectionism Scale (MPS; Hewitt & Flett, 1991) is a 45 items 
self-report questionnaire designed to assess three different domains of perfectionism: 
self-oriented, socially prescribed and other-oriented. Self-oriented subscale involves 
self-directed perfectionistic behaviors such as setting high standards for oneself; 
socially prescribed subscale involves the perceived need to attain standards prescribed 
by significant others; other-oriented subscale involves place unrealistic standards for 
significant others and places importance on other people being perfect. Each subscale of 
the questionnaire contains 15 items evaluated on a 7-point Likert scale (ranging from 1 
= ”strongly disagree” to 7 = ”strongly agree”), with higher scores indicating greater 
levels of perfectionism. With respect to the original MPS, good internal consistency 
values have been reported, ranging between α = .79 and α = .89 in a student sample 
(Hewitt & Flett, 1991). The Italian validation of the MPS is not available to date, 
therefore an ad hoc translation was employed. In the present sample, the alpha 
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coefficient was α = .89 for the self-oriented scale, α = .80 for the socially prescribed 
scale and α = .72 for the other-oriented perfectionism subscale. 
The Social Phobia Scale (SPS; Mattick & Clarke, 1998; Italian version by Sica et al., 
2007) consists of 20 items assessing situations that involve being observed by others (e. 
g., public speaking, eating in public, etc.). Items are rated on a 5-point Likert scale, 
ranging from 0 = “not at all” to 4 = “extremely”, with higher scores indicating greater 
social phobia. The SPS showed good psychometric properties: its internal consistency 
was α = .90 in a community sample and α = .89 in patients with social phobia. Test-
retest reliability was r = .91 on a 4 weeks period (Mattick & Clarke, 1998). The Italian 
version proved to be highly reliable and stable as well (internal consistency: α = .87; 30-
days test-retest reliability: r = .87; Sica et al., 2007). Internal consistency coefficient 
was excellent in the present sample (α = .89). 
The ORTO-15 (Donini et al., 2005) is a 15 items self-report questionnaire assessing 
orthorexia. The questionnaire evaluates the presence of obsessive attitudes towards 
choice, preparation and consumption of healthy foods on a 4 point Likert scale ranging 
from 1 = “never” to 4 = “always”, with lower scores indicating orthorexic behaviors. 
Cut-off point values can be set depending on the purpose of the study (Donini et al., 
2005). Within the validation sample, the ORTO-15 demonstrated high specificity 
(73.6%) and high negative predictive value (100%) with a threshold value of 40 points 
(Donini et al., 2005).  
The Depression Anxiety Stress Scale-21 (DASS-21; Lovibond & Lovibond, 1995; 
Italian version by Bottesi et al., 2015) is a 21 items self-report questionnaire assessing 
depression, anxiety, and stress on a 4-point Likert scale (ranging from 0 = “did not 
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apply to me at all” to 3 = “applied to me very much”), with higher scores indicating 
greater distress. Three subscale scores and a “general distress” total score can be 
computed (Bottesi et al., 2015). The original DASS-21 demonstrated adequate 
reliability in non-clinical samples, with coefficient alphas ranging from α = .73 to α 
= .81 (Lovibond & Lovibond, 1995). The Italian version proved to be highly reliable as 
well, with internal consistency values ranging from α = .74 to α = .90 in a community 
sample (Bottesi et al., 2015). Given that findings on the Italian version suggested that 
use of the total score, measuring a “general distress” factor, could be more appropriate 
than calculating the three subscale scores separately (Bottesi et al., 2015), for the 
purpose of the present research we focused only on the total score of the questionnaire. 
In the present study, the alpha coefficient for the total DASS was excellent (α = .91). 
4.2.3 Procedure  
Participants were recruited online through links posted on bodybuilding and 
weightlifting discussion forums (http://www.projectinvictus.it; 
http://www.ironmanager.it). All individuals participated on a voluntary basis and 
provided their informed consent clicking agreement before starting to complete the 
survey about male body image and related psychological and psychopathological 
features; participants were also informed about the possibility to withdraw from the 
survey at any stage without explanation. After provided informed consent, participants 
completed the brief schedule collecting socio-demographic information and the self-
report measures; responses were saved on the Google Drive server. Participants took 
approximately 30 minutes to complete the survey. 
The study was conducted in accordance with the Declaration of Helsinki and approved 
by the Ethical Committee of the Psychological Sciences, University of Padova.  
 
 
97 
4.2.4 Statistical Analyses 
In order to assess the presence of differences among groups on socio-demographic 
variables, one-way analyses of variance (ANOVAs) and Chi-squared analyses were 
conducted. Bonferroni post hoc comparisons were computed when significant mean 
differences emerged.  
For participants who satisfied all the diagnostic criteria for MD (i.e., “probable MD”), 
descriptive analyses (means, frequencies and percentages) were computed.  
Chi-squared analyses and one-way ANOVAs were performed in order to compare 
groups (BB group vs. ST group vs. FW group) on behaviors, psychological and 
psychopathological features related to MD; also in this case, Bonferroni post hoc 
comparisons were computed when appropriate. We calculated Pearson’s correlations to 
examine the association between MD and related psychological and psychopathological 
features within each group (BB group, ST group and FW group). Finally, we performed 
3 two-step hierarchical regression analyses within each group (BB group, ST group and 
FW group) to further understand the relation between MD (as measured by MDDI total 
score) and related psychological and psychopathological features (RSES, MPS, SPS and 
ORTO-15): The MDDI Total score was the dependent variable, the DASS-21 Total 
score was always included in the first block, whereas the other variables were entered in 
the second block.  
Conventional significance levels were used (ps < .05). All statistical analyses were 
conducted using IBM SPSS statistics, version 21. 
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4.3 Results 
4.3.1 MD prevalence 
Overall, eight participants (6.4%) satisfied Pope et al. (1997) diagnostic criteria for MD. 
Specifically, 4 participants were bodybuilders, 2 practised strength training and 2 were 
in the fitness/wellness group. No differences among groups emerged with respect to 
MD prevalence (χ22
 
= 1.94; p > .05). The 8 participants with probable MD were aged 
between 19 and 39 years (M = 28.63; SD = 6.19) and their educational level ranged 
between 13 and 20 years (M = 15; SD = 2.58); BMI ranged between 23.59 and 26.87 
(M = 25.55; SD = 1.28). Five out of 8 participants with probable MD were single, 2 
were partnered and 1 was married. Four participants with probable MD were full 
employed, 2 were unemployed, 1 had a part-time job, and 1 was a student.  
With respect to behaviors related to MD, 4 participants reported they had never used 
anabolic-androgenic steroids, 3 reported they had used steroids in the past, and 1 
declared to think about taking them. Five participants with probable MD declared to 
assume more than 2 daily grams of proteins and 3 participants reported to assume an 
amount ranging between 1.2 and 2 grams a day. Concerning checking weight 
behaviours, 6 participants reported to monitor their weight at least once week, 1 
declared to monitor his weight every day and 1 reported to check his weight less than 
once a week.  
4.3.2 MD behaviors and symptoms among groups 
With respect to behaviors related to MD, Chi-squared analyses showed significant 
differences among groups (BB group, ST group and FW group) on daily proteins 
assumption (p = .004) and AAS use (p = .04), whereas no differences among groups 
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emerged on checking weight behaviors (p > .05; Table 2). Indeed, more individuals in 
the BB group reported to think about taking AAS (10 participants vs 4 participants in 
the ST group and no one in the FW group) and to assume more than 2 daily grams of 
proteins (18 participants vs 6 participants in the ST group and 4 participants in the FW 
group). 
With respect to MD symptoms, the ANOVAs revealed significant differences among 
groups on the MDDI. In particular, the BB group scored significantly higher on the DFS 
scale than the ST (p = .001) and the FW (p = .02) groups, whereas no difference 
between the ST and the FW groups emerged (p > .05). Moreover, the BB group scored 
significantly higher on the total score of the MDDI than the FW group (p = .02), while 
the ST group did not differ from neither the BB (p = .21) nor the FW groups (p = .49). 
With respect to others MDDI subscales, no differences among groups emerged 
(ps > .05). Means, standard deviations and comparisons are reported in Table 3. 
 
Table 2.  
Comparisons among bodybuilders (BB group), strength trainers (ST group) and fitness/wellness 
trainers (FW group) on MD related behaviors 
 BB 
group  
(N = 42) 
ST group  
(N = 61) 
FW group 
(N = 22) 
χ2 gdl p 
Daily protein assumption (% > 2 gr) 42.86 9.84 18.18 19.28 6 .004 
AAS use (% yes) 23.81 6.56 0 13.32 6 .04 
Checking weight behaviors (at least 
one time every day) 
21.43 13.11 22.73 8.86 4 .06 
 
4.3.3 Psychological and psychopathological features related to MD among groups 
As far as concern the MPS, significant differences among groups only in the MPS Self-
oriented scale scores emerged. Specifically, the ST group scored significantly higher 
than the FW group (p = .002), whereas the BB group did not differ from both the ST (p 
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= .07) and the FW (p = .39) groups. Groups did not differ as regards scores on the RSES, 
the SPS, the ORTO-15, and the DASS-21 total score (all ps > .05). Means, standard 
deviations and comparisons are reported in Table 3. 
 
Table 3. 
Comparisons among bodybuilders (BB group), strength trainers (ST group) and fitness/wellness 
trainers (FW group) on MD and related psychological features 
 BB group     
(N = 42) 
ST group     
(N = 61) 
FW group     
(N = 22) 
F(1,123) p 
MDDI desire for size  10.31 (4.32) 7.05 (4.18) 7.14 (4.64) 7.85 .001 
MDDI appearance intolerance 4.17 (2.94) 3.93 (3.02) 3.36 (2.84) 3.07 .06 
MDDI functional impairment 6.93 (4.20) 7.34 (3.61) 4.91 (4.51) .53 .59 
MDDI total score 21.40 (8.44) 18.33 (7.83) 15.41 (9.80) 3.90 .02 
RSES 30.74 (4.95) 31.70 (5.41) 32.77 (4.68) 1.17 .31 
MPS self-oriented 68.09 (15.67) 74.98 (15.35) 62.14 (11.61) 6.78 .02 
MPS other-oriented 57.17 (12.52) 60.87 (9.73) 59.91 (9.20) 1.52 .22 
MPS socially prescribed 50.40 (12.97) 54 (13.31) 50 (8.16) 1.41 .25 
SPS total score 16 (10.57) 14.18 (9.64) 12.41 (7.73) 1.05 .35 
ORTO-15 total score 34.31 (3.54) 35.80 (3.44) 35.54 (4.07) 2.24 .11 
DASS-21 total score 17.74 (8.64) 16.97 (9.73) 14.77 (9.77) .73 .48 
 
4.3.4 Associations between MD and related psychological and psychopathological 
features within groups 
With respect to the BB group, significant positive medium-large range associations 
between the MDDI total score and the MPS Socially prescribed scale (r = .39; p = .01), 
the SPS (r = .65; p < .001), and the DASS-21 total score (r = .38; p = .01) emerged, 
whereas significant negative medium range associations between the MDDI total score 
and the RSES (r = -.45; p = .003) and the ORTO-15 (r = -.36; p = .02) were observed. 
No associations between the MDDI total score and both the MPS self-oriented subscale 
(r = .10; p = .26) and the other-oriented subscale emerged (r = -.03; p = .72). 
With respect to the ST and FW groups, significant positive medium-large range 
associations emerged between the MDDI total score and the SPS (r = .48; p < .001 and r 
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= .47; p = .03, respectively) and the DASS-21 total score (r = .37; p = .004 and r = .64; 
p = .001, respectively), whereas a significant negative association with the RSES 
emerged (r = -.37; p = .003 and r = -.64; p = .001, respectively). No associations 
between the MDDI total score and both the MPS scales (ST group: MPS self-oriented, r 
= .18; p = .16; other oriented, r = .08; p = .53; socially prescribed, r = .18; p = .16; FW 
group: self-oriented, r = -.08; p = .71; other oriented, r = -.01; p = .96; socially 
prescribed, r = .19; p = .39) and the ORTO-15 emerged (ST group: r = -.06; p = .66; 
FW group: r = -.03; p = .90). 
4.3.5 Psychological and psychopathological features as predictors of MD 
In light of correlational findings emerged within the BB group, in the first two steps 
hierarchical multiple regression the RSES, the MPS Socially prescribed scale, the SPS, 
and the ORTO-15 were included in the second step. The overall model explained the 
49.1% of the variance in the MDDI total score. The DASS-21 total score entered in the 
first step emerged to significantly predict the MDDI total score, F(1,40) = 6.62, p = .01, 
explaining the 14% of the variation in the MDDI total score. The inclusion of the other 
variables in the second step explained an additional 41% of variation in the MDDI total 
score (F change = 8.27; p < .001). Results revealed that, after controlling for the DASS-
21 total score, the SPS and the ORTO-15 were significant predictors (β =.51 t = 3.95, p 
< .001 and β =-.24 t = -2.12, p = .04, respectively), whereas the RSES and the MPS 
Socially prescribed scale were not (all ps > .05).  
With respect to the ST group, in the two steps hierarchical multiple regression only the 
RSES and the SPS were included in the second step on the base of correlational findings. 
The overall model explained the 23.3% of the variance in the MDDI total score. Results 
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revealed that, at step one, the DASS-21 total score was a significant predictor, F(1,59) = 
9.22, p = .004, and accounted for 13% of the variation in the MDDI total score. Entering 
the other variables in step 2 explained an additional 14% of variation in the MDDI total 
score (F change = .14; p = .01). Results highlighted that, after controlling for the DASS-
21 total score, only the SPS was a significant predictor of the MDDI total score (β = .37 
t = 2.83, p = .01), while the RSES was not (p > .05).  
Lastly, as far as concern the FW group, in the two steps hierarchical multiple regression 
only the RSES and the SPS were included in the second step on the base of correlational 
findings. The overall model explained the 40.4% of the variance in the MDDI total 
score. Findings revealed that, at step one, the DASS-21 total score was a significant 
predictor, F(1,20) = 14.22, p = .001, and accounted for 42% of the variation in the 
MDDI total score. Entering the other variables in step 2 did not explain additional 
variance in the MDDI total score (F change =1.29; p = .30).  
 
4.4 Discussion 
MD is a subtype of BDD (APA, 2013) that is still under-recognized in the Italian 
context, despite its severity and its associated dangerous behaviours. To the Authors’ 
knowledge, to date only one study has assessed MD prevalence in the Italian context, 
and it found a prevalence rate of 3.4% within a bodybuilding group (Cella et al., 2012). 
The current study evidenced a MD prevalence of 6.4% in Italian participants who 
trained regularly for recreational purposes. Our study found a MD prevalence rate 
higher than the one emerged in Cella and colleague’s (2012) study; the higher 
prevalence emerged in the current study may be explained by methodological and 
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sample differences. Indeed, the study by Cella and colleagues (2012) compared a group 
of competitive bodybuilders with a group of non-bodybuilders; on the contrary, our 
study assessed MD prevalence among three groups of athletes involved in weight 
training activity only for recreational purposes (bodybuilders, strength trainers, and 
fitness wellness trainers). Interestingly, we found that 4 participants (9.52%) in the 
bodybuilding group, 2 participants (3.28%) in the strength group and 2 participants 
(9.09%) in the fitness/wellness group satisfied Pope’s et al. (1997) diagnostic criteria 
for MD, and no differences among the groups with respect to MD prevalence rates 
emerged. These findings are in contrast with studies that underlined a higher MD 
prevalence in bodybuilders than in other weightlifting trainers and athletes (Cella et al., 
2012; Lantz et al., 2002; Skemp et al., 2013). These inconsistent findings may be 
explained, once again, by methodological and sample differences. For example, the 
study by Lantz and colleagues (2002) compared elite-level competitive bodybuilders 
with elite-level power lifters, and the study by Skemp and colleagues (2013) focused 
both on competitive and recreational athletes involved in appearance-related weight 
training (such as bodybuilders) and athletes involved in weight training to improve 
strength (such as strength trainers), and found that athletes involved in appearance-
related weight training were at greater risk for MD development. Therefore, the level of 
competition might influence MD development: in other words, competitive athletes 
involved in appearance-related weight training may be at greater risk to develop MD 
than athletes involved in appearance-related weight training for recreational purposes. 
Although no differences among groups with respect to MD prevalence emerged, the BB 
group, as expected, reported more MD related behaviours than the other two groups; 
specifically, the BB group reported more frequently to think about taking AAS and to 
 
 
104 
assume more than 2 daily grams of proteins than the ST group and the FW group. These 
findings are in accordance with studies underlining that being involved in sports that 
reward building muscles and gaining size such as bodybuilding could expose to a 
greater risk to engage in dangerous behaviours such as heavy use of AAS (Grieve, 2007; 
Irving, Wall, Neumark-Sztainer, & Story, 2002). These results are also in accordance 
with studies that affirmed the strict adherence to a high-calorie, high-protein, and low-
fat diet in bodybuilders (Baghurst & Lirgg, 2009; Muller et al., 2004). Furthermore, as 
expected, bodybuilders reported more beliefs about being smaller and weaker than 
desired or wishes to be more muscular than the others two groups. These findings are in 
accordance with the study by Lantz and colleagues (2002), which highlighted that 
bodybuilders are more likely to report body size-symmetry concerns than strength 
trainers because they are primarily interested in lifting weight to develop a 
hypermesomorphic physique, defined by muscular shape and symmetry. Furthermore, 
the BB group reported more general symptomatology related to MD including negative 
emotions when deviating from daily exercise, anxiety associated with one’s body 
appearance, and avoidance of social situations because of the preoccupation with one’s 
body than the FW group, whereas no differences between the BB group and the ST 
group emerged. These results are consistent with those by Blouin and Goldfield (1995), 
who observed that bodybuilders reported greater MD symptomatology than athletes not 
characterized by weight lifting activities, such as runners and martial artists. However, 
our findings are in contrast with the meta-analysis by Mitchell and colleagues (2016) 
revealing that bodybuilders have greater MD symptomatology than other weightlifters. 
Based on the results obtained in the current study, the BB group presents more MD 
behaviours and negative beliefs about being smaller and weaker than desired, or wishes 
 
 
105 
to be more muscular, than the others two groups, but more severe MD symptomatology 
only with respect to the FW group (Babusa & Túry, 2012). Accordingly, the BB group 
and the ST group differed only with respect to the presence of the negative belief of 
being smaller and weaker that desired, whereas negative emotions when deviating from 
daily exercise, anxiety associated with one’s body appearance and avoidance of social 
situations because of the preoccupation with one’s body emerged to be common both in 
the BB group and in the ST group; therefore, the BB group and the ST group are similar 
with respect to MD general symptomatology. 
As far as concern psychological features related to MD, no differences among groups 
emerged with the exception of perfectionistic traits. The ST group reported to set higher 
standards for themselves than the BB group and the FW group, whereas no differences 
between the BB group and the FW group emerged. These findings are partially in line 
with the study by Muller and colleagues (2004), suggesting the presence of higher 
perfectionistic traits in bodybuilders and weightlifters than in non-weightlifters athletes. 
However, the lack of differences in perfectionistic traits between the BB group and both 
the ST and the FW group was unexpected, because the majority of the studies 
underlined that perfectionistic traits are more prevalent in bodybuilders than in other 
athletes (Anderson et al., 1995; Babusa & Túry, 2012; Blouin & Goldfield, 1995). 
However, these studies focused on both competitive and recreational bodybuilders, and 
it may be possible that perfectionistic traits characterize competitive bodybuilders rather 
than recreational bodybuilders.  
The lack of differences with respect to self-esteem and orthorexic behaviours among the 
groups is another unexpected finding: in accordance with other studies, we expected 
lower levels of self-esteem (Blouin & Goldfield, 1995) and higher orthorexic behaviors 
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(Baghurst & Lirgg, 2009; Muller et al., 2004; Olivardia et al., 2000) in the BB group 
than in both the ST and the FW groups. Indeed, some of the most common appearance-
improving behaviours performed by bodybuilders (e.g. weightlifting and strictly 
adherence to rigid diet) might be endorsed because they experience low of self-esteem 
(Crocker, 2002; Klein, 1992). However, these results are partially in accordance with 
the study by Blouin and Goldfield (1995): even though they found lower levels of self-
esteem in bodybuilders than in martial athletes, they did not find any difference in self-
esteem between bodybuilders and runners. Once again, differences in our study may be 
due to sampling methods.    
Also with respect to social anxiety symptoms, in contrast with our expectations, no 
differences among groups emerged. This result, however, is in accordance with the 
meta-analysis by Mitchell and colleagues (2016) concerning symptoms of anxiety and 
social physique anxiety. Mitchell and colleagues (2016) reported that symptoms of 
anxiety and social physique anxiety in bodybuilders are less than, or comparable to, 
those referred by other weight trainers and physically active controls (Hallsworth, Wade, 
& Tiggemann, 2005; Hurst, Hale, & Smith, 2000; Pickett et al., 2005). Also general 
distress did not differ among groups, and also this result is somewhat unexpected given 
that bodybuilders pursuit a lean and muscular physique through strictly workout 
schedule and rigid diet (Olivardia, 2001; Phillips et al., 1997; Pope et al., 1997). Such a 
finding could be explained by the fact that all the athletes involved in the current study 
train for recreational purposes.  
The lack of differences with respect to psychological features related to MD among 
groups, with the exception of perfectionistic traits, may be also explained by the fact 
that groups did not differed in regard to MD prevalence. Nevertheless, even though the 
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FW was conceptualized as a control group, 2 participants within this group satisfied 
Pope’s et al (1997) diagnostic criteria for MD; therefore, also this is group is somewhat 
characterized by MD features.  
In regards to associations between MD and related psychological features among groups, 
in accordance with the meta-analysis by Mitchell and colleagues (2016), different 
correlational patterns emerged. Concerning the BB group, MD symptoms resulted 
positively associated with socially prescribed perfectionism, social anxiety symptoms, 
and general distress. Therefore, the perceived need to attain high standards prescribed 
by others may increase the pursuit of a lean and muscular physique and the related 
functional impairment. In accordance with MD etiological models, perfectionism may 
play a key role in the development and maintenance of MD, both directly and indirectly 
(Davis, Karvinen, & McCreary, 2005; Grieve, 2007). Furthermore, in accordance with 
other studies, MD symptoms resulted associated with marked distress (Olivardia, 2001; 
Phillips et al., 1997; Pope et al., 1997) and with high levels of anxiety experienced in 
social situations when one’s body may be exposed to others (Olivardia, 2001; Pope et 
al., 1997). Moreover, in line with our expectation, MD symptoms resulted negatively 
associated with self-esteem and orthorexic behaviors, in accordance with studies 
underlining that MD symptomatology is associated with low levels of self-esteem (Cafri 
et al., 2005; Grieve, 2007; Kuennen & Waldron, 2007; Lantz et al., 2001; Olivardia, 
2001; Olivardia et al., 2004) and dysfunctional eating patterns characterized by strict 
adherence to a low-fat, high-calorie, and high-protein diet in bodybuilders (Baghurst & 
Lirgg, 2009; Muller et al., 2004). 
Concerning the ST and the FW groups, positive and significant correlations between 
MD symptomatology, social anxiety symptoms, and general distress were observed in 
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both cases. Furthermore, a negative significant correlation between MD and self-esteem 
emerged. These results are partially in accordance with our expectation given that, in 
line with the meta-analysis by Mitchell and colleagues (2016), we expected a positive 
correlation also with perfectionistic traits in the ST group, since perfectionism appears 
to be related to MD symptoms also in these athletes. However, it is noteworthy that the 
ST athletes who entered the current study train for recreational purposes, whereas other 
studies focused on competitive athletes (Skemp et al., 2013); therefore, the level of 
competition may influence the relation between MD and perfectionistic traits within this 
group of athletes. Finally, we expected no significant correlations between MD 
symptoms and related psychological features in the FW group. The emerged 
correlational patterns might be explained in light of the fact that a growing number of 
males are dissatisfied with their appearance (Pope et al., 2000) and because of the 
presence of MD features within this group; indeed, 2 participants within this group 
satisfied Pope’s et al (1997) diagnostic criteria for MD.  
Lastly, as far as concern the exploratory aim of the current study, different prediction 
models among groups emerged. Results showed that within the BB group, MD 
symptomatology was predicted by social anxiety and by othorexic behaviours. 
Therefore, the strictly adherence to diet regimens and the obsession for healthy food 
may contribute to MD development, in accordance with studies affirming that the 
majority of individuals with MD present a dysfunctional eating pattern characterized by 
rigid diet and by the avoidance of the food when its caloric content is unknown (e.g. 
eating food in restaurant; Olivardia, 2001). As regards social anxiety symptoms, the 
emerged findings are in accordance with the study by Chandler, Grieve, Derryberry, and 
Pegg (2009), who underlined that social anxiety symptoms may represent a 
 
 
109 
motivational factor that influence MD symptoms. Indeed, if individuals are anxious 
about how their physique looks, they are more prone to experience a higher level of 
body focus. Because the social ideal for the male body is a hypermesomorphic physique 
(Grieve, Newton, Kelley, Miller, & Kerr, 2005; Parks & Read, 1997; Ridgeway & 
Tylka, 2005), an acceptable way to decrease social anxiety is to develop a drive for 
muscularity. The same mechanism may be involved concerning the ST group; indeed, 
social anxiety symptomatology resulted the only significant predictor of MD 
symptomatology within this group. Finally, concerning the FW group, no psychological 
features related to MD resulted predictive for MD. These results are not surprising 
given that the FW was conceptualized as a control group, even though 2 athletes within 
this group satisfied Pope’s et al (1997) diagnostic criteria.  
Overall, the present findings suggest that the pursuit of a lean and muscular physique in 
bodybuilding is not always associated with MD and psychological related features as 
already suggested by the meta-analysis by Mitchell and colleagues (2016). Therefore, 
although the BB group reported more negative beliefs about being smaller and weaker 
than desired or wishes to be more muscular than the others two groups, bodybuilders as 
a group may not necessarily have psychological features related to MD such as low self-
esteem, high perfectionism, social anxiety symptoms and dysfunctional eating patterns. 
Furthermore, correlational patterns emerged in the current study are partially in 
accordance with our expectations, and regression analyses underlined that orthorexic 
behaviours, as well as social anxiety symptoms, may predict the MD symptomatology 
in bodybuilders. 
To note, the current study is characterized by several limitations, including the small 
sample size and the online recruitment strategy, that under-sampled those without 
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internet capability. Furthermore, online assessment and data collection prevent the 
opportunity of conducting face-to-face interviews of participants self-identifying as 
bodybuilders, strength trainers and fitness/wellness trainers. This might have lead to a 
great heterogeneity, especially within the fitness/wellness group. Such shortcomings 
limit the generalizability of the emerged results. Furthermore, the absence of 
psychometric information for some of the employed measures (e.g., the PCQ and the 
MPS) is another limitation. Future studies overcoming these issues are highly 
recommended.  
To conclude, despite the above-mentioned shortcomings, the present study represents 
one of the first attempts to assess prevalence, phenomenology and possible predictors of 
MD in the Italian context among athletes who trained regularly for recreational purposes. 
Indeed, only few studies have addressed the distinction between pathological versus 
non-pathological pursuit of hypermuscularity within the Italian context. 
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Chapter 5 
General discussion 
Body Dysmorphic Disorder (BDD) is a severe and debilitating psychological disorder 
characterized by concerns about the presence of one or more perceived defects in 
physical appearance that are not observable or appear slight to others (APA, 2013). 
Individuals with BDD exhibit high levels of functional and social impairment, and a 
substantial portion of those individuals (36%-39%) are unable to work due to their 
mental illness (Didie, Menard, Stern, & Phillips, 2008; Phillips, Quinn, & Stout, 2008; 
Veale, Boocock et al., 1996). However, individuals with BDD are often reluctant to 
seek help because they feel ashamed about revealing their concerns about appearance 
(Phillips, 2006). Therefore, many individuals with BDD may ask for non-psychological 
treatment (such as aesthetic plastic surgery or cosmetic medical procedures) in order to 
fix the perceived defects. Nevertheless, these treatments do not typically result in a 
decrease of BDD symptoms severity (Crerand, Phillips, Menard, & Fay, 2005; Phillips, 
Grant, Siniscalchi, & Albertini, 2001; Phillips, McElroy, Keck, Pope, & Hudson, 1993), 
and some patients experience symptoms exacerbation and develop new areas of concern 
(Crerand et al., 2005; Phillips et al., 2001; Veale, 2000; Veale, Boocock et al., 1996). 
Despite its growing prevalence and severity (Veale, Gledhill, Christodoulou, & Hodsoll, 
2016), BDD is still under-recognized or left untreated in a variety of clinical settings, 
especially in the Italian context. For this reason, it is important that mental health 
professionals improve BDD assessment strategies and acquire skills to recognize 
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clinical and subclinical manifestations of BDD, as well as develop effective 
psychological treatments for this disorder. 
The current contribution has been designed to help in terms of BDD conceptualization 
within the Italian context given that it represents the first study aiming at assessing 
BDD prevalence, phenomenology, and at risk populations in Italy.  
Based on the results emerged from the first study, BDD is not a rare condition in Italy 
(1.63%), and its prevalence rate is comparable to the prevalence rates emerged in other 
Countries (e.g., Germany, Sweden). Also the BDD phenomenology observed in Italian 
individuals is comparable to the one reported in other Countries, with the head and the 
face in general as the most common areas of concern in individuals with BDD 
(Cansever, Uzun, Dönmez, & Özşahin, 2003; Phillips et al., 1993; Rief, Buhlmann, 
Wilhelm, Borkenhagen, & Brähler, 2006; Veale, Boocock et al., 1996). In terms of 
BDD epidemiological features, emerged results have underlined that young women are 
at high risk of developing BDD; indeed, the 90% of individuals screened at risk for 
BDD were female and aged between 18 and 28 years old. Furthermore, among these 
young women, the request for surgical cosmetic procedures was high. This information 
is crucial because it suggests that young women may be vulnerable with respect to BDD 
development and may seek non-psychological treatments in order to reduce their 
concerns about physical appearance. Therefore, a screening of BDD among young 
women, especially among those that require cosmetic procedures, may be useful in 
terms of BDD prevention. An early detection of BDD can improve treatment outcomes; 
indeed, early BDD detection, as well as early psychological treatment, represents the 
most important positive prognostic factors in BDD. Findings from this study are crucial, 
because they may lead to a better recognition of BDD in the Italian context, thus 
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providing crucial cues for both diagnostic and therapeutic issues related to this 
challenging disorder. Furthermore, shedding light on BDD prevalence within the Italian 
context might improve assessment and treatment methodologies, as well as raise 
awareness about this under-diagnosed disorder. 
Screening for BDD is also recommended in patients with AN. In line with literature 
(Dingemans, van Rood, de Groot, & van Furth, 2012; Grant, Kim, & Eckert, 2002; 
Kollei, Schieber, Zwaan, Svitak, & Martin, 2013), the results emerged from the second 
study of the present contribution have underlined the high comorbitity (26.23%) 
between these disorders and the high presence of nonweight-related body image 
concerns in patients with AN. Despite the shared clinical features between these 
disorders, the presence of BDD is usually not investigated in patients with AN nor in 
EDs clinical settings. This limitation should be addressed given that the results of the 
present contribution, in accordance with literature studies (Dingemans et al., 2012; 
Grant et al., 2002), underlined that the comorbidity between these disorders confer 
greater overall severity in terms of body image dissatisfaction and clinical 
symptomatology. Furthermore, a diagnosis of BDD in patients with AN might affect 
treatment choice. Indeed, standard AN treatment programs are usually focused almost 
exclusively on the ED pathology and have limited efficacy in body image improvement 
(Rosen, 1996); indeed, the degree of clinical significant change is much greater for 
disturbance in eating behaviours than for body image (Davis, Olmsted, & Rockert, 1990; 
Rosen, 1990; Rosen, 1996). However, the intense body dissatisfaction may persist after 
a successful treatment for AN and the persistence of body dissatisfaction is a reliable 
predictor for relapse (Marco, Perpina, & Botella, 2013; Stice & Shaw, 2002). Therefore, 
especially when BDD and AN are comorbid, a psychological intervention should target 
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both eating pathology and body image. Thus, psychological treatments focused 
specifically on improving body image disturbance, such as mirror retraining, cognitive 
restructuring, exposure and response prevention (Key et al., 2002; Veale & Neziroglu, 
2010), may be promising in patients with both disorders. Given these findings, a careful 
assessment of body image, nonweight-related body image concerns and BDD symptoms 
and related clinical features in patients with AN is recommended, even though generally 
neglected in clinical practice. 
Lastly, male athletes could be at high risk to develop a subtype of BDD, the Muscle 
Dysmorphia (MD). MD is an under-recognized disorder, especially in the Italian 
context, characterized by preoccupation with the idea that one’s body is not sufficiently 
lean and muscular (APA, 2013). Individuals with MD are characterized by impairment 
in social and occupational functioning, distress, and adoption of unhealthy behaviors 
such as rigid adherence to dietary regimes and anabolic-androgenic steroids (AAS) use 
(Olivardia, Pope, & Hudson, 2000; Phillips, O’ Sullivan, & Pope, 1997; Pope, Gruber, 
Choi, Olivardia, & Phillips, 1997). Results from the third study of the current 
contribution have underlined that MD is not uncommon in the Italian weightlifting 
context (6.4%) and, in accordance with previous studies (Pope et al., 1997; Pope, Katz, 
& Hudson, 1993), have highlighted the presence of MD related behaviors and features 
in bodybuilders and strength trainers. Furthermore, orthorexic behaviors and social 
anxiety symptoms resulted the most relevant predictors of MD symptomatology within 
the bodybuilding group. This information is crucial since it may lead to a better 
understanding and recognition of MD in the Italian context. Furthermore, improving the 
identification of risk factors and predictors for MD, as well as associated psychological 
features in the Italian context, might facilitate the development of prevention strategies 
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and intervention, as well as the identification of at risk trainers. Furthermore, a deeper 
understanding of MD manifestation among athletes may help to distinguish individuals 
participating in a healthy manner versus those participating in an unhealthy manner.  
The current contribution is characterized by several limitations. First of all, the small 
sample size is a common shortcoming across all the studies that implies low power and 
makes difficult drawing generalizable conclusions. Furthermore, we used self-report 
questionnaires rather than clinical structured interviews, which represent the gold 
standard to identify people with probable BDD and MD and to assess associated 
psychological and psychopathological features; future studies should employ clinical 
structured interviews as well as cognitive tasks and/or implicit measures to assess some 
of the psychological features related to BDD and MD. Finally, the absence of 
psychometric information for some of the self-report questionnaires employed across 
the three studies represents a further limitation. Future studies overcoming these issues 
are highly recommended. 
Overall, despite the above-mentioned shortcomings, the present contribution represents 
the first research attempting to shed further light on the conceptualization of BDD and 
one of its subtypes (MD) in the Italian context. Future studies focused on BDD 
psychological treatments in the Italian context are recommended, given that CBT 
treatments have already demonstrated their effectiveness in the majority of the studies 
conducted in other Countries (Williams, Hadjistavropoulos, & Sharpe, 2006), but 
studies on this topic within the Italian context are lacking. Furthermore, research aiming 
at investigating and clarifying BDD etiology and pathophysiology is recommended. 
Such investigation will clarify the relation between BDD and other disorders that share 
clinical features and provide new leads for treatment and prevention strategies.  
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Finally, research on other at risk populations such as patients with EDs other than AN 
and people who seek and undergo to aesthetic plastic surgery or cosmetic medical 
procedures are highly recommended. Indeed, results emerged from a preliminary study 
still in progress are in line with the importance of assessing the prevalence of BDD and 
its related psychological and psychopathological features in individuals who seek 
aesthetic plastic surgery and cosmetic medical procedures. In particular, preliminary 
findings showed that the 23.08% of 23 patients (21 females and 2 males) seeking 
aesthetic plastic surgery and other appearance-enhancing medical treatments satisfied 
DSM-5 (APA, 2013) diagnostic criteria for BDD. The most common aesthetic 
procedures required by all the 23 patients were: rhinoplasty (17.07%), laser treatment 
(17.07%), filler injection (12.19%), and liposuction (7.32%). Furthermore, this group, 
compared with a matched healthy control group, reported higher dysmorphic concerns, 
obsessive-compulsive symptomatology, levels of self-oriented perfectionism, general 
distress, and dysfunctional eating attitudes. Consistently with literature evidence 
(Phillips et al., 2001; Sarwer & Crerand, 2008; Sarwer, Crerand, & Magee, 2010; Veale, 
De Haro, & Lambrou, 2003), these preliminary results highlighted that individuals who 
seek cosmetic procedures in order to improve their satisfaction about physical 
appearance reported an higher prevalence rate and more severe psychopathological 
symptoms than a control group. Despite rather interesting, such data are only 
preliminary, and further studies further exploring BDD features in individuals who seek 
aesthetic surgery and other appearance-enhancing medical treatments are recommended. 
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Informativa ex art.13 D. Lgs. 196/2003 per il trattamento di dati sensibili 
 
Gentile Signore/a, 
ai sensi del D.Lgs. 196/2003, sulla tutela delle persone e di altri soggetti rispetto al trattamento dei dati 
personali, il trattamento delle informazioni che La riguardano, sarà improntato ai principi di correttezza, 
liceità e trasparenza e tutelando la Sua riservatezza e i Suoi diritti. 
In particolare, i dati personali possono essere oggetto di trattamento solo con il consenso scritto 
dell'interessato e previa autorizzazione del Garante per la protezione dei dati personali (articolo 26).  
  
Ai sensi dell'articolo 13 del predetto decreto, La informiamo che, nei limiti dell’Autorizzazione generale 
del Garante n.2/2004: 
1. I dati sensibili da Lei forniti verranno trattati per la finalità della ricerca denominata “Indagine 
esplorativa inerente l’immagine corporea ”. La presente ricerca ha l’obiettivo di indagare la 
percezione dell’immagine corporea nella popolazione generale, in coloro che si sottopongono a 
interventi di chirurgia plastica e di medicina/dermatologia estetica e in individui che presentano 
disturbi psicologici (disturbo di dismorfismo corporeo, disturbi del comportamento alimentare, fobia 
sociale e disturbo ossessivo compulsivo). Inoltre, la presente ricerca si propone di indagare la 
qualità della vita, le caratteristiche psicologiche (ad esempio, perfezionismo) e psicopatologiche (ad 
esempio, ansia, depressione) inerenti l’immagine corporea nei sopracitati gruppi di individui. Infine, 
la ricerca si pone come fine la validazione di questionari self-report volti all’indagine dei disturbi 
dell’immagine corporea. 
2. Gli sperimentatori non comunicheranno a nessuno i dati raccolti; garantendone la riservatezza, i 
dati raccolti potranno essere utilizzati solo nell’ambito della presente ricerca scientifica 
(elaborazione ed eventuale pubblicazione scientifica presentando i dati grezzi medi che non 
rendono individuabili i singoli partecipanti).Il partecipante avrà il diritto di interrompere in qualsiasi 
momento la ricerca senza fornire alcuna spiegazione e senza penalizzazione alcuna e ottenendo il 
non utilizzo dei propri dati. 
3. Qualora il partecipante richiedesse la restituzione dei propri punteggi grezzi, questa gli verrà 
fornita. In caso di risultati di rilevanza clinica è possibile rivolgersi alla responsabile della ricerca 
(Dott.ssa Marta Ghisi: marta.ghisi@unipd.it) per informarla e ottenere chiarificazioni a riguardo. 
4. Il partecipante potrà esercitare i propri diritti ai sensi dell'articolo 7 del D.lgs.196/2003, che 
regolamenta il diritto di accesso ai dati personali. Il partecipante alla ricerca ha il diritto di ottenere 
la conferma dell'esistenza di dati personali che lo riguardano, anche se non ancora registrati, e la 
loro comunicazione. L’interessato, inoltre, ha il diritto di ottenere l’indicazione delle finalità e delle 
modalità di trattamento dei dati, la logica applicata in caso di trattamento effettuato con l’ausilio di 
strumenti elettronici e gli estremi indicativi del responsabile del trattamento dei dati. Il 
partecipante, inoltre, ha il diritto di ottenere l’aggiornamento e l’integrazione dei dati in caso di 
interesse, oltre che la cancellazione dei dati. L’interessato, infine, ha diritto di opporsi al 
trattamento dei dati personali che lo riguardano, anche se pertinenti con gli scopi della ricerca. 
 
Formula di acquisizione del consenso per il trattamento di dati sensibili 
 
Luogo……………………………., Data………………………………. Cognome .................................   Nome ............... 
  
Il/La sottoscritto/a, acquisite le informazioni fornite dal titolare del trattamento ai sensi dell'art. 
13 del D.lgs. n. 196/2003, e consapevole, in particolare, che il trattamento riguarderà i dati "sensibili" di 
cui all'art.4 comma 1 lett. d), nonché art.26 del D.lgs.196/2003, vale a dire i dati "idonei a rivelare 
l'origine razziale ed etnica, le convinzioni religiose, filosofiche o di altro genere, le opinioni politiche, 
l'adesione a partiti, sindacati, associazioni od organizzazioni a carattere religioso, filosofico, politico o 
sindacale, nonché i dati personali idonei a rivelare lo stato di salute e la vita sessuale"; 
 
- presta il suo consenso per il trattamento dei dati necessari allo svolgimento delle operazioni 
indicate nell’informativa. 
 
Firma leggibile ....................................................................... 
 
- presta il suo consenso per la diffusione dei dati nell’ambito indicato nell’informativa 
 
Firma leggibile ....................................................................... 
 
- Il/la sottoscritto/a dichiara inoltre: (1) di non essere stato/a in alcun modo forzato/a alla partecipazione, (2) 
di essere stato/a informato/a sulla possibilità di abbandonare in qualsiasi momento la ricerca stessa senza 
penalizzazione alcuna  e ottenendo il non utilizzo dei propri dati 
Firma leggibile .......................................................................  
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Informativa ex art.13 D. Lgs. 196/2003 per il trattamento di dati sensibili 
 
Gentile Signore/a, 
 
ai sensi del D.Lgs. 196/2003, sulla tutela delle persone e di altri soggetti rispetto al trattamento dei dati 
personali, il trattamento delle informazioni che La riguardano sarà improntato ai principi di correttezza, 
liceità e trasparenza e tutelando la Sua riservatezza e i Suoi diritti. 
 
In particolare, i dati personali possono essere oggetto di trattamento solo con il consenso scritto 
dell'interessato e previa autorizzazione del Garante per la protezione dei dati personali (articolo 26).  
  
Ai sensi dell'articolo 13 del predetto decreto, La informiamo che, nei limiti dell’Autorizzazione generale 
del Garante n.2/2004: 
1. I dati sensibili da Lei forniti verranno trattati per la finalità della ricerca denominata “Indagine delle 
caratteristiche psicologiche delle persone che si allenano in palestra”, i cui responsabili sono la 
Prof.ssa Marta Ghisi e il Prof. Antonio Paoli, che svolgono la propria attività presso il Dipartimento 
di Psicologia Generale e il Dipartimento di Scienze Biomediche, Università degli studi di Padova. La 
presente ricerca ha l’obiettivo di indagare le caratteristiche psicologiche (ad esempio, percezione 
dell’immagine corporea, perfezionismo, autostima) negli individui che si allenano in palestra.  
2. Gli sperimentatori non comunicheranno a nessuno i dati raccolti; garantendone la riservatezza, i 
dati raccolti potranno essere utilizzati solo nell’ambito della presente ricerca scientifica 
(elaborazione ed eventuale pubblicazione scientifica presentando i dati grezzi medi che non 
rendono individuabili i singoli partecipanti). Il partecipante avrà il diritto di interrompere in qualsiasi 
momento la ricerca senza fornire alcuna spiegazione e senza penalizzazione alcuna e ottenendo il 
non utilizzo dei propri dati. 
3. Per avere ulteriori informazioni inerenti la ricerca o per richiedere informazioni inerenti i propri 
punteggi le richieste vanno inoltrate al seguente indirizzo e-mail: unipd.sportresearch@gmail.com. 
4. Il partecipante potrà esercitare i propri diritti ai sensi dell'articolo 7 del D.lgs.196/2003, che 
regolamenta il diritto di accesso ai dati personali. Il partecipante alla ricerca ha il diritto di ottenere 
la conferma dell'esistenza di dati personali che lo riguardano, anche se non ancora registrati, e la 
loro comunicazione. L’interessato, inoltre, ha il diritto di ottenere l’indicazione delle finalità e delle 
modalità di trattamento dei dati, la logica applicata in caso di trattamento effettuato con l’ausilio di 
strumenti elettronici e gli estremi indicativi del responsabile del trattamento dei dati. Il 
partecipante, inoltre, ha il diritto di ottenere l’aggiornamento e l’integrazione dei dati in caso di 
interesse, oltre che la cancellazione dei dati. L’interessato, infine, ha diritto di opporsi al 
trattamento dei dati personali che lo riguardano, anche se pertinenti con gli scopi della ricerca. 
 
Formula di acquisizione del consenso per il trattamento di dati sensibili 
 
Luogo……………………………., Data………………………………. 
 
Cognome .................................   Nome ................................... 
  
Il/La sottoscritto/a, acquisite le informazioni fornite dal titolare del trattamento ai sensi dell'art. 
13 del D.lgs. n. 196/2003, e consapevole, in particolare, che il trattamento riguarderà i dati "sensibili" di 
cui all'art.4 comma 1 lett. d), nonché art.26 del D.lgs.196/2003, vale a dire i dati "idonei a rivelare 
l'origine razziale ed etnica, le convinzioni religiose, filosofiche o di altro genere, le opinioni politiche, 
l'adesione a partiti, sindacati, associazioni od organizzazioni a carattere religioso, filosofico, politico o 
sindacale, nonché i dati personali idonei a rivelare lo stato di salute e la vita sessuale"; 
 
- presta il suo consenso per il trattamento dei dati necessari allo svolgimento delle operazioni 
indicate nell’informativa. 
 
Firma leggibile ....................................................................... 
 
- presta il suo consenso per la diffusione dei dati nell’ambito indicato nell’informativa 
 
Firma leggibile ....................................................................... 
 
- Il/la sottoscritto/a dichiara inoltre: (1) di non essere stato/a in alcun modo forzato/a alla partecipazione, (2) 
di essere stato/a informato/a sulla possibilità di abbandonare in qualsiasi momento la ricerca stessa senza 
penalizzazione alcuna  e ottenendo il non utilizzo dei propri dati 
 
Firma leggibile .......................................................................  
